Source,Text,Link,Verb,Original_Form,Context
Abstract,"""Molecular Mechanisms of Treatment Resistance in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33396284,include,include,of treating glioblastoma are many and include inadequate drug or agent delivery
Abstract,"""Molecular Mechanisms of Treatment Resistance in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33396284,emphasize,emphasizing,"mechanisms underlying glioblastoma's treatment resistance, emphasizing the intrinsic challenges therapeutic"
Title,"""Recurrent Glioblastoma-Molecular Underpinnings and Evolving Treatment Paradigms.""",https://pubmed.ncbi.nlm.nih.gov/38928445,evolve,evolving,recurrent glioblastoma-molecular underpinnings and evolving treatment paradigms.
Abstract,"""Recurrent Glioblastoma-Molecular Underpinnings and Evolving Treatment Paradigms.""",https://pubmed.ncbi.nlm.nih.gov/38928445,include,include,"implicated in glioblastoma recurrence include aberrant molecular pathways, a recurrence-"
Abstract,"""Recurrent Glioblastoma-Molecular Underpinnings and Evolving Treatment Paradigms.""",https://pubmed.ncbi.nlm.nih.gov/38928445,remain,remains,"in recurrent glioblastoma; however, its use remains controversial."
Abstract,"""Recurrent Glioblastoma-Molecular Underpinnings and Evolving Treatment Paradigms.""",https://pubmed.ncbi.nlm.nih.gov/38928445,include,including,"for recurrent glioblastoma, including checkpoint inhibitors, chimeric antigen receptor t"
Abstract,"""Glioblastoma multiforme: Pathogenesis and treatment.""",https://pubmed.ncbi.nlm.nih.gov/25944528,account,accounts,glioblastoma multiforme (gbm) accounts for more than half
Abstract,"""Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.""",https://pubmed.ncbi.nlm.nih.gov/36809318,infiltrate,infiltrating,"tumors are glioblastomas, and 30% are diffusely infiltrating lower-"
Abstract,"""Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.""",https://pubmed.ncbi.nlm.nih.gov/36809318,improve,improved,"patients with glioblastoma, the combination of temozolomide with radiotherapy improved survival"
Abstract,"""Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.""",https://pubmed.ncbi.nlm.nih.gov/36809318,follow,followed,therapy for glioblastoma is surgery followed by radiation and the alkylating chemotherapeutic
Abstract,"""Medicinal Plants for Glioblastoma Treatment.""",https://pubmed.ncbi.nlm.nih.gov/34939551,demonstrate,demonstrates,"glioblastoma, an aggressive brain cancer, demonstrates the least"
Abstract,"""Medicinal Plants for Glioblastoma Treatment.""",https://pubmed.ncbi.nlm.nih.gov/34939551,use,used,valuable for glioblastoma prevention and its incidence by effectively being used as
Abstract,"""Molecular targeted therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31541850,think,thought,glioblastomas are intrinsic brain tumors thought to originate from neuroglial
Abstract,"""Molecular targeted therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31541850,exhibit,exhibit,", uncommon glioblastoma subsets may exhibit specific vulnerabilities amenable to targeted interventions"
Abstract,"""Focused ultrasound for the treatment of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35267132,make,making,"biopsy in glioblastoma, and making device modifications that better support clinical"
Abstract,"""Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25791797,grade,grade,"unfortunately, glioblastoma, the most aggressive (who grade iv)"
Abstract,"""Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25791797,profit,profited,"unfortunately, glioblastoma multiforme (gbm) patients have not yet profited"
Abstract,"""Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25791797,demonstrate,demonstrate,many infiltrative glioblastoma cells that demonstrate 'within-organ-metastasis
Abstract,"""Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25791797,deserve,deserves,delivery in glioblastoma deserves explicit attention as otherwise new experimental therapies will
Abstract,"""Glioblastoma and other malignant gliomas: a clinical review.""",https://pubmed.ncbi.nlm.nih.gov/24193082,base,based,newly diagnosed glioblastoma is based on radiotherapy combined with temozolomide.
Abstract,"""Glioblastoma and other malignant gliomas: a clinical review.""",https://pubmed.ncbi.nlm.nih.gov/24193082,remain,remains,"relevance: glioblastoma remains a difficult cancer to treat, although therapeutic"
Title,"""Investigational treatment strategies in glioblastoma: progress made and barriers to success.""",https://pubmed.ncbi.nlm.nih.gov/37796104,make,made,strategies in glioblastoma: progress made and barriers to success.
Abstract,"""Investigational treatment strategies in glioblastoma: progress made and barriers to success.""",https://pubmed.ncbi.nlm.nih.gov/37796104,remain,remains,"introduction: glioblastoma, isocitrate dehydrogenase wildtype (idhwt), remains"
Title,"""Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.""",https://pubmed.ncbi.nlm.nih.gov/36851761,emerge,emerging,developments in glioblastoma therapy: oncolytic viruses and emerging future strategies.
Abstract,"""Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.""",https://pubmed.ncbi.nlm.nih.gov/36851761,describe,describe,virotherapy for glioblastomas and describe several ovs and their combination with other
Abstract,"""Exosomes: Their role in the diagnosis, progression, metastasis, and treatment of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38806071,improve,improved,prognosis of glioblastoma can be improved.
Abstract,"""Exosomes: Their role in the diagnosis, progression, metastasis, and treatment of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38806071,show,show,treatment of glioblastoma and show how they can be modified for this
Abstract,"""Treatment of Glioblastoma in Older Adults.""",https://pubmed.ncbi.nlm.nih.gov/29075865,diagnose,diagnosed,glioblastoma is the most common primary malignant brain tumor diagnosed
Abstract,"""Treatment of Glioblastoma in Older Adults.""",https://pubmed.ncbi.nlm.nih.gov/29075865,exclude,excluded,temozolomide in glioblastoma excluded patients more than 70 years of age.
Abstract,"""Treatment of Glioblastoma in Older Adults.""",https://pubmed.ncbi.nlm.nih.gov/29075865,discuss,discusses,treatment of glioblastoma in the elderly population and discusses results of recent
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,recur,recur,", primary glioblastomas invariably recur as aggressive, therapy-resistant relapses"
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,emerge,emerging,of recurrent glioblastoma is just slowly emerging.
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,ask,ask,on recurrent glioblastoma and ask whether and how therapies change intra-
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,determine,determine,"in recurrent glioblastoma will determine, whether, one day, glioblastoma"
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,contain,contained,"day, glioblastoma can be contained in a state of chronic disease"
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,rank,ranks,glioblastoma ranks among the most lethal of all human cancers
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,display,display,"glioblastomas display striking cellular heterogeneity, with stem-like"
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,induce,induce,glioblastomas induce a systemic immunosuppression with mixed responses to oncoimmunologic
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,offer,offers,"collectively, glioblastoma offers a reliable cancer to study cancer stem cells"
Abstract,"""Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.""",https://pubmed.ncbi.nlm.nih.gov/30632816,remain,remains,survival for glioblastoma remains poor.
Abstract,"""Immunotherapy for the treatment of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22290259,thrive,thrives,"glioblastoma, the most aggressive primary brain tumor, thrives"
Abstract,"""Current status and recent advances in reirradiation of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33602305,recur,recur,"gliomas (glioblastomas, gbm) will recur locally within 2 years"
Abstract,"""ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37059335,take,took,"concerning contemporary glioblastoma target delineation, then took part in a two"
Abstract,"""Can we rely on synthetic pharmacotherapy for the treatment of glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/34219576,remain,remains,treatment of glioblastoma remains one of the most formidable challenges in oncology
Abstract,"""Can we rely on synthetic pharmacotherapy for the treatment of glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/34219576,cover,covered,options for glioblastoma patients.areas covered: this study reviews synthetic pharmacotherapies that
Abstract,"""Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance.""",https://pubmed.ncbi.nlm.nih.gov/30049045,contribute,contributes,heterogeneity in glioblastoma contributes to significant therapeutic resistance by preventing adequate control
Abstract,"""Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance.""",https://pubmed.ncbi.nlm.nih.gov/30049045,promote,promote,"characteristics of glioblastoma promote resistance to chemotherapy, radiation, and immunotherapy"
Abstract,"""Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance.""",https://pubmed.ncbi.nlm.nih.gov/30049045,prevent,prevent,cascades in glioblastoma prevent effective treatments through the optimization of glucose use
Abstract,"""Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance.""",https://pubmed.ncbi.nlm.nih.gov/30049045,recognize,recognizes,"treatment of glioblastoma, as the field recognizes and addresses these difficulties"
Abstract,"""Progress and prospect in tumor treating fields treatment of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34214730,challenge,challenging,glioblastoma (gbm) is a challenging cancer with poor
Abstract,"""Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology.""",https://pubmed.ncbi.nlm.nih.gov/32194864,exhibit,exhibited,therapies for glioblastoma via systemic administration are exhibited in this review.
Abstract,"""A vasculature-centric approach to developing novel treatment options for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33482697,characterize,characterized,introduction: glioblastoma is invariably deadly and is characterized by extensive vascularization
Abstract,"""A vasculature-centric approach to developing novel treatment options for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33482697,cover,covered,angiogenics in glioblastoma remains.areas covered: resistance to anti-angiogenics is
Abstract,"""A vasculature-centric approach to developing novel treatment options for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33482697,support,supports,immunosuppression in glioblastoma supports the use of anti-angiogenics in combination
Title,"""Combined BNCT-CIRT treatment planning for glioblastoma using the effect-based optimization.""",https://pubmed.ncbi.nlm.nih.gov/38048635,use,using,planning for glioblastoma using the effect-based optimization.
Abstract,"""Combined BNCT-CIRT treatment planning for glioblastoma using the effect-based optimization.""",https://pubmed.ncbi.nlm.nih.gov/38048635,consider,considering,"diagnosed with glioblastoma, considering the different radiosensitivity and fraction."
Abstract,"""Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/26070553,characterize,characterized,glioblastoma multiforme (gbm) is characterized as one of
Abstract,"""Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.""",https://pubmed.ncbi.nlm.nih.gov/33178210,occur,occurring,glioblastoma multiforme (gbm) is the most frequently occurring
Abstract,"""Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis.""",https://pubmed.ncbi.nlm.nih.gov/39560695,associate,associated,) in glioblastoma is rare and associated with perceived poor prognosis.
Abstract,"""Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis.""",https://pubmed.ncbi.nlm.nih.gov/39560695,grade,grade,newly diagnosed glioblastoma (cns who grade 4) were assessed.
Abstract,"""Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis.""",https://pubmed.ncbi.nlm.nih.gov/39560695,treat,treated,suggests that glioblastomas with multiple lesions treated with multimodal therapy equal survival
Abstract,"""Glioblastoma treatment guidelines: Consensus by the Spanish Society of Neurosurgery Tumor Section.""",https://pubmed.ncbi.nlm.nih.gov/32690400,start,starts,introduction: glioblastoma (gbm) treatment starts in most patients with
Abstract,"""Perspectives for immunotherapy in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25210870,grow,growing,to fight glioblastoma is growing.
Abstract,"""Perspectives for immunotherapy in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25210870,lysate,lysate,to present glioblastoma antigens (whole tumor lysate) to the immune
Abstract,"""Perspectives for immunotherapy in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25210870,start,start,cells with glioblastoma stem-like cells will start soon.
Title,"""Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022.""",https://pubmed.ncbi.nlm.nih.gov/36718723,move,moves,glioblastoma treatment slowly moves toward change: novel druggable targets
Abstract,"""An Innovative Immunotherapy Vaccine with Combination Checkpoint Blockade as a First Line Treatment for Glioblastoma in the Context of Current Treatments.""",https://pubmed.ncbi.nlm.nih.gov/32158049,benefit,benefited,patients with glioblastoma have not benefited from these new therapies and techniques
Abstract,"""An Innovative Immunotherapy Vaccine with Combination Checkpoint Blockade as a First Line Treatment for Glioblastoma in the Context of Current Treatments.""",https://pubmed.ncbi.nlm.nih.gov/32158049,combine,combining,in treating glioblastoma through combining a personalized vaccine with new immunotherapy drugs
Abstract,"""Molecular targets in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25952786,consist,consists,"treatment for glioblastoma consists of neurosurgery, followed by radiotherapy and temozolomide"
Abstract,"""Molecular targets in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25952786,allow,allowed,heterogeneity in glioblastoma pathogenesis allowed the design of novel targeted therapies.
Abstract,"""The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.""",https://pubmed.ncbi.nlm.nih.gov/38318180,associate,associated,"yet, glioblastoma-associated changes in peripheral blood immune composition are"
Abstract,"""The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.""",https://pubmed.ncbi.nlm.nih.gov/38318180,hypothesize,hypothesized,administration in glioblastoma patients have been hypothesized to limit the effectiveness of
Abstract,"""The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.""",https://pubmed.ncbi.nlm.nih.gov/38318180,have,had,results: glioblastoma patients had significantly fewer naive cd4+ t cells
Abstract,"""The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.""",https://pubmed.ncbi.nlm.nih.gov/38318180,influence,influenced,"cells in glioblastoma patients were influenced by age and dexamethasone treatment,"
Abstract,"""Treatment of glioblastoma in elderly patients: an overview of current treatments and future perspective.""",https://pubmed.ncbi.nlm.nih.gov/21302607,include,includes,"treatment of glioblastoma in the elderly includes surgery, radiotherapy and chemotherapy"
Abstract,"""Treatment of glioblastoma in elderly patients: an overview of current treatments and future perspective.""",https://pubmed.ncbi.nlm.nih.gov/21302607,show,showing,"patients with glioblastoma, showing survival benefits compared with supportive care alone"
Abstract,"""Treatment of glioblastoma in elderly patients: an overview of current treatments and future perspective.""",https://pubmed.ncbi.nlm.nih.gov/21302607,emerge,emerging,"adults with glioblastoma, is emerging as an effective therapeutic option for"
Abstract,"""Omics sciences and precision medicine in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37994751,have,have,"understanding of glioblastoma biology, and precision medicine approaches have impli-"
Abstract,"""Omics sciences and precision medicine in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37994751,show,shown,"approaches for glioblastoma, and several biomarkers have shown promise in predicting"
Abstract,"""Omics sciences and precision medicine in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37994751,be,is,"approaches in glioblastoma, but there is still a need to improve"
Abstract,"""Omics sciences and precision medicine in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37994751,face,faces,"medicine in glioblastoma treatment faces challenges related to patient selection, drug"
Abstract,"""Treatment options for recurrent glioblastoma: pitfalls and future trends.""",https://pubmed.ncbi.nlm.nih.gov/19445578,increase,increased,"newly diagnosed glioblastoma has increased the median overall survival and, more"
Title,"""Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy.""",https://pubmed.ncbi.nlm.nih.gov/38380331,leverage,leveraging,understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase
Abstract,"""Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy.""",https://pubmed.ncbi.nlm.nih.gov/38380331,account,accounts,glioblastoma (gbm) accounts for approximately half of all
Abstract,"""Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.""",https://pubmed.ncbi.nlm.nih.gov/36357498,evaluate,evaluate,"unilateral and glioblastoma with bilateral corpus callosum infiltration, and to evaluate"
Abstract,"""Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.""",https://pubmed.ncbi.nlm.nih.gov/36357498,include,included,newly diagnosed glioblastoma from 2010 to 2019 were included.
Abstract,"""Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.""",https://pubmed.ncbi.nlm.nih.gov/36357498,have,had,glioblastoma with corpus callosum affection had significantly lower median overall
Abstract,"""Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.""",https://pubmed.ncbi.nlm.nih.gov/36357498,reveal,revealed,analysis of glioblastoma with unilateral corpus callosum infiltration revealed a significant difference
Abstract,"""Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.""",https://pubmed.ncbi.nlm.nih.gov/21214925,prolong,prolong,"newly diagnosed glioblastoma can prolong survival, but it is not curative"
Abstract,"""Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.""",https://pubmed.ncbi.nlm.nih.gov/21214925,associate,associated,with recurrent glioblastoma; combination treatment was associated with an estimated 6
Abstract,"""Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.""",https://pubmed.ncbi.nlm.nih.gov/21214925,progress,progressed,treatment of glioblastoma that has progressed following prior therapy.
Abstract,"""Engineered cells as glioblastoma therapeutics.""",https://pubmed.ncbi.nlm.nih.gov/33753869,lead,led,"biology of glioblastoma, to date, this has not led to"
Abstract,"""Engineered cells as glioblastoma therapeutics.""",https://pubmed.ncbi.nlm.nih.gov/33753869,show,show,therapies for glioblastoma and show some evidence for activity.
Abstract,"""Current Advances in Immunotherapy for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33496872,limit,limited,"application in glioblastoma, which has limited response to other treatments."
Abstract,"""Current Advances in Immunotherapy for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33496872,remain,remains,treatment of glioblastoma remains a serious challenge both with regard to immune
Abstract,"""Current Advances in Immunotherapy for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33496872,illustrate,illustrating,"success in glioblastoma, illustrating the challenging and complex nature of this"
Abstract,"""[What type of adjuvant chemotherapy should be proposed for the initial treatment of glioblastoma?].""",https://pubmed.ncbi.nlm.nih.gov/17350791,deliver,deliver,cavity after glioblastoma resection to deliver local chemotherapy.
Abstract,"""[What type of adjuvant chemotherapy should be proposed for the initial treatment of glioblastoma?].""",https://pubmed.ncbi.nlm.nih.gov/17350791,carmustine,carmustine,"months in glioblastomas, and carmustine a similar benefit in high-"
Abstract,"""Viral Control of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34209584,reside,reside,response against glioblastomas because they reside in the brain (an immunologically
Abstract,"""Viral Control of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34209584,inhabit,inhabit,glioblastomas inhabit the brain like sand in the grass and
Abstract,"""Overcoming delivery barriers in immunotherapy for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34053034,change,changed,prognosis for glioblastoma patients has changed little in the past two decades
Title,"""Glioblastoma: changing expectations?""",https://pubmed.ncbi.nlm.nih.gov/21493184,change,changing,glioblastoma: changing expectations?
Abstract,"""Glioblastoma: changing expectations?""",https://pubmed.ncbi.nlm.nih.gov/21493184,represent,represents,glioblastoma (gb) represents the most aggressive glioma in
Title,"""Glioblastoma-activated pericytes support tumor growth via immunosuppression.""",https://pubmed.ncbi.nlm.nih.gov/29479841,activate,activated,glioblastoma-activated pericytes support tumor growth via immunosuppression.
Abstract,"""Glioblastoma-activated pericytes support tumor growth via immunosuppression.""",https://pubmed.ncbi.nlm.nih.gov/29479841,restrict,restricts,involved in glioblastoma development restricts the design of efficient therapies.
Abstract,"""Glioblastoma-activated pericytes support tumor growth via immunosuppression.""",https://pubmed.ncbi.nlm.nih.gov/29479841,activate,activated,"glioblastoma-activated pericytes develop an immunosuppressive phenotype, reducing"
Abstract,"""Immunoengineering in glioblastoma imaging and therapy.""",https://pubmed.ncbi.nlm.nih.gov/31407522,have,have,diagnosed with glioblastoma have poor prognosis.
Title,"""Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts.""",https://pubmed.ncbi.nlm.nih.gov/28681349,establish,established,pharmacotherapy of glioblastoma: established treatments and emerging concepts.
Abstract,"""Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts.""",https://pubmed.ncbi.nlm.nih.gov/28681349,include,includes,"treatment for glioblastoma includes maximal safe surgical resection, radiation, and"
Abstract,"""Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts.""",https://pubmed.ncbi.nlm.nih.gov/28681349,survive,survive,"% of glioblastoma patients survive to 5 years, and no therapies"
Abstract,"""[Glioblastoma treatment in 2010].""",https://pubmed.ncbi.nlm.nih.gov/19998795,require,requires,treatment of glioblastomas requires a multidisciplinary approach because despite the progresses in
Abstract,"""[Glioblastoma treatment in 2010].""",https://pubmed.ncbi.nlm.nih.gov/19998795,undergo,undergo,patients with glioblastoma should undergo maximum surgical resection followed by concurrent radiation
Abstract,"""[Glioblastoma treatment in 2010].""",https://pubmed.ncbi.nlm.nih.gov/19998795,emphasize,emphasize,combination for glioblastoma therapy and we also emphasize the importance of vaccinotherapy
Abstract,"""A biopolymeric mesh enriched with PLGA microparticles loaded with AT101 for localized glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/37054732,include,including,strategies for glioblastoma (gbm) including surgical resection and adjuvant radio
Abstract,"""Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods.""",https://pubmed.ncbi.nlm.nih.gov/33215339,sponsor,sponsored,newly diagnosed glioblastomas sponsored by the american association of neurological surgeons (
Abstract,"""Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods.""",https://pubmed.ncbi.nlm.nih.gov/33215339,use,used,newly diagnosed glioblastomas over all commonly used diagnostic and treatment modalities in
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,emerge,emerged,pivotal in glioblastoma treatment resistance and dna methylation emerged as an important
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,subject,subjected,"from 47 glioblastoma patients were subjected to dna methylation profiling, including"
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,show,showed,"general, glioblastomas with a subclass transition showed upregulated metabolic processes."
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,display,displayed,newly diagnosed glioblastomas with mesenchymal transition displayed increased stem cell-like
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,show,showed,of recurrent glioblastomas with mesenchymal transition showed increased immune components but decreased
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,impact,impacting,"% of glioblastomas, not impacting patient survival."
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,target,targeted,for recurrent glioblastoma targeted therapies.
Abstract,"""Emerging therapies for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25244650,translate,translated,"biology of glioblastoma are being rapidly translated into innovative clinical trials,"
Abstract,"""Emerging therapies for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25244650,include,including,"characterization of glioblastomas as well as host factors, including the brain"
Title,"""Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood-Brain Barrier.""",https://pubmed.ncbi.nlm.nih.gov/37415556,cross,cross,therapy of glioblastoma: bypass or cross the blood-brain barrier
Abstract,"""Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood-Brain Barrier.""",https://pubmed.ncbi.nlm.nih.gov/37415556,discuss,discussed,nanotechnology in glioblastoma is discussed in depth.
Abstract,"""Management of Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28324304,represent,represents,review: glioblastoma represents one of the major challenges in neurooncology and
Abstract,"""Management of Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28324304,remain,remains,patients with glioblastoma remains poor.
Abstract,"""[(89)Zr]-CD8 ImmunoPET imaging of glioblastoma multiforme response to combination oncolytic viral and checkpoint inhibitor immunotherapy reveals CD8 infiltration differential changes in preclinical models.""",https://pubmed.ncbi.nlm.nih.gov/38250045,show,shown,treatment of glioblastoma multiforme (gbm) have shown potential for tumor
Abstract,"""Surgery for Glioblastoma in Elderly Patients.""",https://pubmed.ncbi.nlm.nih.gov/33223022,represent,represents,management of glioblastoma in the elderly population represents a field of growing
Abstract,"""Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29074604,conduct,conducted,with recurrent glioblastoma.experimental design: we conducted a prospective genomics-informed
Abstract,"""Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35008740,represent,represents,"treatment, glioblastoma (gbm) represents the most common and aggressive"
Title,"""Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.""",https://pubmed.ncbi.nlm.nih.gov/26103989,target,targeted,delivery for glioblastoma: targeted delivery of antitumor therapeutics.
Abstract,"""Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37154886,undergo,undergoing,-wildtype glioblastomas which are undergoing evaluation in clinical trials.
Abstract,"""Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37154886,offer,offer,-wildtype glioblastomas offer hope and the prospect of incremental improvements in
Title,"""DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.""",https://pubmed.ncbi.nlm.nih.gov/34036721,target,targeting,ddrugging glioblastoma: understanding and targeting the dna damage response to
Abstract,"""DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.""",https://pubmed.ncbi.nlm.nih.gov/34036721,diagnose,diagnosed,glioblastoma is the most frequently diagnosed type of primary brain
Abstract,"""DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.""",https://pubmed.ncbi.nlm.nih.gov/34036721,find,found,approved for glioblastoma in some countries after it was found to increase
Abstract,"""DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.""",https://pubmed.ncbi.nlm.nih.gov/34036721,recognise,recognised,and highlights glioblastoma as a recognised tumour of unmet clinical need.
Abstract,"""DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.""",https://pubmed.ncbi.nlm.nih.gov/34036721,contain,contain,revealed that glioblastomas contain stem cell-like subpopulations that exhibit heightened
Abstract,"""Perioperative Management of Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33223018,require,requires,"presentation of glioblastomas is varied, and definitive diagnosis requires pathologic examination"
Abstract,"""Perioperative Management of Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33223018,include,includes,"management of glioblastomas includes surgery and adjuvant chemotherapy and radiotherapy, with"
Abstract,"""Perioperative Management of Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33223018,include,including,patients with glioblastoma including tools and surgical adjuncts to maximize extent of
Abstract,"""A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34335972,remain,remains,treatment of glioblastoma (gb) remains a challenge.
Abstract,"""Recent advances in therapy for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20212224,include,including,"therapy for glioblastoma, including surgery, radiotherapy, cytotoxic chemotherapies,"
Abstract,"""Recent advances in therapy for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20212224,discuss,discussed,treatment of glioblastoma is discussed in a separate article in this issue
Abstract,"""[Radiosurgery for recurrent glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/34951763,occur,occurs,", recurrent glioblastoma usually occurs within several months after resection and causes"
Abstract,"""[Radiosurgery for recurrent glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/34951763,identify,identify,with recurrent glioblastoma and to identify the factors determining its effectiveness.
Abstract,"""Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/16709035,recur,recur,glioblastoma multiforme (gbm) tumors almost invariably recur despite
Abstract,"""Using viral vectors to deliver local immunotherapy to glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33524947,see,seen,treatment for glioblastoma (gbm) has not seen significant improvement in
Abstract,"""Present and potential future issues in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/16759163,require,requires,treatment of glioblastomas requires a multidisciplinary approach that takes the presently incurable
Abstract,"""Present and potential future issues in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/16759163,undergo,undergo,"patients with glioblastomas should undergo maximum surgical resection, followed by concurrent"
Abstract,"""Present and potential future issues in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/16759163,describe,described,to treat glioblastoma patients are described.
Abstract,"""Present and potential future issues in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/16759163,recur,recur,"however, glioblastomas almost invariably recur near their initial sites."
Title,"""Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted Therapies.""",https://pubmed.ncbi.nlm.nih.gov/39477295,target,targeted,landscape of glioblastoma: opportunities for targeted therapies.
Abstract,"""Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted Therapies.""",https://pubmed.ncbi.nlm.nih.gov/39477295,categorize,categorized,glioblastoma (gbm) is categorized by the world health
Abstract,"""Towards personalized therapy for patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22117160,base,based,"therapy for glioblastoma, based on molecular tumor profiling or patients'"
Abstract,"""Checkpoint: Inspecting the barriers in glioblastoma immunotherapies.""",https://pubmed.ncbi.nlm.nih.gov/35150865,continue,continues,"resection, glioblastoma multiforme (gbm) continues to exhibit very high"
Abstract,"""Individualized targeted therapy for glioblastoma: fact or fiction?""",https://pubmed.ncbi.nlm.nih.gov/22290256,originate,originating,glioblastomas are highly malignant primary brain tumors presumably originating from
Abstract,"""Individualized targeted therapy for glioblastoma: fact or fiction?""",https://pubmed.ncbi.nlm.nih.gov/22290256,review,reviewed,"classification of glioblastoma were reviewed, and their impact on clinical decision"
Abstract,"""Individualized targeted therapy for glioblastoma: fact or fiction?""",https://pubmed.ncbi.nlm.nih.gov/22290256,classify,classified,"results: glioblastomas can be classified by morphology, clinical characteristics,"
Abstract,"""Individualized targeted therapy for glioblastoma: fact or fiction?""",https://pubmed.ncbi.nlm.nih.gov/22290256,base,based,decisions for glioblastoma patients are still based on age and performance status
Abstract,"""A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35505129,infiltrate,infiltrate,within each glioblastoma and the ability of glioma cells to diffusely infiltrate
Abstract,"""A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35505129,tend,tend,"is that glioblastomas tend to be poorly infiltrated by t cells,"
Abstract,"""A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35505129,direct,directed,"to induce glioblastoma-directed t cell responses, including neoantigen-"
Abstract,"""Feasibility of Targeting Glioblastoma Stem Cells: From Concept to Clinical Trials.""",https://pubmed.ncbi.nlm.nih.gov/31721715,contain,contain,discovered that glioblastomas contain a population of cells with stem-like
Abstract,"""Feasibility of Targeting Glioblastoma Stem Cells: From Concept to Clinical Trials.""",https://pubmed.ncbi.nlm.nih.gov/31721715,signal,signaling,", 'glioblastoma stem cells and wnt signaling' is an example"
Abstract,"""How We Treat Recurrent Glioblastoma Today and Current Evidence.""",https://pubmed.ncbi.nlm.nih.gov/31606796,have,has,: recurrent glioblastoma (rgbm) has no standard treatment.
Abstract,"""Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development.""",https://pubmed.ncbi.nlm.nih.gov/33572835,continue,continues,approaches for glioblastoma patients continues.
Abstract,"""Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development.""",https://pubmed.ncbi.nlm.nih.gov/33572835,include,including,"applied for glioblastoma, including vaccines, oncolytic viruses, immune checkpoint"
Abstract,"""Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development.""",https://pubmed.ncbi.nlm.nih.gov/33572835,drive,drive,"summarize the glioblastoma characteristics that drive tolerance to immunotherapy, the currently"
Abstract,"""Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies.""",https://pubmed.ncbi.nlm.nih.gov/33389564,remain,remained,treatment for glioblastoma (gbm) has remained unchanged for the past
Title,"""Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events.""",https://pubmed.ncbi.nlm.nih.gov/33370846,optimize,optimize,understanding the glioblastoma tumor biology to optimize photodynamic therapy: from molecular
Abstract,"""Palliative Radiotherapy of Primary Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33402500,achieve,achieved,resection of glioblastomas cannot be achieved.
Abstract,"""Palliative Radiotherapy of Primary Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33402500,analyze,analyzed,of primary glioblastoma were retrospectively analyzed.
Title,"""Immunotherapy for glioblastoma: going viral.""",https://pubmed.ncbi.nlm.nih.gov/30082860,go,going,immunotherapy for glioblastoma: going viral.
Abstract,"""Immunotherapy for glioblastoma: going viral.""",https://pubmed.ncbi.nlm.nih.gov/30082860,demonstrate,demonstrates,for recurrent glioblastoma demonstrates safety and promising preliminary treatment responses.
Abstract,"""Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis.""",https://pubmed.ncbi.nlm.nih.gov/37578350,relate,related,of a glioblastoma-related status.
Abstract,"""Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma Treatment.""",https://pubmed.ncbi.nlm.nih.gov/39684289,t98,t98,effect on glioblastoma cell lines t98g and ln229 at a virus
Abstract,"""Optimal Therapies for Newly Diagnosed Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29080109,treat,treated,) with glioblastoma should be treated with a patient-centred approach
Abstract,"""The impact of anatomical changes during photon or proton based radiation treatment on tumor dose in glioblastoma dose escalation trials.""",https://pubmed.ncbi.nlm.nih.gov/34592361,integrate,integrate,trials in glioblastoma patients integrate the escalated dose throughout the standard course
Abstract,"""The impact of anatomical changes during photon or proton based radiation treatment on tumor dose in glioblastoma dose escalation trials.""",https://pubmed.ncbi.nlm.nih.gov/34592361,base,based,for 24 glioblastoma patients a photon- and proton-based dose escalation
Abstract,"""Immunomodulatory signalling networks in glioblastoma multiforme: a comprehensive review of therapeutic approaches.""",https://pubmed.ncbi.nlm.nih.gov/39085713,present,presents,glioblastoma multiforme (gbm) presents a complex tumour microenvironment
Abstract,"""Novel vaccines for glioblastoma: clinical update and perspective.""",https://pubmed.ncbi.nlm.nih.gov/27993092,have,have,glioblastomas have a formidable tumor microenvironment that is hostile to
Title,"""Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications.""",https://pubmed.ncbi.nlm.nih.gov/35163563,target,targeted,nanotechnology in glioblastoma-targeted theranostic applications.
Abstract,"""Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications.""",https://pubmed.ncbi.nlm.nih.gov/35163563,associate,associated,such as glioblastoma are typically associated with an unstoppable cell proliferation with
Abstract,"""Management of glioblastoma multiforme in pregnancy.""",https://pubmed.ncbi.nlm.nih.gov/22404670,present,presenting,glioblastoma multiforme presenting during pregnancy presents unique challenges to the
Abstract,"""Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets.""",https://pubmed.ncbi.nlm.nih.gov/32268863,study,studied,progression in glioblastoma are being studied.
Abstract,"""Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets.""",https://pubmed.ncbi.nlm.nih.gov/32268863,discuss,discussed,therapy for glioblastoma has also been discussed.
Abstract,"""Current therapeutic options for glioblastoma and future perspectives.""",https://pubmed.ncbi.nlm.nih.gov/36100970,affect,affects,introduction: glioblastoma is a malignant primary brain tumor that affects approximately
Abstract,"""Current therapeutic options for glioblastoma and future perspectives.""",https://pubmed.ncbi.nlm.nih.gov/36100970,include,include,"therapies for glioblastoma include surgical resection, radiation therapy and systemic chemotherapy"
Abstract,"""Current therapeutic options for glioblastoma and future perspectives.""",https://pubmed.ncbi.nlm.nih.gov/36100970,treat,treating,"newly diagnosed glioblastoma, mainly temozolomide, lomustine and tumor treating fields"
Abstract,"""Current therapeutic options for glioblastoma and future perspectives.""",https://pubmed.ncbi.nlm.nih.gov/36100970,include,include,"for recurrent glioblastoma include nitrosureas, bevacizumab and temozolomide rechallenge, as"
Abstract,"""Viral vector: potential therapeutic for glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/31316136,find,found,glioblastoma multiforme is a highly malignant primary brain tumour found
Abstract,"""Viral vector: potential therapeutic for glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/31316136,have,has,"glioblastoma has many distinctive characteristics, which makes it a"
Title,"""Auger electron therapy of glioblastoma using [(125)I]5-iodo-2'-deoxyuridine and concomitant chemotherapy - Evaluation of a potential treatment strategy.""",https://pubmed.ncbi.nlm.nih.gov/33784592,use,using,therapy of glioblastoma using [(125)i]5-iodo-2'-deoxyuridine and concomitant chemotherapy
Abstract,"""Auger electron therapy of glioblastoma using [(125)I]5-iodo-2'-deoxyuridine and concomitant chemotherapy - Evaluation of a potential treatment strategy.""",https://pubmed.ncbi.nlm.nih.gov/33784592,use,using,treatment of glioblastomas (gbm) using the auger electron emitting compound
Abstract,"""Nano delivery of natural substances as prospective autophagy modulators in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32702467,review,reviewed,modulators in glioblastoma are prudently reviewed in this article.
Title,"""Human gamma-delta (gammadelta) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy.""",https://pubmed.ncbi.nlm.nih.gov/37544475,overcome,overcome,therapy for glioblastoma: a novel alternative to overcome challenges of adoptive
Abstract,"""Immunocompetent murine models for the study of glioblastoma immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/24779345,remain,remains,glioblastoma remains a lethal diagnosis with a 5-year
Abstract,"""Understanding the Role of Endothelial Cells in Glioblastoma: Mechanisms and Novel Treatments.""",https://pubmed.ncbi.nlm.nih.gov/38892305,facilitate,facilitating,"role in glioblastoma growth and progression, facilitating angiogenesis, cellular communication"
Abstract,"""Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.""",https://pubmed.ncbi.nlm.nih.gov/38383875,progress,progressed,previously irradiated glioblastoma patients who progressed and received second course hypofractionated srt
Title,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,target,targeting,glioblastoma stem cell targeting peptide isolated through phage display binds
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,have,have,glioblastoma stem cells (gscs) have unique properties of
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,target,targeting,to isolate glioblastoma targeting peptides.
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,localize,localized,"intracranially xenografted glioblastoma, the peptide localized to the site of the"
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,target,targeted,as the glioblastoma cell surface receptor targeted by the peptides.
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,demonstrate,demonstrated,interrogation of glioblastoma databases demonstrated that cadherin 2 expression correlated with tumor
Abstract,"""Molecular alterations in glioblastoma: potential targets for immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/21199773,know,known,"immunotherapeutics against glioblastoma, little is known about glioblastoma-specific immune"
Abstract,"""Molecular alterations in glioblastoma: potential targets for immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/21199773,biomarker,biomarker,"alterations in glioblastoma, their effects on ag and biomarker expression,"
Abstract,"""Magnetic resonance-guided laser induced thermal therapy for glioblastoma multiforme: a review.""",https://pubmed.ncbi.nlm.nih.gov/24527455,examine,examines,challenge of glioblastoma multiforme and examines the potential applications of next-
Title,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,base,based,newly diagnosed glioblastoma multiforme: a systematic review and evidence-based
Abstract,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,give,given,"newly diagnosed glioblastoma, is the rt regimen of 60 gy given"
Abstract,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,improve,improve,newly diagnosed glioblastoma to improve overall survival.
Abstract,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,delay,delaying,newly diagnosed glioblastoma is there advantage to delaying the initiation of rt
Abstract,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,undergo,undergone,newly diagnosed glioblastoma that have undergone surgical resection.
Abstract,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,modulate,modulated,diagnosed supratentorial glioblastoma is image-modulated rt (imrt) or
Abstract,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,improve,improve,newly diagnosed glioblastoma does the use of radiosensitizers with rt improve the
Abstract,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,hypofractionate,hypofractionated,newly diagnosed glioblastoma is hypofractionated rt indicated instead of a standard fractionation
Abstract,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,fractionate,fractionated,newly diagnosed glioblastoma is the addition of brachytherapy to standard fractionated rt
Abstract,"""The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.""",https://pubmed.ncbi.nlm.nih.gov/33215344,accelerate,accelerated,newly diagnosed glioblastoma under what circumstances is accelerated hyperfractionated rt indicated instead
Abstract,"""Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?""",https://pubmed.ncbi.nlm.nih.gov/38649630,remain,remains,immunotherapy for glioblastoma (gbm) remains an intensive area of investigation
Title,"""Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.""",https://pubmed.ncbi.nlm.nih.gov/33575970,use,using,therapies for glioblastoma (gbm) using nanoparticle-based delivery systems
Abstract,"""Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17676389,develop,developed,"and curing glioblastoma, new and innovative therapeutic strategies must be developed"
Abstract,"""Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17676389,gap,gaps,"options for glioblastomas, gaps in our knowledge of immune recognition of"
Abstract,"""Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33524942,show,shown,treatment of glioblastoma (gbm) but have shown limited success in
Abstract,"""Radiation-Triggered Selenium-Engineered Mesoporous Silica Nanocapsules for RNAi Therapy in Radiotherapy-Resistant Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36759969,remain,remains,-resistant glioblastoma (rrgbm) remains a significant clinical challenge because
Abstract,"""Toward Personalized Targeted Therapeutics: An Overview.""",https://pubmed.ncbi.nlm.nih.gov/27995437,create,created,analysis of glioblastoma have created optimism that personalized targeted therapy is within
Abstract,"""Toward Personalized Targeted Therapeutics: An Overview.""",https://pubmed.ncbi.nlm.nih.gov/27995437,increase,increased,"complexity of glioblastoma has increased over the years, the path to"
Abstract,"""Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.""",https://pubmed.ncbi.nlm.nih.gov/28816643,serve,serve,suggest that glioblastomas serve as a useful application paradigm.
Abstract,"""Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?""",https://pubmed.ncbi.nlm.nih.gov/23183634,drive,driven,glioblastomas are heterogeneous neoplasms that are driven by complex signalling
Abstract,"""Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?""",https://pubmed.ncbi.nlm.nih.gov/23183634,remain,remains,patients with glioblastomas remains poor.
Abstract,"""Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?""",https://pubmed.ncbi.nlm.nih.gov/23183634,stimulate,stimulated,"pathogenesis of glioblastomas has stimulated the development of novel therapies, including"
Abstract,"""Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?""",https://pubmed.ncbi.nlm.nih.gov/23183634,target,targeted,"biology of glioblastomas, targeted, antiangiogenic and immunotherapies that have impacted"
Abstract,"""Glioblastoma multiforme: a review of therapeutic targets.""",https://pubmed.ncbi.nlm.nih.gov/19409033,present,present,such as glioblastoma multiforme (gbm) present some of the greatest
Abstract,"""The Cryo-immunologic effect: A therapeutic advance in the treatment of glioblastomas?""",https://pubmed.ncbi.nlm.nih.gov/33045247,become,become,of cerebral glioblastoma has become a hot topic.
Abstract,"""Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.""",https://pubmed.ncbi.nlm.nih.gov/29081039,remain,remains,glioblastoma remains a clinical challenge in spite of years of
Abstract,"""Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.""",https://pubmed.ncbi.nlm.nih.gov/29081039,base,based,in vivo glioblastomas based on contemporary imaging techniques.
Abstract,"""Hypoxia Is the Driving Force Behind GBM and Could Be a New Tool in GBM Treatment.""",https://pubmed.ncbi.nlm.nih.gov/26559096,divide,divided,glioblastoma (gbm) can be divided into two distinct
Abstract,"""Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25885672,represent,represents,"feature of glioblastomas (gbm), and its inhibition represents a"
Abstract,"""Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.""",https://pubmed.ncbi.nlm.nih.gov/28358371,affect,affect,glioblastomas are incurable primary brain tumors that affect patients of
Abstract,"""Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.""",https://pubmed.ncbi.nlm.nih.gov/28358371,alter,altered,together with glioblastoma stem-like cells efficiently altered the tumor development
Abstract,"""[Angiogenesis and anti-angiogenic strategies for glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/15888393,summarize,summarized,studies in glioblastoma models in vivo are summarized and clinical perspectives are
Title,"""Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.""",https://pubmed.ncbi.nlm.nih.gov/36402744,exploit,exploiting,a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.
Abstract,"""Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.""",https://pubmed.ncbi.nlm.nih.gov/36402744,comprise,comprise,"background: glioblastomas comprise heterogeneous cell populations with dynamic, bidirectional plasticity"
Abstract,"""Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.""",https://pubmed.ncbi.nlm.nih.gov/36402744,base,based,interventions to glioblastoma patients based on the corresponding survival benefit in the
Abstract,"""Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.""",https://pubmed.ncbi.nlm.nih.gov/36402744,optimize,optimize,model of glioblastoma radiation response to optimize a radiation therapy fractionation schedule
Abstract,"""Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.""",https://pubmed.ncbi.nlm.nih.gov/36402744,develop,developed,irradiation for glioblastoma and developed a first-in-human trial
Abstract,"""Update on the effects of the sodium pump alpha1 subunit on human glioblastoma: from the laboratory to the clinic.""",https://pubmed.ncbi.nlm.nih.gov/30130132,debilitate,debilitating,introduction: glioblastoma is a debilitating disease that is associated with poor
Abstract,"""Update on the effects of the sodium pump alpha1 subunit on human glioblastoma: from the laboratory to the clinic.""",https://pubmed.ncbi.nlm.nih.gov/30130132,compare,compared,"in most glioblastomas compared with that in normal brain tissues, is"
Abstract,"""Update on the effects of the sodium pump alpha1 subunit on human glioblastoma: from the laboratory to the clinic.""",https://pubmed.ncbi.nlm.nih.gov/30130132,analyze,analyze,subunit in glioblastoma and analyze its potential therapeutic applications.
Abstract,"""Update on the effects of the sodium pump alpha1 subunit on human glioblastoma: from the laboratory to the clinic.""",https://pubmed.ncbi.nlm.nih.gov/30130132,signal,signaling,"mediated pivotal antiglioblastoma signaling pathways have been reviewed, and their impact"
Abstract,"""Update on the effects of the sodium pump alpha1 subunit on human glioblastoma: from the laboratory to the clinic.""",https://pubmed.ncbi.nlm.nih.gov/30130132,clarify,clarified,sensitivity of glioblastoma cells to anticancer drugs has recently been clarified.
Abstract,"""Glioblastoma of the cerebellum in children: report of five cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/23299302,compare,compared,"with cerebellar glioblastomas is dismal, even when compared to adult counterparts"
Abstract,"""Glioblastoma of the cerebellum in children: report of five cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/23299302,have,have,cerebellar glioblastomas have a tendency to recur and disseminate despite treatment
Abstract,"""A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37427593,lack,lack,glioblastomas (gbm) are aggressive tumors that lack effective
Abstract,"""The treatment of glioblastomas: a systematic update on clinical Phase III trials.""",https://pubmed.ncbi.nlm.nih.gov/23453191,associate,associated,glioblastomas (gbms) are invariably associated with unavoidable tumor
Abstract,"""Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics.""",https://pubmed.ncbi.nlm.nih.gov/37305160,destroy,destroyed,"development of glioblastoma (gbm), bbb is pathologically destroyed with"
Abstract,"""Standard therapy for glioblastoma--a review of where we are.""",https://pubmed.ncbi.nlm.nih.gov/20885105,base,based,"and recurrent glioblastomas, based on the most authoritative guidelines, the"
Abstract,"""Surgery, tamoxifen, carboplatin, and radiotherapy in the treatment of newly diagnosed glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/11206010,undergo,underwent,newly diagnosed glioblastomas underwent surgery and were subsequently treated with 200 mg
Abstract,"""Development of an exercise intervention as part of rehabilitation in a glioblastoma multiforme survivor during irradiation treatment: a case report.""",https://pubmed.ncbi.nlm.nih.gov/29382243,discuss,discusses,patient with glioblastoma multiforme (gbm ) and discusses potential relations of
Abstract,"""Application of RNA-based therapeutics in glioma: A review.""",https://pubmed.ncbi.nlm.nih.gov/38458736,remain,remains,suffering from glioblastoma multiforme remains highly detrimental.
Title,"""Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/23590435,radio-,radio-,mechanisms of glioblastoma resistance to radio- and chemotherapy.
Abstract,"""Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/23590435,characterize,characterized,"and multiform glioblastoma are characterized by highly pronounced anaplasia, malignization,"
Abstract,"""GammaTile(): Surgically targeted radiation therapy for glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32618209,recur,recur,% of glioblastomas recur in proximity to the resection cavity.
Abstract,"""Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study.""",https://pubmed.ncbi.nlm.nih.gov/34797526,pool,pooled,-wt glioblastoma were pooled for this retrospective observational international multi-
Abstract,"""The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31058901,diagnose,diagnosed,of recurrent glioblastoma in 2011 and for newly diagnosed glioblastoma in 2015
Abstract,"""Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).""",https://pubmed.ncbi.nlm.nih.gov/37060055,remain,remains,prognosis of glioblastoma patients remains poor.
Abstract,"""Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).""",https://pubmed.ncbi.nlm.nih.gov/37060055,combine,combined,", including glioblastoma with a potential synergetic effect when combined with tmz"
Abstract,"""Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).""",https://pubmed.ncbi.nlm.nih.gov/37060055,operate,operated,"grade iv glioblastoma, not operated or partially operated, with a"
Abstract,"""Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).""",https://pubmed.ncbi.nlm.nih.gov/37060055,have,have,newly diagnosed glioblastomas that have the poorest prognosis (incomplete resection or
Title,"""[Epidemiological, clinical, therapeutic and evolutionary features of patients with glioblastoma: series of cases managed in the Department of Hematology-Oncology at the Mohammed VI University Hospital Center in Marrakech in 2016 and 2017].""",https://pubmed.ncbi.nlm.nih.gov/34603572,manage,managed,patients with glioblastoma: series of cases managed in the department of
Abstract,"""[Epidemiological, clinical, therapeutic and evolutionary features of patients with glioblastoma: series of cases managed in the Department of Hematology-Oncology at the Mohammed VI University Hospital Center in Marrakech in 2016 and 2017].""",https://pubmed.ncbi.nlm.nih.gov/34603572,admit,admitted,patients with glioblastoma admitted to the department of hematology-oncology (
Abstract,"""[Epidemiological, clinical, therapeutic and evolutionary features of patients with glioblastoma: series of cases managed in the Department of Hematology-Oncology at the Mohammed VI University Hospital Center in Marrakech in 2016 and 2017].""",https://pubmed.ncbi.nlm.nih.gov/34603572,account,accounted,glioblastoma accounted for 47.6% of treated intracranial tumours.
Abstract,"""[Epidemiological, clinical, therapeutic and evolutionary features of patients with glioblastoma: series of cases managed in the Department of Hematology-Oncology at the Mohammed VI University Hospital Center in Marrakech in 2016 and 2017].""",https://pubmed.ncbi.nlm.nih.gov/34603572,have,had,cases had glioblastomas-idh1-wild and one case had glioblastoma
Abstract,"""Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19194651,represent,represent,"of which glioblastomas represent the ultimate grade of malignancy, they remain"
Abstract,"""Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19194651,have,have,"indeed, glioblastoma patients have a median survival expectancy of only 14"
Abstract,"""Current and Future Drug Treatments for Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27758718,have,have,glioblastomas are the most aggressive of all gliomas and have
Abstract,"""Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/20679253,play,plays,", including glioblastoma, and it plays a significant role in inhibiting"
Abstract,"""Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/20679253,treat,treated,survivin in glioblastoma u251mg and u118mg cells and simultaneously treated
Title,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,consider,considering,optimization for glioblastomas considering immune responses.
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,show,shown,", including glioblastomas, but little has been shown to be effective"
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,have,have,is that glioblastomas have a high ability to evade attacks from the
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,vary,varies,therapy for glioblastomas varies among guidelines and clinical trials.
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,conduct,conducted,"radiotherapy for glioblastomas was conducted, and it was reported that the"
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,propose,propose,immunotherapy to glioblastomas and the novel role of radiotherapy and propose the
Title,"""Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.""",https://pubmed.ncbi.nlm.nih.gov/28576716,functionalize,functionalized,of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel
Abstract,"""Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.""",https://pubmed.ncbi.nlm.nih.gov/28576716,compose,composed,glioblastoma multiforme (gbm) tumors are usually composed of
Title,"""Hurdles in radiation planning for glioblastoma: Can delayed-contrast enhanced computed tomography be a potential solution?""",https://pubmed.ncbi.nlm.nih.gov/30698349,delay,delayed,planning for glioblastoma: can delayed-contrast enhanced computed tomography be
Abstract,"""Hurdles in radiation planning for glioblastoma: Can delayed-contrast enhanced computed tomography be a potential solution?""",https://pubmed.ncbi.nlm.nih.gov/30698349,treat,treated,patients of glioblastoma treated at our center between 2011 and 2014 were
Abstract,"""Study protocol for a multicenter randomised controlled trial on the (cost)effectiveness of biopsy combined with same-session MR-guided LITT versus biopsy alone in patients with primary irresectable glioblastoma (EMITT trial).""",https://pubmed.ncbi.nlm.nih.gov/37612610,resect,resected,", a glioblastoma is resected and further treated with chemoradiation therapy ("
Abstract,"""Study protocol for a multicenter randomised controlled trial on the (cost)effectiveness of biopsy combined with same-session MR-guided LITT versus biopsy alone in patients with primary irresectable glioblastoma (EMITT trial).""",https://pubmed.ncbi.nlm.nih.gov/37612610,compare,compared,patients with glioblastoma as compared with current standard of care.
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,affect,affecting,"glioblastoma, the most common and heterogeneous tumor affecting brain"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,explore,explored,"features of glioblastomas that are, indeed, currently explored in preclinical"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,discuss,discussing,"landscapes of glioblastomas, in each case discussing the corresponding targeted therapies"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,enforce,enforcing,"investigate many glioblastoma epigenetic biomarkers in clinical practice, further enforcing the"
Abstract,"""Glioblastoma Multiforme: The Genetic Perspective of the Treatment Planning.""",https://pubmed.ncbi.nlm.nih.gov/26559087,divide,divided,glioblastoma multiforme (gbm) is divided into two distinct
Abstract,"""Dosimetric evaluation and treatment planning considerations for GammaTile permanent brain implants - a pilot, institutional experience.""",https://pubmed.ncbi.nlm.nih.gov/38902561,characterize,characterized,for recurrent glioblastomas and characterized dosimetric parameter and associated clinical outcome.
Abstract,"""Dosimetric evaluation and treatment planning considerations for GammaTile permanent brain implants - a pilot, institutional experience.""",https://pubmed.ncbi.nlm.nih.gov/38902561,follow,followed,of recurrent glioblastoma underwent resection followed by intraoperative gt implant between 01/2019
Abstract,"""Development of a murine laser interstitial thermotherapy system.""",https://pubmed.ncbi.nlm.nih.gov/39486063,investigate,investigate,for human glioblastoma treatment to investigate thermal diffusion in heterogeneous brain tissue
Abstract,"""MGMT methylation status: the advent of stratified therapy in glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/17325429,test,testing,newly diagnosed glioblastoma testing the addition of the alkylating agent temozolomide to
Abstract,"""MGMT methylation status: the advent of stratified therapy in glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/17325429,become,become,"agents in glioblastoma patients, but many others may hopefully become part"
Title,"""Boron neutron capture therapy for glioblastoma: is it worth pursuing?""",https://pubmed.ncbi.nlm.nih.gov/18198928,pursue,pursuing,therapy for glioblastoma: is it worth pursuing?
Abstract,"""Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/29374810,treat,treated,"patients with glioblastoma, treated with 3d-crt or imrt,"
Abstract,"""Functional brain imaging interventions for radiation therapy planning in patients with glioblastoma: a systematic review.""",https://pubmed.ncbi.nlm.nih.gov/36371225,support,support,patients with glioblastoma to support clinicians and further research.
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,base,based,"glioblastoma, grade iv malignant glioma based on the world"
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,cause,caused,prognosis of glioblastoma patients is largely caused by the striking radioresistance of
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,provide,provide,phenotype of glioblastomas and plausible mechanisms of radiation resistance can provide new
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,result,result,patients with glioblastoma and result in a better prognosis for these patients
Abstract,"""Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27485530,increase,increased,patients with glioblastomas has increased.
Abstract,"""Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27485530,age,aged,study of glioblastoma patients aged 60 years old or older who were
Abstract,"""Applying a Radiation Therapy Volume Analysis Pipeline to Determine the Utility of Spectroscopic MRI-Guided Adaptive Radiation Therapy for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37218946,challenge,challenging,crucial for glioblastoma treatment but may be challenging using clinical imaging alone
Abstract,"""Applying a Radiation Therapy Volume Analysis Pipeline to Determine the Utility of Spectroscopic MRI-Guided Adaptive Radiation Therapy for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37218946,receive,received,) where glioblastoma patients received high-dose rt guided by the
Abstract,"""Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21656012,occur,occurs,glioblastoma occurs rarely in pediatric patients (0.6-7.9
Abstract,"""Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21656012,appear,appeared,histopathologically confirmed glioblastoma multiforme whose lesions appeared within just 1 week of
Abstract,"""Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21656012,emphasize,emphasizes,development of glioblastoma in childhood and emphasizes the importance of serial neuroimaging
Abstract,"""Stem cell-based therapies for tumors in the brain: are we there yet?""",https://pubmed.ncbi.nlm.nih.gov/27282399,result,resulted,", particularly glioblastoma have not resulted in a marked increase in patient"
Abstract,"""[Targeted therapy in glioblastoma: update and perspectives].""",https://pubmed.ncbi.nlm.nih.gov/29874421,remain,remains,prognosis of glioblastoma patients remains dismal with a median overall survival below
Abstract,"""[Targeted therapy in glioblastoma: update and perspectives].""",https://pubmed.ncbi.nlm.nih.gov/29874421,throughput,throughput,characterization of glioblastoma mainly thanks to high throughput molecular biology techniques.
Abstract,"""[Targeted therapy in glioblastoma: update and perspectives].""",https://pubmed.ncbi.nlm.nih.gov/29874421,target,targeted,"knowledge of glioblastoma molecular biology, these molecular targeted therapies also appear"
Abstract,"""[Targeted therapy in glioblastoma: update and perspectives].""",https://pubmed.ncbi.nlm.nih.gov/29874421,improve,improve,directed against glioblastomas to improve survival and quality of ife of patients
Abstract,"""Immunogenic Cell Death Induced by Chemoradiotherapy of Novel pH-Sensitive Cargo-Loaded Polymersomes in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34712045,represent,represents,treatment of glioblastoma which represents a promising nanoplatform for future translational research
Abstract,"""Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres.""",https://pubmed.ncbi.nlm.nih.gov/35538218,remain,remain,glioblastomas remain the most lethal primary brain tumors.
Abstract,"""Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres.""",https://pubmed.ncbi.nlm.nih.gov/35538218,select,select,"treatment of glioblastomas, since these cells can select and lyse therapy"
Title,"""Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/23229792,underline,underline,secreted by glioblastoma stem-like cells underline the need for combinatorial
Abstract,"""Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/23229792,endow,endowed,populations of glioblastoma stem-like cells (gscs) endowed with
Abstract,"""Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/23229792,vascularize,vascularized,glioblastomas are highly vascularized tumors resulting in a rich dialog
Abstract,"""Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/23229792,overcome,overcome,attack of glioblastoma vasculature that could overcome the development of resistance to
Title,"""Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity.""",https://pubmed.ncbi.nlm.nih.gov/37114043,potent,potent,virus inhibits glioblastoma growth and elicits potent antitumor immunity.
Title,"""Comparison of healthcare utilization and life-sustaining interventions between patients with glioblastoma receiving palliative care or not: A population-based study.""",https://pubmed.ncbi.nlm.nih.gov/36789966,receive,receiving,patients with glioblastoma receiving palliative care or not: a population-
Abstract,"""Comparison of healthcare utilization and life-sustaining interventions between patients with glioblastoma receiving palliative care or not: A population-based study.""",https://pubmed.ncbi.nlm.nih.gov/36789966,limit,limited,stage of glioblastoma has been limited.
Abstract,"""Comparison of healthcare utilization and life-sustaining interventions between patients with glioblastoma receiving palliative care or not: A population-based study.""",https://pubmed.ncbi.nlm.nih.gov/36789966,receive,received,patients with glioblastoma who received palliative care and who did not based
Abstract,"""Comparison of healthcare utilization and life-sustaining interventions between patients with glioblastoma receiving palliative care or not: A population-based study.""",https://pubmed.ncbi.nlm.nih.gov/36789966,identify,identified,"patients with glioblastoma identified, 1784 fulfilled the inclusion criteria, 613"
Abstract,"""Comparison of healthcare utilization and life-sustaining interventions between patients with glioblastoma receiving palliative care or not: A population-based study.""",https://pubmed.ncbi.nlm.nih.gov/36789966,have,had,reveals that glioblastoma patients without palliative care had greater odds of receiving
Abstract,"""Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology.""",https://pubmed.ncbi.nlm.nih.gov/35561836,remain,remains,glioblastoma (gbm) remains a disease with a dismal
Title,"""Glioblastoma Treated With Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy: Safety, Efficacy, and Outcomes.""",https://pubmed.ncbi.nlm.nih.gov/30137606,treat,treated,glioblastoma treated with magnetic resonance imaging-guided laser interstitial
Abstract,"""Glioblastoma Treated With Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy: Safety, Efficacy, and Outcomes.""",https://pubmed.ncbi.nlm.nih.gov/30137606,remain,remains,"treatments, glioblastoma (gbm) remains an aggressive and uniformly fatal"
Abstract,"""Glioblastoma oncometry.""",https://pubmed.ncbi.nlm.nih.gov/2176356,see,seen,appearance of glioblastomas seen at the completion of radiation therapy.
Abstract,"""Cell-based immunotherapy against gliomas: from bench to bedside.""",https://pubmed.ncbi.nlm.nih.gov/23648695,comprise,comprises,glioblastoma (gbm) comprises 51% of all gliomas
Title,"""Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance.""",https://pubmed.ncbi.nlm.nih.gov/37022791,build,build,glioblastomas: hijacking metabolism to build a flexible shield for
Abstract,"""The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations.""",https://pubmed.ncbi.nlm.nih.gov/34014534,develop,develops,glioblastoma multiforme (gbm) develops on glial cells and
Abstract,"""Biomarker-based prognostic stratification of young adult glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26452024,investigate,investigated,"the pediatric glioblastomas have been extensively investigated, young adult glioblastomas were"
Abstract,"""Biomarker-based prognostic stratification of young adult glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26452024,examine,examine,"young adult glioblastomas by braf, h3f3a and idh1 mutations and examine"
Abstract,"""Biomarker-based prognostic stratification of young adult glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26452024,age,aged,"in 107 glioblastomas aged from 17 to 35 years, mutually exclusive"
Abstract,"""Biomarker-based prognostic stratification of young adult glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26452024,associate,associated,m mutated glioblastomas were tightly associated with midline locations and showed dismal
Abstract,"""The end-of-life hospital setting in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18370888,die,died,"patients with glioblastoma, who died in our department, were included"
Abstract,"""The end-of-life hospital setting in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18370888,have,has,patients with glioblastoma has several periods with different clinical aspects with respect
Abstract,"""Primary glioblastoma of the trigeminal nerve root entry zone: case report.""",https://pubmed.ncbi.nlm.nih.gov/25380115,involve,involving,have a glioblastoma involving the trigeminal nerve root entry zone.
Abstract,"""[Neutron capture therapy in the treatment of glioblastoma multiforme. Initial experience in the Czech Republic].""",https://pubmed.ncbi.nlm.nih.gov/15061119,accumulate,accumulate,"that of glioblastomas, are able to accumulate boron compounds."
Abstract,"""Modeling the effects of resection, radiation and chemotherapy in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18836688,follow,followed,newly diagnosed glioblastoma multiforme is surgical resection followed by radiotherapy and chemotherapy
Title,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,depend,depends,cells towards glioblastoma cells depends on hepatocyte-growth factor and is
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,contribute,contributes,"expressed by glioblastomas and contributes to their growth, migration and invasion"
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,exploit,exploited,"tropism for glioblastomas, which is exploited in gene therapy to deliver"
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,mediate,mediated,msc by glioblastoma cells and whether aminolaevulinic acid-mediated photodynamic therapy
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,affect,affects,"apoptosis in glioblastoma cells, affects hgf release and this migratory response"
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,express,express,"thus, glioblastoma cells express hgf, which contributes to the attraction"
Title,"""Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.""",https://pubmed.ncbi.nlm.nih.gov/32470780,treat,treated,with recurrent glioblastoma treated with laser interstitial thermal therapy (litt):
Abstract,"""Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.""",https://pubmed.ncbi.nlm.nih.gov/32470780,assess,assess,in recurrent glioblastoma and to assess its effect in the overall survival
Abstract,"""Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.""",https://pubmed.ncbi.nlm.nih.gov/32470780,select,selected,of recurrent glioblastoma after laser interstitial thermal therapy were selected.
Abstract,"""Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.""",https://pubmed.ncbi.nlm.nih.gov/32470780,undergo,underwent,with recurrent glioblastoma who underwent 219 laser interstitial thermal therapy treatments.
Abstract,"""Glioblastoma multiforme of the pineal region.""",https://pubmed.ncbi.nlm.nih.gov/1965444,restrict,restricted,case of glioblastoma multiforme restricted to the pineal region is presented.
Abstract,"""Joint Optimization of Photon-Carbon Ion Treatments for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34058258,show,show,"for 6 glioblastoma patient cases, we show that our approach results"
Abstract,"""Biologic principles of immunotherapy for malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/19944962,associate,associated,"neoplasm is glioblastoma multiforme, which is associated with a dismal prognosis"
Abstract,"""Analysis Suggests Drug Combos for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27165727,develop,develop,shown that glioblastomas can develop resistance to a drug by rewiring their
Abstract,"""[Surgical treatment of glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/20869732,confirm,confirm,need for glioblastoma surgery to confirm the histology and decrease the mass
Abstract,"""[Surgical treatment of glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/20869732,treat,treated,"of 952 glioblastomas treated in france in 2004, 56% were"
Abstract,"""Prognostic implications of epilepsy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26489387,improve,improved,and secondary glioblastomas were factors that improved survival (p<0.001).
Abstract,"""Prognostic implications of epilepsy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26489387,predict,predict,symptom in glioblastomas predict longer survival.
Abstract,"""Systemically targeting monocytic myeloid-derived suppressor cells using dendrimers and their cell-level biodistribution kinetics.""",https://pubmed.ncbi.nlm.nih.gov/39103055,examine,examining,"models of glioblastoma, by examining the cell-level biodistribution kinetics"
Abstract,"""Prognostic value of complete response after the initial treatment for malignant astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/8875449,divide,divided,and 24 glioblastomas) were divided into two groups.
Abstract,"""Use of a neural network-based prediction method to calculate the therapeutic dose in boron neutron capture therapy of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36647729,solve,solve,patients with glioblastoma to solve the time-consuming problem of bnct
Abstract,"""Use of a neural network-based prediction method to calculate the therapeutic dose in boron neutron capture therapy of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36647729,collect,collected,patients with glioblastoma are collected.
Abstract,"""Use of a neural network-based prediction method to calculate the therapeutic dose in boron neutron capture therapy of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36647729,use,using,patient with glioblastoma by monte carlo method using intel xeon e5-
Abstract,"""Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes.""",https://pubmed.ncbi.nlm.nih.gov/27832093,provide,provide,material to glioblastoma cells where they can provide therapeutic benefits.
Abstract,"""Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes.""",https://pubmed.ncbi.nlm.nih.gov/27832093,compare,compared,"nanoparticles to glioblastoma cells, as compared to neurons and glial cells"
Title,"""Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth.""",https://pubmed.ncbi.nlm.nih.gov/37162706,exhibit,exhibit,-derived glioblastoma cell line while exhibit moderate effect on normal stem
Abstract,"""Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth.""",https://pubmed.ncbi.nlm.nih.gov/37162706,know,known,"glioblastomas (gbm), also known as glioblastoma multiforme"
Abstract,"""Gene therapeutics: the future of brain tumor therapy?""",https://pubmed.ncbi.nlm.nih.gov/16831077,have,has,primary glioblastoma multiforme is an aggressive brain tumor that has no
Abstract,"""Dendritic cell immunotherapy for brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/26037466,characterize,characterized,"glioblastomas are characterized by immunosuppression, rapid proliferation, angiogenesis"
Abstract,"""[Radiotherapy for glioblastomas: from radiobiology to concomitant chemotherapy].""",https://pubmed.ncbi.nlm.nih.gov/16095943,remain,remains,prognosis of glioblastoma remains extremely poor.
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,suggest,suggesting,newly diagnosed glioblastoma patients with clinical characteristics suggesting poor prognosis.
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,undergo,undergoing,newly diagnosed glioblastoma undergoing surgery.
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,undergo,undergo,newly diagnosed glioblastoma undergo pretreatment radio-labeled amino acid tracer positron
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of radiation
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of chemotherapy
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of molecular
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of immunologically
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,undergo,undergone,newly diagnosed glioblastoma who have undergone surgical debulking and completed concurrent chemoradiation
Abstract,"""Adult immuno-oncology: using past failures to inform the future.""",https://pubmed.ncbi.nlm.nih.gov/32391559,have,had,immunotherapy for glioblastoma (gbm) has had mixed results in early
Abstract,"""Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.""",https://pubmed.ncbi.nlm.nih.gov/29291951,consist,consists,newly diagnosed glioblastoma consists of surgery followed by conventional radiotherapy (crt
Abstract,"""Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.""",https://pubmed.ncbi.nlm.nih.gov/29291951,treat,treated,newly diagnosed glioblastoma patients treated with crt 60 gy/30 fractions or hfrt
Abstract,"""Performance of adjuvant treatment correlates with survival in reoperated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27901253,subject,subjected,of recurrent glioblastoma subjected to reoperation at a brazilian public healthcare service
Title,"""Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies.""",https://pubmed.ncbi.nlm.nih.gov/35650594,target,targeting,assessment of glioblastoma-targeting car-t based immunotherapies.
Abstract,"""Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies.""",https://pubmed.ncbi.nlm.nih.gov/35650594,overexpresse,overexpressing,mg human glioblastoma (gbm) cells overexpressing the tumor-specific
Abstract,"""Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period.""",https://pubmed.ncbi.nlm.nih.gov/9694343,define,defined,giant cell glioblastomas are defined as glioblastomas with a marked predominance of
Abstract,"""Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period.""",https://pubmed.ncbi.nlm.nih.gov/9694343,occur,occur,of all glioblastomas and can occur at any site of the central
Abstract,"""Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period.""",https://pubmed.ncbi.nlm.nih.gov/9694343,show,show,giant cell glioblastomas show a prolonged survival period compared with common glioblastoma
Title,"""Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.""",https://pubmed.ncbi.nlm.nih.gov/23333277,recapitulate,recapitulate,specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human
Abstract,"""Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.""",https://pubmed.ncbi.nlm.nih.gov/23333277,use,using,of orthotopic glioblastoma (gbm) xenograft models using surgical samples of
Abstract,"""Safety of stereotactic laser ablations performed as treatment for glioblastomas in a conventional magnetic resonance imaging suite.""",https://pubmed.ncbi.nlm.nih.gov/27690648,perform,performed,sla for glioblastoma (gbm) treatment was performed entirely within a
Abstract,"""Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34290904,remain,remains,"therapeutic, glioblastoma (gbm) remains resistant to using checkpoint blockade"
Title,"""Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.""",https://pubmed.ncbi.nlm.nih.gov/30712777,treat,treated,newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: a multicenter cohort study
Abstract,"""Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.""",https://pubmed.ncbi.nlm.nih.gov/30712777,involve,involves,treatment of glioblastomas involves maximal safe resection and adjuvant temozolomide chemo-
Abstract,"""Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.""",https://pubmed.ncbi.nlm.nih.gov/30712777,mean,mean,147 adult glioblastoma patients (mean age 53 years) that underwent
Abstract,"""Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy.""",https://pubmed.ncbi.nlm.nih.gov/28169234,carry,carries,background: glioblastoma multiforme (gbm) carries a poor prognosis with
Abstract,"""Intra-operative radiation therapy for malignant brain tumors: rationale, method, and treatment results of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/7709789,treat,treated,patients with glioblastoma treated by iort (mean 18.3 gy) combined
Abstract,"""Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy.""",https://pubmed.ncbi.nlm.nih.gov/23264191,analyze,analyzed,newly diagnosed glioblastoma were analyzed by early post-operative magnetic resonance
Abstract,"""Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy.""",https://pubmed.ncbi.nlm.nih.gov/23264191,observe,observed,of resected glioblastomas are frequently observed.
Abstract,"""Glioblastoma multiforme of the cerebellum in an elderly man. A case report.""",https://pubmed.ncbi.nlm.nih.gov/2559527,comprise,comprises,glioblastoma multiforme of the cerebellum is rare and comprises a
Abstract,"""Failure of Inositol Trispyrophosphate to Enhance Highly Effective Radiotherapy of GL261 Glioblastoma in Mice.""",https://pubmed.ncbi.nlm.nih.gov/28314273,treat,treated,whether aggressive glioblastomas could be effectively treated with itpp alone or in
Abstract,"""Failure of Inositol Trispyrophosphate to Enhance Highly Effective Radiotherapy of GL261 Glioblastoma in Mice.""",https://pubmed.ncbi.nlm.nih.gov/28314273,treat,treated,syngeneic gl261 glioblastoma cells and treated with hypofractionated radiation (5 gy
Abstract,"""Failure of Inositol Trispyrophosphate to Enhance Highly Effective Radiotherapy of GL261 Glioblastoma in Mice.""",https://pubmed.ncbi.nlm.nih.gov/28314273,appear,appeared,monotherapy for glioblastoma and appeared to interfere with the beneficial impact of
Abstract,"""Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/8824552,suppress,suppress,"of human glioblastomas, and re-introduction of p53 can suppress"
Abstract,"""Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/8824552,analyze,analyzed,"therapy of glioblastoma, we have analyzed the response of human glioblastoma"
Abstract,"""Spatial optimization for radiation therapy of brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/31251755,involve,involve,"treatments for glioblastomas commonly involve a combination of surgical intervention, chemotherapy"
Abstract,"""Spatial optimization for radiation therapy of brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/31251755,show,show,"growth of glioblastomas in vivo, but also show potential for the"
Title,"""A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.""",https://pubmed.ncbi.nlm.nih.gov/26859136,report,reported,primary spinal glioblastomas or gliosarcomas reported in literature until march 2015.
Abstract,"""A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.""",https://pubmed.ncbi.nlm.nih.gov/26859136,report,reported,primary spinal glioblastomas (gb) or gliosarcomas (gs) reported
Abstract,"""A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.""",https://pubmed.ncbi.nlm.nih.gov/26859136,use,using,"cases of glioblastomas / gliosarcomas with primary spinal origin, using predefined"
Abstract,"""A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.""",https://pubmed.ncbi.nlm.nih.gov/26859136,enter,entered,primary spinal glioblastomas should be entered into a central registry in order
Abstract,"""Intratumoural and intraventricular human lymphoblastoid alpha interferon (HLBI) for treatment of glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/2554692,treat,treated,patients with glioblastoma multiforme were treated with human lymphoblastoid alpha interferon (
Abstract,"""Amino Acid PET Imaging of the Early Metabolic Response During Tumor-Treating Fields (TTFields) Therapy in Recurrent Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29261637,detect,detected,"in recurrent glioblastoma, and this treatment response can be detected by"
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,associate,associated,"of 98 glioblastoma patients, idh1 ( r132 ) mutations were associated"
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,carry,carried,to 51 glioblastoma samples of which 16 carried an idh1 (r132
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,provide,provided,capacity in glioblastoma was provided for 65% by idh activity and
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,explain,explaining,"may sensitize glioblastoma to irradiation and chemotherapy, thus explaining the prolonged"
Abstract,"""Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model.""",https://pubmed.ncbi.nlm.nih.gov/36195571,-,-,both human glioblastoma cells and pre-established human glioblastoma mouse model
Abstract,"""Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model.""",https://pubmed.ncbi.nlm.nih.gov/36195571,compare,compared,established human glioblastoma mouse model compared with an srrv system.
Abstract,"""Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model.""",https://pubmed.ncbi.nlm.nih.gov/36195571,inject,injected,"u-87 mg glioblastomas, the group of mice injected with sprrv expressing"
Abstract,"""Quantifying Uncertainty and Robustness in a Biomathematical Model-Based Patient-Specific Response Metric for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30758984,know,known,"purpose: glioblastomas, lethal primary brain tumors, are known for"
Abstract,"""Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29546530,recur,recur,glioblastomas are aggressive brain tumors that frequently recur in the
Abstract,"""Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29546530,treat,treated,"diagnosed with glioblastoma and treated with surgery, radiation, and concurrent"
Abstract,"""Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29546530,recur,recurred,"glioblastomas frequently recurred in the subventricular zone, and patient"
Title,"""Optic nerve and visual pathways primary glioblastoma treated with radiotherapy and temozolomide chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/24366773,treat,treated,pathways primary glioblastoma treated with radiotherapy and temozolomide chemotherapy.
Abstract,"""Optic nerve and visual pathways primary glioblastoma treated with radiotherapy and temozolomide chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/24366773,treat,treated,"and chiasm glioblastoma (gbm), treated with radiotherapy and concomitant"
Title,"""Feasibility of voxel-based Dose Painting for recurrent Glioblastoma guided by ADC values of Diffusion-Weighted MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/27989415,guide,guided,for recurrent glioblastoma guided by adc values of diffusion-weighted mr
Title,"""Successful Preoperative Endovascular Embolization of an Extreme Hypervascular Glioblastoma Mimicking an Arteriovenous Malformation.""",https://pubmed.ncbi.nlm.nih.gov/26463396,mimic,mimicking,extreme hypervascular glioblastoma mimicking an arteriovenous malformation.
Abstract,"""Successful Preoperative Endovascular Embolization of an Extreme Hypervascular Glioblastoma Mimicking an Arteriovenous Malformation.""",https://pubmed.ncbi.nlm.nih.gov/26463396,establish,established,for hypervascular glioblastomas has not been established.
Abstract,"""Successful Preoperative Endovascular Embolization of an Extreme Hypervascular Glioblastoma Mimicking an Arteriovenous Malformation.""",https://pubmed.ncbi.nlm.nih.gov/26463396,mimic,mimicking,extreme hypervascular glioblastoma mimicking an arteriovenous malformation that was successfully treated with
Abstract,"""A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease.""",https://pubmed.ncbi.nlm.nih.gov/23216891,have,has,"glioblastoma multiformae, the most aggressive glioma subtype, has"
Abstract,"""A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease.""",https://pubmed.ncbi.nlm.nih.gov/23216891,correlate,correlates,rest in glioblastoma but how rest function correlates with disease outcome has
Abstract,"""Patterns of care and survival for glioblastoma patients in the Veterans population.""",https://pubmed.ncbi.nlm.nih.gov/21881877,follow,followed,", supratentorial glioblastoma multiforme in male veterans actively followed by the vaccr"
Abstract,"""Patterns of care and survival for glioblastoma patients in the Veterans population.""",https://pubmed.ncbi.nlm.nih.gov/21881877,diagnose,diagnosed,veterans with glioblastomas diagnosed between 1997 and 2006.
Abstract,"""Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.""",https://pubmed.ncbi.nlm.nih.gov/32307022,proliferate,proliferating,background: glioblastoma is a rapidly proliferating tumor.
Title,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,use,using,of human glioblastoma using quantitative sodium mr imaging.
Abstract,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,fractionate,fractionated,of human glioblastoma to fractionated chemoradiation are described by changes in the
Abstract,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,use,using,patients with glioblastomas (n = 20) using tsc obtained from
Abstract,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,undergo,undergoing,diagnosed human glioblastomas undergoing treatment were compared with time-to-
Abstract,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,produce,produces,chemoradiotherapy of glioblastomas produces variable responses with low cell killing efficiency.
Title,"""Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier.""",https://pubmed.ncbi.nlm.nih.gov/26910903,lead,leads,of recurrent glioblastoma leads to temporary disruption of the peritumoral blood brain
Abstract,"""Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier.""",https://pubmed.ncbi.nlm.nih.gov/26910903,occur,occur,most recurrent glioblastomas (gbm) occur within the peritumoral region.
Abstract,"""Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33399987,guide,guide,of cerebellar glioblastomas in order to guide patient management.
Abstract,"""Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33399987,diagnose,diagnosed,with cerebellar glioblastoma diagnosed between 2003 and 2017.
Abstract,"""Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33399987,analyze,analyzed,"118 cerebellar glioblastoma patients were analyzed (mean age 55.9 years,"
Abstract,"""Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33399987,associate,associated,"of cerebellar glioblastoma is associated with improved onco-functional outcomes,"
Abstract,"""Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33223826,remain,remain,recurrences of glioblastoma (gbm) after heavy standard treatments remain frequent
Abstract,"""Neuro-oncology: unmasking the multiforme in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20531430,require,required,classification of glioblastomas into various molecular entities is required for the successful
Abstract,"""The multi-target small-molecule inhibitor SB747651A shows in vitro and in vivo anticancer efficacy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33727611,observe,observed,"with intracranial glioblastoma xenografts, while no adverse effects were observed in"
Abstract,"""Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, France.""",https://pubmed.ncbi.nlm.nih.gov/24582303,change,changed,treatment of glioblastomas (gbms) has changed significantly since 2005.
Title,"""Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/11048748,treat,treated,survival of glioblastoma in patients treated with an ecog protocol of pre
Abstract,"""Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/11048748,enter,entered,from the glioblastomas of 23 patients entered into a phase ii ecog
Abstract,"""Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/11048748,predict,predict,in the glioblastoma multiforme did not predict treatment benefit.
Abstract,"""Initial experience involving treatment and retreatment with carmustine wafers in combination with oral temozolomide: long-term survival in a child with relapsed glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/20523247,occur,occur,"background: glioblastomas occur infrequently in children, and the prognosis is"
Abstract,"""Initial experience involving treatment and retreatment with carmustine wafers in combination with oral temozolomide: long-term survival in a child with relapsed glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/20523247,see,seen,than for glioblastomas seen in adults.
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,grade,grade,glioblastomas (who grade iv) may develop de novo
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,show,show,(secondary glioblastomas) both glioblastomas show similar histological features.
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,show,show,) both glioblastomas show similar histological features.
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,involve,involve,subtypes of glioblastoma involve distinct disease entities that evolve through different genetic
Title,"""Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients.""",https://pubmed.ncbi.nlm.nih.gov/32313150,predict,predicts,untreated human glioblastomas predicts the survival time for patients.
Abstract,"""Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients.""",https://pubmed.ncbi.nlm.nih.gov/32313150,collect,collected,"untreated human glioblastoma data collected in trondheim, norway, we first"
Abstract,"""Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients.""",https://pubmed.ncbi.nlm.nih.gov/32313150,re,re,"untreated human glioblastoma data in seattle, us, re-verify"
Abstract,"""Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients.""",https://pubmed.ncbi.nlm.nih.gov/32313150,predict,predict,"given the glioblastoma size in a patient, our model can predict"
Abstract,"""Photodynamic therapy of malignant brain tumours: a phase I/II trial.""",https://pubmed.ncbi.nlm.nih.gov/2855780,survive,surviving,a primary glioblastoma are surviving now up to 22 months.
Abstract,"""[Analysis of three-year survivors in patients with glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/7656829,treat,treated,"patients with glioblastomas surgically treated, there were nine patients (11"
Abstract,"""Recent advances in the molecular genetics of primary gliomas.""",https://pubmed.ncbi.nlm.nih.gov/12778011,remain,remain,", particularly glioblastomas, remain a challenge for oncology."
Title,"""Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/27683556,treat,treated,of hypermutated glioblastoma: a patient with germline pole deficiency treated with
Abstract,"""Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/27683556,hypermutate,hypermutated,left frontal glioblastoma with primitive neuroectodermal tumor features and hypermutated genotype in
Abstract,"""Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/27683556,treat,treated,principle that glioblastomas with dna-repair defects treated with checkpoint blockade
Abstract,"""INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial.""",https://pubmed.ncbi.nlm.nih.gov/30053213,characterize,characterized,"background: glioblastoma (gbm) is characterized by marked proliferation,"
Abstract,"""INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial.""",https://pubmed.ncbi.nlm.nih.gov/30053213,carry,carried,therapy for glioblastomas) treatment will be carried out in addition to
Abstract,"""INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial.""",https://pubmed.ncbi.nlm.nih.gov/30053213,follow,followed,) of glioblastoma: maximum resection surgery followed by concomitant radio-
Abstract,"""Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France.""",https://pubmed.ncbi.nlm.nih.gov/24526367,increase,increased,incidence of glioblastoma (gbm) has increased in patients aged 70
Abstract,"""Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy.""",https://pubmed.ncbi.nlm.nih.gov/30916923,prolong,prolonged,decrease in glioblastoma growth and prolonged mouse survival.
Abstract,"""Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy.""",https://pubmed.ncbi.nlm.nih.gov/30916923,extend,extended,"immunotherapy against glioblastomas, which can be extended to other aggressive tumor"
Abstract,"""MR-guided laser irradiation of recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16270287,use,using,with recurrent glioblastoma multiforme using nd:yag laser irradiation in the
Abstract,"""Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/6306179,randomize,randomized,with supratentorial glioblastomas and malignant astrocytomas were randomized to one of three
Abstract,"""Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/16820883,pretreate,pretreated,glioblastoma cells pretreated with imatinib demonstrated an enhanced sensitivity to
Abstract,"""Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/16820883,expose,exposed,in irradiated glioblastoma cells exposed to imatinib may be a consequence of
Abstract,"""Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/16820883,receive,receive,treatment of glioblastomas that receive radiation therapy.
Title,"""In vitro biological dosimeter modeling of the glioblastoma response to radiation delivered by the Gamma Knife. Laboratory investigation.""",https://pubmed.ncbi.nlm.nih.gov/21121805,deliver,delivered,of the glioblastoma response to radiation delivered by the gamma knife.
Abstract,"""Parameters influencing the efficiency of the thymidine kinase/ganciclovir strategy in human glioblastoma cell lines.""",https://pubmed.ncbi.nlm.nih.gov/9711725,expect,expected,treating human glioblastomas has not been as effective as expected after the
Title,"""Optimal timing of chemoradiation after resection or biopsy of glioblastomas: a nationwide population-based study.""",https://pubmed.ncbi.nlm.nih.gov/39587516,base,based,biopsy of glioblastomas: a nationwide population-based study.
Abstract,"""Cathepsin S expression: An independent prognostic factor in glioblastoma tumours--A pilot study.""",https://pubmed.ncbi.nlm.nih.gov/16550604,associate,associated,scores in glioblastomas were associated with significantly shorter survival (10 vs.
Abstract,"""A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/10923098,analyze,analyzed,patients with glioblastoma multiforme (gm) was analyzed retrospectively in 133
Abstract,"""Primary cerebellar glioblastomas in children: clinical presentation and management.""",https://pubmed.ncbi.nlm.nih.gov/32845414,remain,remain,pediatric cerebellar glioblastomas (pcgbms) are rare and their characteristics remain
Abstract,"""Primary cerebellar glioblastomas in children: clinical presentation and management.""",https://pubmed.ncbi.nlm.nih.gov/32845414,undergo,underwent,pediatric cerebellar glioblastomas who underwent surgery from 2008 to 2019 in our
Title,"""Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.""",https://pubmed.ncbi.nlm.nih.gov/27342976,guide,guided,radiochemotherapy of glioblastoma with fet pet-guided boost irradiation and simulation
Abstract,"""Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.""",https://pubmed.ncbi.nlm.nih.gov/27342976,compare,compared,volumes in glioblastomas compared with mri.
Abstract,"""Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.""",https://pubmed.ncbi.nlm.nih.gov/27342976,perform,perform,) of glioblastomas to perform an optimized target volume definition.
Abstract,"""Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.""",https://pubmed.ncbi.nlm.nih.gov/27342976,treat,treated,in 13 glioblastoma patients treated with radiochemotherapy within a prospective phase-
Title,"""Cerebral glioblastomas can be cured!""",https://pubmed.ncbi.nlm.nih.gov/2987748,cure,cured,cerebral glioblastomas can be cured!
Abstract,"""Cerebral glioblastomas can be cured!""",https://pubmed.ncbi.nlm.nih.gov/2987748,remove,removed,"if glioblastomas and other cerebral gliomas are removed completely, the"
Title,"""A theoretical investigation into post-operative, intracavitary beta therapy of high-grade glioblastomas using yttrium-90.""",https://pubmed.ncbi.nlm.nih.gov/17019045,use,using,-grade glioblastomas using yttrium-90.
Abstract,"""A theoretical investigation into post-operative, intracavitary beta therapy of high-grade glioblastomas using yttrium-90.""",https://pubmed.ncbi.nlm.nih.gov/17019045,cure,cure,"for malignant glioblastoma, a generally radioresistant tumour for which cure rates"
Abstract,"""Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: implications for gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/9382960,expect,expected,treating human glioblastomas has not been as effective as expected after the
Abstract,"""Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: implications for gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/9382960,transfecte,transfected,"six human glioblastoma cell lines stably transfected with the tk gene,"
Title,"""True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.""",https://pubmed.ncbi.nlm.nih.gov/23901325,normalize,normalized,treatment of glioblastomas: a comparison study of normalized cerebral blood volume
Abstract,"""True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.""",https://pubmed.ncbi.nlm.nih.gov/23901325,treat,treated,pseudoprogression of glioblastomas treated with concurrent chemoradiotherapy (ccrt) with temozolomide
Abstract,"""True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.""",https://pubmed.ncbi.nlm.nih.gov/23901325,receive,received,histopathologically proven glioblastoma who had received ccrt with tmz underwent perfusion-
Abstract,"""Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32890893,analyze,analyzed,operated for glioblastoma were analyzed.
Abstract,"""A modality-adaptive method for segmenting brain tumors and organs-at-risk in radiation therapy planning.""",https://pubmed.ncbi.nlm.nih.gov/30952038,undergo,undergoing,risk in glioblastoma patients undergoing radiation therapy.
Title,"""Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/28430038,treat,treated,survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
Abstract,"""Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/28430038,include,includes,"newly diagnosed glioblastoma (gbm) includes surgery, radiotherapy, and"
Abstract,"""Combining intraoperative carmustine wafers and Stupp regimen in multimodal first-line treatment of primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25724425,undergo,underwent,supratentorial primary glioblastomas that underwent surgical resection with intraoperative carmustine wafers implantation
Title,"""Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one.""",https://pubmed.ncbi.nlm.nih.gov/16356835,convert,convert,rays in glioblastoma cells: a strategy to convert a radio-
Abstract,"""Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one.""",https://pubmed.ncbi.nlm.nih.gov/16356835,show,show,"activity, glioblastomas show a high degree of radioresistance."
Abstract,"""Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9274449,use,using,"radiation on glioblastoma, using an organotypic multicellular spheroid (oms)"
Abstract,"""Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9274449,treat,treated,from four glioblastomas were treated with hypofractionated radiation with a radiobiologically equivalent
Abstract,"""Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23054563,invade,invade,glioblastomas (gbm) are highly motile cancers that invade
Title,"""Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI.""",https://pubmed.ncbi.nlm.nih.gov/25164691,enhance,enhanced,survival in glioblastomas by intratreatment dynamic contrast-enhanced mri.
Abstract,"""Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI.""",https://pubmed.ncbi.nlm.nih.gov/25164691,assess,assessed,patients with glioblastomas (gbms) cannot be reliably assessed until
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,treat,treated,patients with glioblastoma multiforme treated with alkylating agents.
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,analyze,analyzed,53 primary glioblastomas by the immunohistochemistry (ihc) and analyzed the
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,show,showed,-immunonegative glioblastomas showed significantly longer progression-free survival (pfs
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,treat,treated,in 41 glioblastomas treated with temozolomide (tmz) therapy (mgmt
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,receive,receiving,with primary glioblastoma receiving tmz and suggest the use of mgmt-
Abstract,"""Pediatric high grade gliomas: Clinico-pathological profile, therapeutic approaches and factors affecting overall survival.""",https://pubmed.ncbi.nlm.nih.gov/30922839,subdivide,subdivided,glioblastomas were subdivided into 26 cases of classical subtype (
Abstract,"""Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16244591,accompany,accompanied,astrocytoma to glioblastoma is often accompanied by increased angiogenesis and the upregulation
Abstract,"""Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16244591,transduce,transduced,glioblastoma cells were transduced with an adenoviral vector encoding bai1
Abstract,"""Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16244591,transplant,transplanted,-transduced glioblastoma cells transplanted into transparent skinfold chambers of scid mice
Title,"""Development of an integrated Monte Carlo model for glioblastoma multiforme treated with boron neutron capture therapy.""",https://pubmed.ncbi.nlm.nih.gov/28765533,treat,treated,model for glioblastoma multiforme treated with boron neutron capture therapy.
Title,"""Response patterns of recurrent glioblastomas treated with tumor-treating fields.""",https://pubmed.ncbi.nlm.nih.gov/25213870,treat,treated,of recurrent glioblastomas treated with tumor-treating fields.
Abstract,"""A mathematical approach to virus therapy of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26738889,benefit,benefit,treatment of glioblastomas (gbm) could benefit from oncolytic virus therapy
Abstract,"""A mathematical approach to virus therapy of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26738889,observe,observed,vsv on glioblastoma observed in vitro.
Abstract,"""Radiological assessment of necrosis in glioblastoma: variability and prognostic value.""",https://pubmed.ncbi.nlm.nih.gov/9561517,have,had,of supratentorial glioblastomas and had ct and/or mri with contrast medium before
Abstract,"""Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23960453,undergo,underwent,patients with glioblastoma who underwent gtr and postoperative rt were analyzed.
Abstract,"""Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23960453,undergo,underwent,patients with glioblastoma who underwent gtr.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,account,accounts,glioblastoma accounts for more than half of diffuse gliomas.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,remain,remains,patients with glioblastoma remains poor despite comprehensive and intensive treatments.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,remain,remains,prediction of glioblastomas remains limited.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,aid,aid,model for glioblastomas may aid in clinical prognosis evaluation.
Abstract,"""Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.""",https://pubmed.ncbi.nlm.nih.gov/18343632,correlate,correlate,subclasses of glioblastomas that correlate with survival phenotypes.
Abstract,"""Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.""",https://pubmed.ncbi.nlm.nih.gov/18343632,perform,performed,stratify unknown glioblastomas between survival groups and performed this task with 100
Abstract,"""In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15328202,respond,respond,"glioblastomas, the most common primary brain cancers, respond"
Abstract,"""In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15328202,do,did,"in several glioblastoma cell lines and primary cultures, as did gene"
Title,"""Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23418780,have,have,glioblastomas with oligodendroglial component have the same clinical phenotype as
Abstract,"""Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23418780,consider,considered,introduction: glioblastomas are the commonest primary brain tumour and are considered
Abstract,"""Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23418780,identify,identified,newly diagnosed glioblastomas were identified: 294 (74.2%) had
Title,"""3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation.""",https://pubmed.ncbi.nlm.nih.gov/10624854,plan,planned,patterns of glioblastomas after ct-planned postoperative irradiation.
Abstract,"""3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation.""",https://pubmed.ncbi.nlm.nih.gov/10624854,document,documented,-confirmed glioblastoma multiforma and documented recurrence who were irradiated in our
Title,"""Age as a predictive factor in glioblastomas: population-based study.""",https://pubmed.ncbi.nlm.nih.gov/19325245,base,based,factor in glioblastomas: population-based study.
Abstract,"""Age as a predictive factor in glioblastomas: population-based study.""",https://pubmed.ncbi.nlm.nih.gov/19325245,diagnose,diagnosed,evaluated 715 glioblastoma patients diagnosed during 1980-1994 in the canton
Abstract,"""Gene therapy of experimental brain tumors using neural progenitor cells.""",https://pubmed.ncbi.nlm.nih.gov/10742153,limit,limited,therapy of glioblastomas is limited by the short survival of viral vectors
Abstract,"""Gene therapy of experimental brain tumors using neural progenitor cells.""",https://pubmed.ncbi.nlm.nih.gov/10742153,infiltrate,infiltrating,in reaching glioblastoma cells infiltrating the brain parenchyma.
Abstract,"""Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29788727,involve,involved,64 primary glioblastomas and 4 secondary glioblastomas were involved in this study
Abstract,"""Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29788727,involve,involved,4 secondary glioblastomas were involved in this study.
Abstract,"""Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29788727,target,targeting,treatment of glioblastomas targeting hcmv was needed to be revalued by studied
Abstract,"""Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group.""",https://pubmed.ncbi.nlm.nih.gov/17122945,collect,collected,histologically proven glioblastomas from 9 lombardy hospitals collected in the same database
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,show,shown,radiotherapy for glioblastoma was recently shown to improve median and 2-
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,perform,performed,patients with glioblastoma at our institute was performed.
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,treat,treated,pathologically confirmed glioblastoma were treated with radiotherapy (daily fractions of 2
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,share,share,"temozolomide for glioblastoma in korean patients, who share a common genetic"
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,use,using,"the recurrent glioblastomas refractory to temozolomide, further clinical trials using other"
Abstract,"""Histological changes in glioblastoma after intratumoral injection of autologous lymphocytes and human lymphoblastoid interferon.""",https://pubmed.ncbi.nlm.nih.gov/2166927,study,studied,seven glioblastomas were studied between 1 and 6 months after intratumoral
Abstract,"""Histological changes in glioblastoma after intratumoral injection of autologous lymphocytes and human lymphoblastoid interferon.""",https://pubmed.ncbi.nlm.nih.gov/2166927,suggest,suggesting,"lymphocytes and glioblastoma cells, suggesting a killing phenomenon."
Abstract,"""Histological changes in glioblastoma after intratumoral injection of autologous lymphocytes and human lymphoblastoid interferon.""",https://pubmed.ncbi.nlm.nih.gov/2166927,activate,activated,patients with glioblastoma by means of intratumoral administration of activated lymphoid cells
Abstract,"""Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan.""",https://pubmed.ncbi.nlm.nih.gov/24675671,evaluate,evaluate,"in recurrent glioblastomas (rgbm), and to evaluate if changes"
Title,"""Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.""",https://pubmed.ncbi.nlm.nih.gov/20708556,include,including,"therapeutics in glioblastomas, including targeted molecular therapies, current and future"
Abstract,"""Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.""",https://pubmed.ncbi.nlm.nih.gov/20708556,target,targeted,"therapies for glioblastoma, with an emphasis on targeted agents."
Abstract,"""Diffusion tensor invasive phenotypes can predict progression-free survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23445331,remain,remain,introduction: glioblastomas multiformes (gbm) remain incurable in most cases
Abstract,"""LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.""",https://pubmed.ncbi.nlm.nih.gov/22553327,screen,screened,"against human glioblastomas, we screened 12 parvoviruses at a high multiplicity"
Abstract,"""LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.""",https://pubmed.ncbi.nlm.nih.gov/22553327,test,tested,five human glioblastomas tested. h-1
Abstract,"""LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.""",https://pubmed.ncbi.nlm.nih.gov/22553327,infect,infected,", human glioblastoma xenografts were selectively infected by luiii when administered intratumorally"
Abstract,"""High dose hyperfractionated radiotherapy for adults with glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/8280367,treat,treated,patients with glioblastoma multiforme or anaplastic astrocytoma of the brain were treated
Abstract,"""Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.""",https://pubmed.ncbi.nlm.nih.gov/22865003,develop,develop,and secondary glioblastomas develop through different genetic pathways.
Abstract,"""Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.""",https://pubmed.ncbi.nlm.nih.gov/22865003,confirm,confirming,"in primary glioblastoma, confirming that this mutation is a hallmark of"
Abstract,"""An extent of resection threshold for newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21417701,remain,remains,patients with glioblastoma multiforme (gbm) remains controversial.
Abstract,"""Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings.""",https://pubmed.ncbi.nlm.nih.gov/2535765,distinguish,distinguished,appearance of glioblastomas multiforme distinguished them from less malignant gliomas.
Title,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,give,given,outcome in glioblastomas given temozolomide and radiotherapy.
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,treat,treated,survival in glioblastomas treated with alkylating agents.
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,treat,treated,methylation in glioblastomas treated with temozolomide and radiotherapy in a single uk
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,show,showed,of 109 glioblastomas showed average methylation >non-neoplastic brain in
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,give,given,"significant in glioblastomas given chemoradiotherapy in the routine clinic; furthermore,"
Abstract,"""Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/8200000,remain,remains,patients with glioblastomas remains poor.
Title,"""Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.""",https://pubmed.ncbi.nlm.nih.gov/12884028,treat,treated,patients with glioblastoma multiforme treated with a combined modality approach.
Abstract,"""Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.""",https://pubmed.ncbi.nlm.nih.gov/12884028,treat,treated,patients with glioblastoma multiforme (gbm) treated with a combined modality
Title,"""Gene therapy of glioblastomas: from suicide to homicide.""",https://pubmed.ncbi.nlm.nih.gov/11545030,homicide,homicide,therapy of glioblastomas: from suicide to homicide.
Abstract,"""[A case of primary cerebellar glioblastoma in childhood].""",https://pubmed.ncbi.nlm.nih.gov/12491584,deteriorate,deteriorated,"primary cerebellar glioblastoma, who rapidly deteriorated due to cerebrospinal fluid dissemination"
Abstract,"""[A case of primary cerebellar glioblastoma in childhood].""",https://pubmed.ncbi.nlm.nih.gov/12491584,carry,carry,primary cerebellar glioblastomas in children carry a very poor prognosis and tend
Title,"""Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.""",https://pubmed.ncbi.nlm.nih.gov/26450533,use,using,patients with glioblastomas using diffusion tensor imaging and dynamic susceptibility contrast mri
Abstract,"""Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.""",https://pubmed.ncbi.nlm.nih.gov/26450533,exhibit,exhibiting,patients with glioblastomas exhibiting enhancing lesions within 6 months after completion of
Title,"""Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.""",https://pubmed.ncbi.nlm.nih.gov/8570130,compare,compared,in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared
Abstract,"""Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.""",https://pubmed.ncbi.nlm.nih.gov/8570130,treat,treated,patients with glioblastoma treated with radical or adjuvant radiotherapy (rt)
Abstract,"""Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.""",https://pubmed.ncbi.nlm.nih.gov/8570130,randomize,randomized,"patients with glioblastoma, who were randomized to receive rt alone ("
Abstract,"""Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results.""",https://pubmed.ncbi.nlm.nih.gov/18647495,receive,receiving,"study, glioblastomas with low mgmt expression receiving surgical resection, radiotherapy"
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,amplify,amplified,"of all glioblastomas have amplified the egfr gene, and about half"
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,remain,remain,"versus primary glioblastomas remain controversial, but such data are highly relevant"
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,assess,assessed,-amplified glioblastomas from 106 patients were assessed for egfrviii positivity.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,evaluate,evaluated,to recurrent glioblastomas were evaluated in 40 patients with egfr-amplified
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,acquire,acquired,-nonamplified glioblastomas acquired egfr amplification or egfrviii at recurrence.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,maintain,maintain,-positive glioblastomas maintain egfrviii positivity at recurrence.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,receive,receive,with recurrent glioblastoma to receive egfrviii-targeting agents.
Abstract,"""Radiation of infratentorial and supratentorial brain-stem tumors.""",https://pubmed.ncbi.nlm.nih.gov/167136,extend,extended,that all glioblastomatous tumors extended beyond the treatment field; this suggested
Abstract,"""Interstitial thermoradiotherapy of brain tumors: preliminary results of a phase I clinical trial.""",https://pubmed.ncbi.nlm.nih.gov/2175738,have,had,"diagnosis of glioblastoma multiforme, whereas three had anaplastic astrocytoma."
Abstract,"""[Secondary intraspinal localizations of glioblastoma. Apropos of a case].""",https://pubmed.ncbi.nlm.nih.gov/8577358,describe,described,of intracranial glioblastomas have been described for the first time more than
Abstract,"""[Secondary intraspinal localizations of glioblastoma. Apropos of a case].""",https://pubmed.ncbi.nlm.nih.gov/8577358,suggest,suggested,diagnosis of glioblastoma metastasis was suggested by intra-operative pathological findings
Title,"""Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes.""",https://pubmed.ncbi.nlm.nih.gov/22806339,qualitative,qualitative,butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes
Abstract,"""Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes.""",https://pubmed.ncbi.nlm.nih.gov/22806339,perform,performed,"of butterfly glioblastomas, we performed a ten year retrospective analysis of"
Abstract,"""The glioblastoma multiforme: a lifelong challenge to the neurosurgeon.""",https://pubmed.ncbi.nlm.nih.gov/3008012,undertake,undertaken,therapy of glioblastomas various attempts have been undertaken to prevent recurrences:
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,occur,occur,"glioblastomas, the most aggressive primary brain tumors, occur"
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,induce,induce,migrate to glioblastomas and induce tumor cell death.
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,divert,diverted,at a glioblastoma are diverted from their normal migratory path to the
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,result,resulted,induced cortical glioblastomas resulted in decreased subventricular proliferation in adult (postnatal
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,have,had,npcs to glioblastomas and had larger tumors than young mice.
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,isolate,isolated,to kill glioblastomas was similar in npcs isolated from young and adult
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,depend,depended,npcs to glioblastomas depended on the expression of d-type cyclins
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,compare,compared,npcs to glioblastomas and the generation of larger tumors compared with wild
Abstract,"""Extent of tumor-brain interface: a new tool to predict evolution of malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11235948,target,targeted,"recurrences of glioblastoma were targeted with suicide genes, the authors developed"
Abstract,"""Extent of tumor-brain interface: a new tool to predict evolution of malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11235948,enrol,enrolled,with recurrent glioblastomas were enrolled in this study.
Abstract,"""[Follow-up study of malignant astrocytomas showing complete response after initial treatment].""",https://pubmed.ncbi.nlm.nih.gov/8015675,grade,grade,and 24 glioblastomas (who grade iv).
Abstract,"""Postoperative irradiation of glioblastomas. Results in a randomized series.""",https://pubmed.ncbi.nlm.nih.gov/216238,present,presented,patients with glioblastoma is presented.
Abstract,"""Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol.""",https://pubmed.ncbi.nlm.nih.gov/11349882,yield,yield,astrocytomas and glioblastomas do not yield sufficient results.
Abstract,"""Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol.""",https://pubmed.ncbi.nlm.nih.gov/11349882,enrol,enrolled,patients with glioblastomas and anaplastic astrocytomas were enrolled in a phase ii
Abstract,"""Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol.""",https://pubmed.ncbi.nlm.nih.gov/11349882,exhibit,exhibited,", 2 glioblastomas and 1 astrocytoma grade iii, exhibited a particular"
Abstract,"""Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol.""",https://pubmed.ncbi.nlm.nih.gov/11349882,show,showed,"patients with glioblastomas, 2 cases showed this response; after 4"
Abstract,"""Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/15666327,undergo,underwent,patients with glioblastomas and 916 patients with brain metastases who underwent radiotherapy
Abstract,"""Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/15666327,determine,determined,patients with glioblastomas or brain metastases was not determined by age-
Abstract,"""Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.""",https://pubmed.ncbi.nlm.nih.gov/16808884,support,supports,bearing intracranial glioblastomas and supports the development of dc-based clinical
Abstract,"""Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.""",https://pubmed.ncbi.nlm.nih.gov/16808884,respond,respond,patients with glioblastomas that do not respond to standard therapies.
Abstract,"""Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/3037617,include,including,resection of glioblastoma with different total doses and fractionation schedules including 38
Abstract,"""Role of MIB1 in predicting survival in patients with glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16234986,predict,predicted,"survival with glioblastoma was predicted by kps, age, extent of"
Abstract,"""MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome.""",https://pubmed.ncbi.nlm.nih.gov/18000822,grade,grade,"and recurrent glioblastomas (gbm, who grade iv) of patients"
Title,"""Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/9581814,harbor,harboring,of cerebral glioblastomas harboring p53 mutations.
Abstract,"""Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/9581814,determine,determined,patients with glioblastomas whose p53 status was determined by a sensitive yeast
Abstract,"""Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/9581814,result,results,"response in glioblastomas, and this results in significantly longer survival."
Abstract,"""A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas.""",https://pubmed.ncbi.nlm.nih.gov/9893629,be,was,among glioblastoma patients < 55 years of age there was a
Abstract,"""Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation.""",https://pubmed.ncbi.nlm.nih.gov/20205512,show,showing,patients with glioblastomas showing progression; in 9 of these 16 patients
Abstract,"""Primary cerebellar glioblastomas multiforme in children. Report of four cases.""",https://pubmed.ncbi.nlm.nih.gov/10067927,have,has,"with cerebellar glioblastomas is extremely poor, and the tumor has a"
Title,"""Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/15484695,correlate,correlates,nuclei in glioblastomas correlates with preoperative data from proton-mr-
Abstract,"""Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/15484695,represent,representing,histomorphology of glioblastomas representing the most frequent type of brain tumors was
Abstract,"""Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/15484695,support,supporting,characteristics of glioblastomas supporting the biological relevance of spectroscopic data for the
Abstract,"""Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features.""",https://pubmed.ncbi.nlm.nih.gov/19616898,attempt,attempted,"with primary glioblastomas, and attempted to identify any associations with ki-67"
Abstract,"""Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin).""",https://pubmed.ncbi.nlm.nih.gov/11789404,remain,remains,radioresistance of glioblastoma multiforme the prognosis of this disease remains poor.
Abstract,"""Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin).""",https://pubmed.ncbi.nlm.nih.gov/11789404,undergo,underwent,histologically proven glioblastoma multiforme underwent a simultaneous radio-chemotherapy.
Abstract,"""Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin).""",https://pubmed.ncbi.nlm.nih.gov/11789404,tolerate,tolerated,patients with glioblastoma multiforme is well tolerated.
Abstract,"""Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/7763035,study,studied,of 27 glioblastomas multiforme were studied to compare the prognostic value of
Abstract,"""Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/6297227,study,studied,reproliferation of glioblastomas after radiation and chemotherapy has been studied in 25
Abstract,"""[Prediction of clinical course of glioblastomas by MRI during radiotherapy].""",https://pubmed.ncbi.nlm.nih.gov/21221885,predict,predict,radiotherapy for glioblastomas pre and during radiotherapy to predict the clinical course
Abstract,"""[Prediction of clinical course of glioblastomas by MRI during radiotherapy].""",https://pubmed.ncbi.nlm.nih.gov/21221885,allow,allow,"radiotherapy for glioblastomas allow for prognostic appraisal, and potentially early modification"
Abstract,"""[Interest of clinical classification in prognosis and therapeutics of multiform glioblastomas of adult patients (author's transl)].""",https://pubmed.ncbi.nlm.nih.gov/6259742,have,had,whose multiform glioblastoma had an histological confirmation.
Abstract,"""Anti-Angiogenics: Their Role in the Treatment of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29562225,fall,fallen,"hallmark of glioblastomas, but anti-angiogenic therapies have fallen short"
Abstract,"""Anti-Angiogenics: Their Role in the Treatment of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29562225,limit,limited,"and recurrent glioblastoma, this efficacy is, however, limited to"
Abstract,"""Anti-Angiogenics: Their Role in the Treatment of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29562225,include,including,"therapy in glioblastoma, including how it is currently used in the"
Abstract,"""Anti-Angiogenics: Their Role in the Treatment of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29562225,profit,profiting,identify those glioblastoma patients with a higher likelihood of profiting from anti
Abstract,"""The Role of Checkpoint Inhibitors in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31290002,represent,represents,"prognosis, glioblastoma represents an area of high unmet clinical need."
Abstract,"""The Role of Checkpoint Inhibitors in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31290002,limit,limited,treatment of glioblastoma in the frontline setting is limited to surgical resection
Abstract,"""The Role of Checkpoint Inhibitors in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31290002,restrict,restricted,"in glioblastoma, the notion of a highly immune-restricted"
Abstract,"""The Role of Checkpoint Inhibitors in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31290002,include,including,"inhibitors in glioblastoma, including the optimal combinations, and identification of"
Abstract,"""Therapeutic strategies for inhibiting invasion in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19344303,invade,invade,patients with glioblastomas is the propensity of the tumor to invade into
Title,"""IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy.""",https://pubmed.ncbi.nlm.nih.gov/38326875,stratify,stratified,idhwt glioblastomas can be stratified by their transcriptional response to standard
Abstract,"""IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy.""",https://pubmed.ncbi.nlm.nih.gov/38326875,lack,lacking,background: glioblastoma (gbm) brain tumors lacking idh1 mutations (
Abstract,"""Patterns of intracranial glioblastoma recurrence after aggressive surgical resection and adjuvant management: retrospective analysis of 43 cases.""",https://pubmed.ncbi.nlm.nih.gov/22976141,change,change,of intracranial glioblastoma may change its recurrence pattern.
Abstract,"""CD44 expression and tumour cell density correlate with response to tamoxifen/carboplatin chemotherapy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15015779,consist,consisting,"-operative glioblastoma therapy consisting of tamoxifen, carboplatin and radiotherapy,"
Abstract,"""Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25768833,diagnose,diagnosed,with primary glioblastoma diagnosed since 2005 and treated according to the standard
Abstract,"""Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25768833,know,known,newly diagnosed glioblastoma with known time to initiation of radiotherapy identified in
Title,"""Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/37236575,target,targeted,for orthotopic glioblastoma targeted photothermal immunotherapy.
Abstract,"""Concept of a fully-implantable system to monitor tumor recurrence.""",https://pubmed.ncbi.nlm.nih.gov/37773315,include,includes,"treatment for glioblastoma includes tumor resection followed by radiation, chemotherapy,"
Abstract,"""Concept of a fully-implantable system to monitor tumor recurrence.""",https://pubmed.ncbi.nlm.nih.gov/37773315,intend,intended,to monitor glioblastoma patients is intended to early detect recurrent cancerous tissue
Abstract,"""Percent change of perfusion skewness and kurtosis: a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22771885,undergo,underwent,newly diagnosed glioblastomas who underwent concurrent chemotherapy and radiation therapy (ccrt
Abstract,"""Graphene nanomesh promises extremely efficient in vivo photothermal therapy.""",https://pubmed.ncbi.nlm.nih.gov/23625739,have,having,"of human glioblastoma u87mg tumors having  3 integrin receptors,"
Title,"""Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system.""",https://pubmed.ncbi.nlm.nih.gov/34015380,use,using,drugs for glioblastoma treatment using nanostructured system.
Title,"""Multifocal glioblastoma multiforme in the posterior fossa mimicking cerebral metastases: case presentation and review of the current literature.""",https://pubmed.ncbi.nlm.nih.gov/23427036,mimic,mimicking,multifocal glioblastoma multiforme in the posterior fossa mimicking cerebral metastases:
Abstract,"""Multifocal glioblastoma multiforme in the posterior fossa mimicking cerebral metastases: case presentation and review of the current literature.""",https://pubmed.ncbi.nlm.nih.gov/23427036,arise,arise,"general, glioblastomas multiforme (gbm) arise in the supratentorial region"
Abstract,"""Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30176837,suggest,suggested,"bearing orthotopic glioblastomas, it also suggested the administration did not completely"
Abstract,"""Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30176837,inoculate,inoculated,rat rg2 glioblastoma cells were inoculated into the brains of 36 rats
Title,"""Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy-GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study.""",https://pubmed.ncbi.nlm.nih.gov/34930368,use,using,glioblastoma radiotherapy using intensity modulated radiotherapy (imrt) or
Abstract,"""Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.""",https://pubmed.ncbi.nlm.nih.gov/26585720,improve,improves,grade iv glioblastomas improves survival while preserving outcome in selected patients.
Abstract,"""Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.""",https://pubmed.ncbi.nlm.nih.gov/26585720,undergo,underwent,grade iv glioblastomas who underwent craniotomy and excision.
Abstract,"""Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.""",https://pubmed.ncbi.nlm.nih.gov/26585720,repeat,repeated,"grade iv glioblastomas, repeated excision, aiming for gross total resection"
Abstract,"""Metabolic Vulnerabilities in Brain Cancer.""",https://pubmed.ncbi.nlm.nih.gov/33781499,alter,altered,glioblastomas (gbms) exhibit altered metabolism to support a
Title,"""Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors.""",https://pubmed.ncbi.nlm.nih.gov/28212808,improve,improving,amplification in glioblastoma in vivo: improving patient selection to mdm2-
Abstract,"""Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors.""",https://pubmed.ncbi.nlm.nih.gov/28212808,exhibit,exhibited,% of glioblastomas exhibited high mdm2 amplification (in vivo) with
Abstract,"""Glioblastoma: Part I. Current state of affairs.""",https://pubmed.ncbi.nlm.nih.gov/21736079,offer,offered,treatment of glioblastoma (gbm) have offered new hope for patients
Title,"""Effectiveness of different treatment strategies in elderly patients with glioblastoma: An evidence map of randomized controlled trials.""",https://pubmed.ncbi.nlm.nih.gov/35227898,randomize,randomized,patients with glioblastoma: an evidence map of randomized controlled trials.
Abstract,"""Effectiveness of different treatment strategies in elderly patients with glioblastoma: An evidence map of randomized controlled trials.""",https://pubmed.ncbi.nlm.nih.gov/35227898,define,defined,patients with glioblastoma (gbm) (defined as 60 years old
Abstract,"""[Glioblastoma multiforme--new hope due to modern therapeutical approaches].""",https://pubmed.ncbi.nlm.nih.gov/20205087,encounter,encountered,glioblastoma multiforme (gbm) is the most frequently encountered
Abstract,"""[Glioblastoma multiforme--new hope due to modern therapeutical approaches].""",https://pubmed.ncbi.nlm.nih.gov/20205087,accomplish,accomplished,studies with glioblastoma patients are accomplished with the aim to further improve
Abstract,"""System-based approaches as prognostic tools for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31718568,diagnose,diagnosed,influence how glioblastoma is diagnosed and treated in the future.
Abstract,"""Molecular heterogeneity of glioblastoma and its clinical relevance.""",https://pubmed.ncbi.nlm.nih.gov/25156108,constitute,constitutes,glioblastoma is the most common intracranial malignancy and constitutes about
Abstract,"""Molecular heterogeneity of glioblastoma and its clinical relevance.""",https://pubmed.ncbi.nlm.nih.gov/25156108,explain,explain,profiles in glioblastoma may explain the difficulties encountered in the validation of
Abstract,"""Molecular heterogeneity of glioblastoma and its clinical relevance.""",https://pubmed.ncbi.nlm.nih.gov/25156108,call,call,"heterogeneity of glioblastomas, and call attention to the importance of this"
Title,"""Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability-an in-silico study.""",https://pubmed.ncbi.nlm.nih.gov/37102792,base,based,radiotherapy for glioblastoma based on diffusion-weighted mri and tumor control
Title,"""Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/38504986,target,targeted,"subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and"
Abstract,"""Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/38504986,present,presents,introduction: glioblastoma (gbm) presents significant challenges due to its
Abstract,"""A novel tool to analyze MRI recurrence patterns in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18676355,occur,occur,% of glioblastoma relapses occur at distant and even contralateral locations.
Abstract,"""Harnessing the immune system in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30393372,harness,harness,therapies for glioblastoma that harness the immune system and their current clinical
Abstract,"""[Cerebellar glioblastoma multiforme: a case report].""",https://pubmed.ncbi.nlm.nih.gov/15152353,account,accounts,: cerebellar glioblastoma multiforme (cgm) accounts for less than 1
Abstract,"""[Cerebellar glioblastoma multiforme: a case report].""",https://pubmed.ncbi.nlm.nih.gov/15152353,spread,spreads,"all intracranial glioblastomas; it spreads quickly locally, above all towards"
Abstract,"""[Cerebellar glioblastoma multiforme: a case report].""",https://pubmed.ncbi.nlm.nih.gov/15152353,make,made,diagnosis of glioblastoma multiforme to be made; radio and chemotherapy were
Abstract,"""Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle.""",https://pubmed.ncbi.nlm.nih.gov/18308523,cluster,clustering,"show that glioblastomas, although clustering at the high end of rates"
Abstract,"""Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle.""",https://pubmed.ncbi.nlm.nih.gov/18308523,identify,identified,that individual glioblastomas may be identified as having been radio-resistant
Abstract,"""Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27891815,cause,caused,enhancement of glioblastomas (gbm) is caused by the decrease in
Title,"""Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.""",https://pubmed.ncbi.nlm.nih.gov/20880389,use,using,glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently
Abstract,"""Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.""",https://pubmed.ncbi.nlm.nih.gov/20880389,constitute,constituted,glioblastoma treatment as now constituted offers increased survival measured in
Abstract,"""Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.""",https://pubmed.ncbi.nlm.nih.gov/20880389,synthesize,synthesizing,because glioblastomas are active in synthesizing a bewildering variety of growth
Abstract,"""Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.""",https://pubmed.ncbi.nlm.nih.gov/20880389,review,reviewed,changes in glioblastoma is reviewed in this paper.
Abstract,"""Updates on Surgical Management and Advances for Brain Tumors.""",https://pubmed.ncbi.nlm.nih.gov/33630180,correlate,correlated,patients with glioblastoma are strongly correlated with extent of initial surgical resection
Abstract,"""Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/31704835,transplant,transplanted,u251 human glioblastoma cell lines and subcutaneously transplanted u87 cells in scid
Abstract,"""Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/31704835,lead,lead,cytotoxicity toward glioblastoma cells in vitro and its intratumoral injections lead to
Abstract,"""Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/31704835,internalize,internalize,capability of glioblastoma cancer stem cells to internalize a fluorescent-labeled
Abstract,"""Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.""",https://pubmed.ncbi.nlm.nih.gov/32202316,report,reported,"newly diagnosed glioblastoma, the other six reported data for an elderly"
Abstract,"""Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.""",https://pubmed.ncbi.nlm.nih.gov/32202316,care,caring,"people with glioblastoma who are self-caring, evidence suggests that"
Abstract,"""Interleukin-2 (IL-2) in the treatment of malignant brain tumors (glioblastomas).""",https://pubmed.ncbi.nlm.nih.gov/8011483,control,control,"treatment of glioblastomas, in an effort to control the extremely severe"
Abstract,"""Interleukin-2 (IL-2) in the treatment of malignant brain tumors (glioblastomas).""",https://pubmed.ncbi.nlm.nih.gov/8011483,operate,operated,in 9 glioblastoma patients (operated on at the neurosurgery department vii
Title,"""Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report.""",https://pubmed.ncbi.nlm.nih.gov/18034212,treat,treated,recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-
Abstract,"""Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report.""",https://pubmed.ncbi.nlm.nih.gov/18034212,continue,continues,glioblastoma multiforme continues to be a devastating disease despite modest
Abstract,"""Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report.""",https://pubmed.ncbi.nlm.nih.gov/18034212,treat,treated,"left frontal glioblastoma multiforme treated by surgery, radiation and chemotherapy,"
Abstract,"""Neoplastic Myelopathies.""",https://pubmed.ncbi.nlm.nih.gov/29613896,recognize,recognized,"grade iv glioblastomas, and newly recognized pediatric diffuse midline gliomas with"
Abstract,"""Evolution of care for patients with relapsed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22050021,challenge,challenging,"with relapsed glioblastoma is challenging, with no widely agreed standard of"
Abstract,"""Evolution of care for patients with relapsed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22050021,highlight,highlighting,"challenge in glioblastoma, highlighting the need for relevant and standardized patient"
Title,"""Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.""",https://pubmed.ncbi.nlm.nih.gov/21052775,randomize,randomized,newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase iii trial
Abstract,"""Longitudinal analysis of treatment-induced genomic alterations in gliomas.""",https://pubmed.ncbi.nlm.nih.gov/28153049,constitute,constitutes,background: glioblastoma multiforme (gbm) constitutes nearly half of all
Abstract,"""Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.""",https://pubmed.ncbi.nlm.nih.gov/29768997,remain,remain,presence of glioblastoma stem cells (gscs) remain as two problems
Title,"""Biomimeting ultra-small lipid nanoconstructs for glioblastoma treatment: A computationally guided experimental approach.""",https://pubmed.ncbi.nlm.nih.gov/32693289,guide,guided,nanoconstructs for glioblastoma treatment: a computationally guided experimental approach.
Abstract,"""Biomimeting ultra-small lipid nanoconstructs for glioblastoma treatment: A computationally guided experimental approach.""",https://pubmed.ncbi.nlm.nih.gov/32693289,develop,developed,"potential in glioblastoma research and therapy, we have developed an usnlc"
Abstract,"""Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy.""",https://pubmed.ncbi.nlm.nih.gov/216819,perform,performed,irradiation for glioblastoma multiforme was performed.
Abstract,"""MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities.""",https://pubmed.ncbi.nlm.nih.gov/17219056,treat,treated,of 219 glioblastomas (gbms) treated with various modalities.
Title,"""Reply to: age as a predictive factor in glioblastomas: population-based study.""",https://pubmed.ncbi.nlm.nih.gov/20068359,base,based,factor in glioblastomas: population-based study.
Title,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,locate,located,glioblastomas located in proximity to the subventricular zone (svz
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,locate,located,results: glioblastoma located in proximity to the svz showed increased mrna
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,exhibit,exhibit,"suggesting that glioblastoma stem cells exhibit increased dna repair capacity, glioblastomas"
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,show,showed,"capacity, glioblastomas in proximity to the svz also showed increased expression"
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,harbor,harbored,genomes of glioblastomas in svz proximity harbored fewer single nucleotide polymorphisms relative
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,exhibit,exhibited,patients with glioblastoma in proximity to svz exhibited poorer progression free and
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,locate,located,suggests that glioblastomas located in proximity to the svz exhibited mrna expression
Abstract,"""Therapeutic Hypothermia in Treating Glioblastoma: A Review.""",https://pubmed.ncbi.nlm.nih.gov/37184912,occur,occurring,glioblastoma (gbm) is the most commonly occurring of
Abstract,"""Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12711288,establish,established,orthotopic c6 glioblastomas were established in wistar rats.
Abstract,"""Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12711288,increase,increased,"model of glioblastoma, encapsulation of a xenogeneic packaging cell line increased"
Abstract,"""Operability of glioblastomas: 'sins of action' versus 'sins of non-action'.""",https://pubmed.ncbi.nlm.nih.gov/23479032,mount,mounting,"prognosis of glioblastomas is still poor, mounting evidence suggests that more"
Abstract,"""Operability of glioblastomas: 'sins of action' versus 'sins of non-action'.""",https://pubmed.ncbi.nlm.nih.gov/23479032,operate,operated,results of glioblastoma resection in 104 patients operated on between march 2005
Abstract,"""Operability of glioblastomas: 'sins of action' versus 'sins of non-action'.""",https://pubmed.ncbi.nlm.nih.gov/23479032,find,found,removal of glioblastoma with many complexities (group 1) was found
Title,"""Intraarterial drug delivery for glioblastoma mutiforme: Will the phoenix rise again?""",https://pubmed.ncbi.nlm.nih.gov/26108656,rise,rise,delivery for glioblastoma mutiforme: will the phoenix rise again?
Abstract,"""Intraarterial drug delivery for glioblastoma mutiforme: Will the phoenix rise again?""",https://pubmed.ncbi.nlm.nih.gov/26108656,attempt,attempted,treatment of glioblastoma multiforme (gbm) has been attempted since the
Title,"""Refined efficacy and outcome estimates of surgical treatment in oldest-old patients with glioblastomas based on competing risk model and conditional survival analysis: A surveillance, epidemiology, and end results population-based study.""",https://pubmed.ncbi.nlm.nih.gov/35930955,base,based,patients with glioblastomas based on competing risk model and conditional survival analysis
Abstract,"""Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape.""",https://pubmed.ncbi.nlm.nih.gov/36311702,indicate,indicates,of the glioblastoma tumor indicates that tam-targeting immunotherapy could represent
Abstract,"""Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape.""",https://pubmed.ncbi.nlm.nih.gov/36311702,describe,describe,tams in glioblastoma; ii) describe the formation of the immunosuppressive
Abstract,"""A local water molecular-heating strategy for near-infrared long-lifetime imaging-guided photothermal therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37179387,target,targeted,"in the glioblastoma multiforme male mouse model, tumor-targeted water"
Abstract,"""Novel Clinical Trials and Approaches in the Management of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38546941,maximize,maximize,patients with glioblastoma to maximize efficacy in discovering effective treatments.
Abstract,"""Optimal control of combination immunotherapy for a virtual murine cohort in a glioblastoma-immune dynamics model.""",https://pubmed.ncbi.nlm.nih.gov/39307417,include,include,-free glioblastoma-immune dynamics ode model to include interventions with
Abstract,"""High-grade gliomas: reality and hopes.""",https://pubmed.ncbi.nlm.nih.gov/24384235,remain,remains,", especially glioblastoma, remains poor, and more research is needed"
Abstract,"""Radiotherapy in Glioblastoma: the Past, the Present and the Future.""",https://pubmed.ncbi.nlm.nih.gov/27743773,advance,advanced,"treatment of glioblastoma, but techniques have significantly advanced over this time"
Abstract,"""Synergistic effect of STAT3-targeted small interfering RNA and AZD0530 against glioblastoma in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/31485668,divide,divided,glioblastoma cell lines u87 and u251 were divided into four
Abstract,"""Synergistic effect of STAT3-targeted small interfering RNA and AZD0530 against glioblastoma in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/31485668,assess,assessed,capacity of glioblastoma cells was assessed by cell counting kit8 and double
Abstract,"""Synergistic effect of STAT3-targeted small interfering RNA and AZD0530 against glioblastoma in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/31485668,evaluate,evaluated,azd0530 on glioblastoma was evaluated in vivo.
Abstract,"""Synergistic effect of STAT3-targeted small interfering RNA and AZD0530 against glioblastoma in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/31485668,support,supporting,"effects on glioblastoma, supporting the idea that the combination of lvstat3"
Abstract,"""Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.""",https://pubmed.ncbi.nlm.nih.gov/35938932,attribute,attributed,nature of glioblastoma is multifactorial and has been attributed to its biological
Abstract,"""Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/9191875,express,express,malignant glioblastoma may over-express the epidermal-growth-
Abstract,"""Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/9191875,enter,entered,"-positive glioblastomas entered the study, which was designed to evaluate"
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,remain,remains,treatment of glioblastomas remains ineffective and essentially palliative.
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,display,display,cells called glioblastoma stem cells (gscs) display relative resistance to
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,metastasize,metastasize,"while glioblastomas rarely metastasize beyond the central nervous system, glioblastomas"
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,invade,invade,"system, glioblastomas invade into brain structures to prevent surgical cure and"
Abstract,"""In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26202682,release,released,newly diagnosed glioblastoma (gbm) patients were released.
Abstract,"""[Hypofractioned radiotherapy in elderly patient with glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/30197025,consist,consists,treatment of glioblastoma consists of adjuvant chemoradiotherapy.
Abstract,"""The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33524945,progress,progressed,"pathogenesis of glioblastoma has progressed in recent years, therapeutic options have"
Abstract,"""The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33524945,bring,brought,signaling in glioblastoma has brought new hope to the field of neuro
Abstract,"""The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33524945,provide,providing,"activity against glioblastoma, providing a promising avenue of potential treatment."
Abstract,"""miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks.""",https://pubmed.ncbi.nlm.nih.gov/26439688,lead,leading,glioblastoma (gbm) has long been the leading cause
Abstract,"""Emerging therapies for glioblastoma: current state and future directions.""",https://pubmed.ncbi.nlm.nih.gov/35428347,translate,translated,"science of glioblastoma are rapidly translated into innovative clinical trials, utilizing"
Title,"""Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/19250783,treat,treated,glioblastoma treated with postoperative radio-chemotherapy: prognostic value
Abstract,"""Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/19250783,obtain,obtained,) of glioblastomas obtained from pretreatment mr images is of prognostic value
Abstract,"""Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/19250783,undergo,underwent,with supratentorial glioblastoma underwent pretreatment magnetic resonance (mr) imaging.
Abstract,"""Cell death-based treatment of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29371590,evolve,evolved,cells including glioblastoma have typically evolved multiple mechanisms to escape programmed cell
Title,"""[Glioblastoma That Does Not Improve with Standard Treatment: Standard and Personalized Treatment Making The Most of Limited Modalities].""",https://pubmed.ncbi.nlm.nih.gov/35589663,improve,improve,[glioblastoma that does not improve with standard treatment: standard
Abstract,"""[Glioblastoma That Does Not Improve with Standard Treatment: Standard and Personalized Treatment Making The Most of Limited Modalities].""",https://pubmed.ncbi.nlm.nih.gov/35589663,follow,followed,treatment for glioblastoma is maximal surgical resection followed by postoperative temozolomide administration
Abstract,"""[Glioblastoma That Does Not Improve with Standard Treatment: Standard and Personalized Treatment Making The Most of Limited Modalities].""",https://pubmed.ncbi.nlm.nih.gov/35589663,remain,remains,"years, glioblastoma remains a fatal malignant brain tumor."
Abstract,"""STAT3 as a Therapeutic Target for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20879983,express,express,derived primary glioblastomas and cell lines express constitutively activated signal transducers and
Abstract,"""STAT3 as a Therapeutic Target for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20879983,target,targeting,"stat3 in glioblastoma, and targeting stat3 for glioblastoma therapy."
Title,"""Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery.""",https://pubmed.ncbi.nlm.nih.gov/33307416,make,making,for relapsing glioblastoma: a decision-making tree for choosing between
Abstract,"""Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity.""",https://pubmed.ncbi.nlm.nih.gov/27521450,induce,induces,-infected glioblastomas with a proteasome inhibitor induces necroptotic cell death to
Title,"""Survival outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/16162092,include,including,"outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy."
Title,"""Glioblastoma targeted therapy: updated approaches from recent biological insights.""",https://pubmed.ncbi.nlm.nih.gov/28863449,target,targeted,glioblastoma targeted therapy: updated approaches from recent biological insights
Abstract,"""Glioblastoma targeted therapy: updated approaches from recent biological insights.""",https://pubmed.ncbi.nlm.nih.gov/28863449,grade,grade,glioblastoma (who grade iv astrocytoma) is the most
Abstract,"""Glioblastoma targeted therapy: updated approaches from recent biological insights.""",https://pubmed.ncbi.nlm.nih.gov/28863449,lead,led,malignancy in glioblastoma has led to the development of various biomarkers and
Abstract,"""Glioblastoma targeted therapy: updated approaches from recent biological insights.""",https://pubmed.ncbi.nlm.nih.gov/28863449,examine,examine,"therapies in glioblastoma, and examine recent data from clinical trials evaluating"
Abstract,"""Therapy of glioblastoma multiforme: a cumulative experience of 10 years.""",https://pubmed.ncbi.nlm.nih.gov/8748864,operate,operated,patients with glioblastoma multiforme operated on during the last decade (1980
Abstract,"""Therapy of glioblastoma multiforme: a cumulative experience of 10 years.""",https://pubmed.ncbi.nlm.nih.gov/8748864,analyse,analysed,diagnosis of glioblastoma multiforme were analysed for survival with respect to age
Abstract,"""Therapy of glioblastoma multiforme: a cumulative experience of 10 years.""",https://pubmed.ncbi.nlm.nih.gov/8748864,include,include,management of glioblastoma multiforme should include surgical resection followed by adjuvant treatment
Abstract,"""Re-Irradiation for Recurrent Glioblastoma Multiforme.""",https://pubmed.ncbi.nlm.nih.gov/33288605,benefit,benefit,for recurrent glioblastoma multiforme (gbm) may benefit from individualized therapy
Abstract,"""Personalized radiation therapy for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38453659,be,is,"successfully treat glioblastoma, there is consensus that the tumor bed with"
Abstract,"""Personalized radiation therapy for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38453659,use,used,management of glioblastoma and methods used to personalize radiation treatment for patients
Abstract,"""Insurance correlates with improved access to care and outcome among glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/29893906,constitute,constitutes,"care for glioblastoma (gbm) constitutes maximal safe surgical resection,"
Abstract,"""Insurance correlates with improved access to care and outcome among glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/29893906,optimize,optimize,"diagnoses of glioblastoma is critical to optimize survival, especially as therapies"
Abstract,"""Glioblastoma multiforme: a review of where we have been and where we are going.""",https://pubmed.ncbi.nlm.nih.gov/19555299,present,present,such as glioblastoma multiforme (gbm) present some of the greatest
Abstract,"""The Impediments of Cancer Stem Cells and An Exploration into the Nanomedical Solutions for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36056850,affect,affects,glioblastoma is an aggressive and recurrent tumour that affects our
Abstract,"""The Impediments of Cancer Stem Cells and An Exploration into the Nanomedical Solutions for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36056850,develop,developing,progression of glioblastomas by developing novel nanotherapeutic interventions which target cscs.
Abstract,"""Bone Marrow-Derived Mesenchymal Stem Cell-Mediated Dual-Gene Therapy for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29993289,treat,treated,mice bearing glioblastoma were treated with 188re post-therapeutic intravenous bmsc
Abstract,"""Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33418005,provide,provide,progression in glioblastoma may provide an opportunity to personalize treatment.
Abstract,"""Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33418005,undergo,undergoing,-wildtype glioblastoma undergoing 6-week/30-fraction chemoradiation had standardized
Abstract,"""[Giant cell glioblastoma. Case report].""",https://pubmed.ncbi.nlm.nih.gov/15259347,account,account,"giant cells glioblastomas, a subtype of these, account for less"
Abstract,"""Molecularly targeted therapies for recurrent glioblastoma: current and future targets.""",https://pubmed.ncbi.nlm.nih.gov/25434384,lead,led,profile of glioblastoma has led to numerous molecularly targeted therapies.
Abstract,"""Molecularly targeted therapies for recurrent glioblastoma: current and future targets.""",https://pubmed.ncbi.nlm.nih.gov/25434384,identify,identify,) and glioblastoma' as a search term in pubmed to identify
Abstract,"""Molecularly targeted therapies for recurrent glioblastoma: current and future targets.""",https://pubmed.ncbi.nlm.nih.gov/25434384,target,targeted,of recurrent glioblastoma with molecular targeted therapies.
Abstract,"""Molecularly targeted therapies for recurrent glioblastoma: current and future targets.""",https://pubmed.ncbi.nlm.nih.gov/25434384,target,targeted,"of recurrent glioblastoma, various targeted therapies have been tested over the"
Abstract,"""Molecularly targeted therapies for recurrent glioblastoma: current and future targets.""",https://pubmed.ncbi.nlm.nih.gov/25434384,remain,remains,": recurrent glioblastoma remains very difficult to treat, even with molecular"
Abstract,"""Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine.""",https://pubmed.ncbi.nlm.nih.gov/2546093,treat,treated,"gliomas and glioblastomas, were treated with 1,3-bis(2-chloroethyl)-1"
Abstract,"""A hypothesis and theoretical model speculating the possible role of therapy mediated neoplastic cell loss in promoting the process of glioblastoma relapse.""",https://pubmed.ncbi.nlm.nih.gov/20655317,comprise,comprising,"which envisages glioblastomas as neoplasms comprising of multiple, differentially regulated and"
Abstract,"""Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32551496,remain,remains,"to improve glioblastoma multiforme (gbm) treatment, gbm remains one"
Abstract,"""Cell death forms and HSP70 expression in U87 cells after ionizing radiation and/or chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/22110193,analyze,analyzing,using u87 glioblastoma cell line after radio-chemotherapy treatments by analyzing
Title,"""C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.""",https://pubmed.ncbi.nlm.nih.gov/29913253,detect,detecting,imaging of glioblastoma for detecting postoperative residual disease and response to chemoradiation
Abstract,"""C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.""",https://pubmed.ncbi.nlm.nih.gov/29913253,account,account,criteria of glioblastoma after chemoradiation do not account for metabolic changes that
Abstract,"""C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.""",https://pubmed.ncbi.nlm.nih.gov/29913253,undergo,undergoing,newly diagnosed glioblastoma undergoing standard chemoradiation treatment were enrolled in this prospective
Title,"""Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/9619833,induce,induced,human malignant glioblastoma cells to cisplatin-induced apoptosis.
Abstract,"""Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/9619833,grow,grow,malignant glioblastomas grow very rapidly and are generally resistant to either
Abstract,"""Fluosol and hyperbaric oxygen as an adjunct to radiation therapy in the treatment of malignant gliomas: a pilot study.""",https://pubmed.ncbi.nlm.nih.gov/1327243,treat,treated,astrocytoma or glioblastoma multiforme were treated in a phase i trial of
Abstract,"""Comparison of outcomes between overlapping structure-based and non-overlapping structure-based optimization for simultaneous integrated boost IMRT for malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/15616880,analyze,analyzed,for three glioblastomas and one anaplastic astrocytoma were analyzed in the present
Title,"""Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35309323,reveal,reveals,landscape in glioblastoma reveals tumor heterogeneity and implications for prognosis and immunotherapy
Title,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,measure,measured,glioblastoma blood flow measured with stable xenon ct indicates tumor
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,use,using,patients with glioblastoma using stable xenon ct.
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,have,have,type i glioblastomas have unimodal high blood flow histograms; histologically there
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,have,have,type ii glioblastomas have unimodal low blood flow histograms; histologically there
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,induce,induced,"type ii glioblastoma, the abnormal vessels induced by hypoxia are inefficient"
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,multimodal,multimodal,type iii glioblastomas have multimodal blood flow histograms.
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,develop,develop,type iii glioblastomas were more likely to develop a post-surgical
Abstract,"""Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37866784,remain,remained,effect on glioblastomas remained unclear.
Abstract,"""Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37866784,base,based,the multicenter glioblastoma cohorts based on the oxidative-stress-responsive
Abstract,"""Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37866784,discover,discovered,potential in glioblastoma and discovered sod3's potential role in regulating macrophage
Abstract,"""Challenges in the diagnosis of leptomeningeal dissemination of glioblastoma in a patient with fever and xanthochromic CSF: a case report.""",https://pubmed.ncbi.nlm.nih.gov/37148304,treat,treated,"left temporal glioblastoma, treated with surgical resection and adjuvant chemo- and"
Abstract,"""Challenges in the diagnosis of leptomeningeal dissemination of glioblastoma in a patient with fever and xanthochromic CSF: a case report.""",https://pubmed.ncbi.nlm.nih.gov/37148304,associate,associated,"patient with glioblastoma associated leptomeningeal dissemination, as high fever and xanthochromic"
Abstract,"""Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?""",https://pubmed.ncbi.nlm.nih.gov/28726173,treat,treated,in elderly glioblastoma patients treated by maximal safe resection followed by standard
Abstract,"""Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?""",https://pubmed.ncbi.nlm.nih.gov/28726173,age,aged,of recurrent glioblastomas between 660 adult patients aged of < 70 years
Abstract,"""Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?""",https://pubmed.ncbi.nlm.nih.gov/28726173,treat,treated,a supratentorial glioblastoma treated by maximal first-line therapy.
Abstract,"""Brain-Targeted Aggregation-Induced-Emission Nanoparticles with Near-Infrared Imaging at 1550 nm Boosts Orthotopic Glioblastoma Theranostics.""",https://pubmed.ncbi.nlm.nih.gov/34713508,surmount,surmounting,treatment of glioblastoma multiforme (gbm) is surmounting the blood-
Abstract,"""Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas - a planning study.""",https://pubmed.ncbi.nlm.nih.gov/29471879,approve,approved,strategy for glioblastoma (gbm) that is approved for the use
Abstract,"""Primary intramedullary glioblastoma multiforme of the spinal cord: report of eight cases.""",https://pubmed.ncbi.nlm.nih.gov/12690787,locate,located,primary glioblastoma multiforme located intramedullary in the spinal cord is a
Abstract,"""Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.""",https://pubmed.ncbi.nlm.nih.gov/15667976,xenografte,xenografted,a human glioblastoma tumor line xenografted in nude mice.
Abstract,"""Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.""",https://pubmed.ncbi.nlm.nih.gov/15667976,implant,implanted,a human glioblastoma xenograft tumor line was implanted in nude mice.
Abstract,"""Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28030635,attribute,attributed,resistance of glioblastomas has been attributed to the presence of tumor initiating
Title,"""Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.""",https://pubmed.ncbi.nlm.nih.gov/26159214,emerge,emerging,glioblastoma multiforme: emerging treatments and stratification markers beyond new
Abstract,"""An update on the epigenetics of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27585647,know,known,"glioblastomas, also known as glioblastoma multiforme (gbm)"
Abstract,"""An update on the epigenetics of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27585647,noncode,noncoding,"modification, glioblastoma stem cells, dna methylation, noncoding rnas expression"
Abstract,"""Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/8832669,investigate,investigates,"therapy for glioblastoma, the present study investigates the influence of systemically"
Abstract,"""Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/8832669,receive,received,histologically confirmed glioblastomas) received bsh at a dose used in earlier
Abstract,"""Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression.""",https://pubmed.ncbi.nlm.nih.gov/19221865,cause,cause,to treat glioblastomas may cause increased contrast enhancement on the first post
Abstract,"""Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression.""",https://pubmed.ncbi.nlm.nih.gov/19221865,treat,treated,scans in glioblastoma patients treated with radiation alone versus patients treated with
Abstract,"""Treatment of glioblastoma multiforme. A review.""",https://pubmed.ncbi.nlm.nih.gov/178151,review,reviewed,patients with glioblastoma multiforme is reviewed.
Abstract,"""Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro.""",https://pubmed.ncbi.nlm.nih.gov/9336158,repopulate,repopulate,scc and glioblastoma cells to repopulate during fractionated irradiation could be demonstrated
Abstract,"""Immunotherapy for glioblastoma: concepts and challenges.""",https://pubmed.ncbi.nlm.nih.gov/26402401,promote,promote,immunotherapy against glioblastoma is overall well tolerated and able to promote a
Abstract,"""Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/34824133,remain,remains,"survival for glioblastoma remains very poor despite decades of research, with"
Abstract,"""Can 3D-CRT meet the desired dose distribution to target and OARs in glioblastoma? A tertiary cancer center experience.""",https://pubmed.ncbi.nlm.nih.gov/32945180,use,using,the postoperative glioblastoma by using 3d-conformal radiotherapy to a total
Abstract,"""Can 3D-CRT meet the desired dose distribution to target and OARs in glioblastoma? A tertiary cancer center experience.""",https://pubmed.ncbi.nlm.nih.gov/32945180,make,makes,"survival of glioblastoma despite the best treatment available, makes 3d-"
Abstract,"""Treatment of recurrent glioblastoma with intra-arterial BCNU [1, 3-bis (2-chloroethyl)-1-nitrosourea].""",https://pubmed.ncbi.nlm.nih.gov/21049193,remain,remain,"patients with glioblastomas remain marginally efficient, and recurrence following surgery,"
Abstract,"""Treatment of recurrent glioblastoma with intra-arterial BCNU [1, 3-bis (2-chloroethyl)-1-nitrosourea].""",https://pubmed.ncbi.nlm.nih.gov/21049193,treat,treated,recurrent unilateral glioblastomas treated with intra-arterial bcnu were evaluated retrospectively
Abstract,"""Positron emission tomographic evaluations in the diagnosis and therapy of multifocal glioblastoma. Report of a pediatric case.""",https://pubmed.ncbi.nlm.nih.gov/3039475,report,reported,of multifocal glioblastoma is reported with special reference to positron emission tomography
Abstract,"""Positron emission tomographic evaluations in the diagnosis and therapy of multifocal glioblastoma. Report of a pediatric case.""",https://pubmed.ncbi.nlm.nih.gov/3039475,predict,predicted,"to be glioblastomas, and, as predicted by the pet findings"
Abstract,"""Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/20413754,determine,determine,) to glioblastomas in rats with induced tumors and determine if such
Abstract,"""Low-dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo.""",https://pubmed.ncbi.nlm.nih.gov/29752716,migrate,migrate,"in gl261 glioblastoma, irmscs migrate extensively and selectively within the tumor"
Title,"""Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System.""",https://pubmed.ncbi.nlm.nih.gov/36847383,use,using,treatment of glioblastoma multiforme in a mouse model using a portable benchtop
Abstract,"""Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System.""",https://pubmed.ncbi.nlm.nih.gov/36847383,lack,lacking,"treatments for glioblastoma (gbm) are lacking, leading to low"
Abstract,"""Positive influence of partial resection on overall survival of patients with overlapping glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28837843,know,known,with overlapping glioblastomas (former known as gliomatosis cerebri according to the
Abstract,"""Positive influence of partial resection on overall survival of patients with overlapping glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28837843,show,showed,with overlapping glioblastomas (og) who showed who iv in the
Abstract,"""Positive influence of partial resection on overall survival of patients with overlapping glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28837843,accord,according,of overlapping glioblastomas in the mri according to who criteria (3
Abstract,"""Positive influence of partial resection on overall survival of patients with overlapping glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28837843,know,known,"with overlapping glioblastomas (former known as gliomatosis cerebri), although"
Abstract,"""Understanding glioblastoma at the single-cell level: Recent advances and future challenges.""",https://pubmed.ncbi.nlm.nih.gov/38814900,provide,providing,"cells within glioblastomas, providing previously unattainable insights into the genetic and"
Abstract,"""Understanding glioblastoma at the single-cell level: Recent advances and future challenges.""",https://pubmed.ncbi.nlm.nih.gov/38814900,expect,expected,"heterogeneity of glioblastomas are expected, which will help guide the development"
Title,"""Immunotherapy in glioblastoma: emerging options in precision medicine.""",https://pubmed.ncbi.nlm.nih.gov/27225028,emerge,emerging,immunotherapy in glioblastoma: emerging options in precision medicine.
Abstract,"""Immunotherapy in glioblastoma: emerging options in precision medicine.""",https://pubmed.ncbi.nlm.nih.gov/27225028,provide,provides,immunotherapy for glioblastoma (gbm) provides a unique opportunity for targeted
Abstract,"""Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23634286,have,have,"with unresectable glioblastomas have a poor prognosis, with median survival of"
Abstract,"""Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23634286,tolerate,tolerated,for unresectable glioblastoma was well tolerated and provided a significant level of
Abstract,"""Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23634286,randomize,randomized,treatment of glioblastoma in the unresectable population warrants further investigation in randomized
Title,"""Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: comparison of clinical results obtained with BNCT and conventional treatment.""",https://pubmed.ncbi.nlm.nih.gov/25264042,obtain,obtained,-diagnosed glioblastoma: comparison of clinical results obtained with bnct and
Abstract,"""Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions.""",https://pubmed.ncbi.nlm.nih.gov/39409094,know,known,glioblastoma is known to be one of the most aggressive
Abstract,"""Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions.""",https://pubmed.ncbi.nlm.nih.gov/39409094,achieve,achieves,understanding how glioblastoma achieves tumor-mediated immune suppression in both local
Abstract,"""Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29740075,lead,leading,glioblastoma (gbm) is the leading cause of high
Abstract,"""Pathological findings and prognostic factors in recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22331317,affect,affected,features of glioblastomas are affected by tumor regrowth and the influence of
Title,"""Targeting DUSPs in glioblastomas - wielding a double-edged sword?""",https://pubmed.ncbi.nlm.nih.gov/24155099,wield,wielding,dusps in glioblastomas - wielding a double-edged sword?
Abstract,"""Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25407354,have,has,glioblastoma is the most common type of glioma and has
Abstract,"""Does gender matter in glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/21975336,receive,receive,outcome of glioblastoma (gbm) patients who receive radiotherapy alone or
Title,"""Effects of Postoperative Intravenous Cyclosporine Treatment on the Survival and Functional Performance Status of Patients With Glioblastoma: A Randomized, Triple-Blinded, Placebo-Controlled Clinical Trial.""",https://pubmed.ncbi.nlm.nih.gov/37268192,blind,blinded,"patients with glioblastoma: a randomized, triple-blinded, placebo"
Abstract,"""Effects of Postoperative Intravenous Cyclosporine Treatment on the Survival and Functional Performance Status of Patients With Glioblastoma: A Randomized, Triple-Blinded, Placebo-Controlled Clinical Trial.""",https://pubmed.ncbi.nlm.nih.gov/37268192,associate,associated,background: glioblastoma is associated with low median survival time irrespective of
Abstract,"""Effects of Postoperative Intravenous Cyclosporine Treatment on the Survival and Functional Performance Status of Patients With Glioblastoma: A Randomized, Triple-Blinded, Placebo-Controlled Clinical Trial.""",https://pubmed.ncbi.nlm.nih.gov/37268192,undergo,underwent,patients with glioblastoma who underwent surgery were treated with standard chemoradiotherapy regimen
Title,"""The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.""",https://pubmed.ncbi.nlm.nih.gov/29378228,include,including,alterations in glioblastoma including brain tumor initiating cells.
Abstract,"""The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.""",https://pubmed.ncbi.nlm.nih.gov/29378228,think,thought,", within glioblastoma and other solid tumors, is thought to be"
Abstract,"""The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.""",https://pubmed.ncbi.nlm.nih.gov/29378228,initiate,initiating,profiling of glioblastoma and brain tumor initiating cells reveals changes in metabolism
Abstract,"""Role of micro-RNA (miRNA) in pathogenesis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26004603,play,play,"pathogenesis of glioblastoma, as mirnas play a critical role in the"
Abstract,"""A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32375830,range,ranging,"patients with glioblastoma (gbm), ranging from ultrahypofractionated radiotherapy ("
Title,"""Glioblastoma stem cells and stem cell-targeting immunotherapies.""",https://pubmed.ncbi.nlm.nih.gov/25682090,stem,stem,glioblastoma stem cells and stem cell-targeting immunotherapies.
Abstract,"""Glioblastoma stem cells and stem cell-targeting immunotherapies.""",https://pubmed.ncbi.nlm.nih.gov/25682090,disrupt,disrupt,directly target glioblastoma cancer stem cells (gcsc) or indirectly disrupt
Abstract,"""[Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas].""",https://pubmed.ncbi.nlm.nih.gov/18067234,bear,bearing,with g422 glioblastomas rna in mice bearing intracranially g422 glioblastomas.
Abstract,"""Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.""",https://pubmed.ncbi.nlm.nih.gov/28669011,treat,treated,newly diagnosed glioblastomas treated with resection in association with the standard combined
Abstract,"""Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.""",https://pubmed.ncbi.nlm.nih.gov/28669011,undergo,underwent,diagnosed supratentorial glioblastoma who underwent surgical resection with (n = 123
Abstract,"""Postoperative radiotherapy for glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/1338021,treat,treated,pathologically documented glioblastoma multiforme were treated with radiotherapy after biopsy (5
Abstract,"""Tumour-infiltrating T-cell subpopulations in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21707245,undergo,underwent,patients with glioblastomas underwent surgery between 2003 and april 2009.
Abstract,"""Tumour-infiltrating T-cell subpopulations in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21707245,be,was,"frequently in glioblastomas and there was a consistent response, even after"
Abstract,"""The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.""",https://pubmed.ncbi.nlm.nih.gov/19899008,analyze,analyzed,suffering from glioblastoma were analyzed retrospectively.
Abstract,"""Immunotherapy for primary brain tumors: no longer a matter of privilege.""",https://pubmed.ncbi.nlm.nih.gov/25398845,remain,remain,"form, glioblastoma, remain as a particularly devastating solid tumor for"
Abstract,"""Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.""",https://pubmed.ncbi.nlm.nih.gov/17409412,represent,represent,glioblastomas represent an important cause of cancer-related mortality
Abstract,"""Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.""",https://pubmed.ncbi.nlm.nih.gov/17409412,distribute,distributed,"directly into glioblastomas, hsdscs distributed themselves extensively throughout the tumor mass"
Abstract,"""18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16754352,undergo,underwent,patients with glioblastoma recurrences underwent mr and fet-pet imaging for
Abstract,"""18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16754352,define,defining,in recurrent glioblastomas and is highly valuable for defining the target volume
Title,"""Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/11121212,graft,grafted,two human glioblastomas grafted in nude mice.
Abstract,"""Gene and viral therapy for glioblastoma: a review of clinical trials and future directions.""",https://pubmed.ncbi.nlm.nih.gov/22290261,rely,relied,patients with glioblastoma has been modest and has predominantly relied on informative
Abstract,"""Augmenting Glioblastoma Chemotherapy with Polymers.""",https://pubmed.ncbi.nlm.nih.gov/28594164,treat,treated,"such as glioblastoma, an aggressive and prolific cancer predominantly treated with"
Abstract,"""Augmenting Glioblastoma Chemotherapy with Polymers.""",https://pubmed.ncbi.nlm.nih.gov/28594164,limit,limited,"efficacy of antiglioblastoma drugs, such as temozolomide, is limited by"
Abstract,"""New Avenues and Major Achievements in Phytocompounds Research for Glioblastoma Therapy.""",https://pubmed.ncbi.nlm.nih.gov/38611962,include,including,"improvement of glioblastoma therapy, including the ways to enhance the response"
Title,"""Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/23385995,follow,following,relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.
Abstract,"""Combined modality treatment of glioblastoma multiforme: the role of temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/18393779,associate,associated,characterization of glioblastoma multiforme and studies of factors associated with tumor growth
Title,"""Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.""",https://pubmed.ncbi.nlm.nih.gov/22218709,base,based,glioblastoma angiogenesis: vegf resistance solutions and new strategies based
Abstract,"""Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.""",https://pubmed.ncbi.nlm.nih.gov/22218709,provide,provides,"only nourishes glioblastomas, but also provides a specialized microenvironment for tumor"
Abstract,"""Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.""",https://pubmed.ncbi.nlm.nih.gov/22218709,result,result,biology of glioblastomas which may ultimately result in new modes of treatment
Abstract,"""Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities.""",https://pubmed.ncbi.nlm.nih.gov/18492463,discuss,discusses,"research on glioblastoma angiogenesis and discusses its underlying biology, clinical trial"
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,refer,refers,'secondary glioblastoma' refers to a minority of glioblastomas that evolve
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,evolve,evolve,minority of glioblastomas that evolve from previously diagnosed who grade ii or
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,include,include,changes in glioblastoma include mutations in genes regulating receptor tyrosine kinase (
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,include,includes,"treatment of glioblastoma includes surgery, radiotherapy, and alkylating chemotherapy."
Abstract,"""[Palliative care for glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/27281945,have,have,patients with glioblastoma have a limited life expectancy and an impaired quality
Abstract,"""[Epidermic growth factor receptor (EGFR) in glioblastomas: the mechanism of tumorigenesis and its role as a therapeutic target].""",https://pubmed.ncbi.nlm.nih.gov/26156444,outline,outline,egfr in glioblastomas and outline the therapeutic approaches aimed against this receptor
Abstract,"""[Epidermic growth factor receptor (EGFR) in glioblastomas: the mechanism of tumorigenesis and its role as a therapeutic target].""",https://pubmed.ncbi.nlm.nih.gov/26156444,base,based,"therapies for glioblastomas, based on inhibiting the egfr function."
Abstract,"""Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.""",https://pubmed.ncbi.nlm.nih.gov/28616821,undergo,undergo,of recurrent glioblastoma (rgbm) undergo adjuvant chemotherapy or are followed
Abstract,"""Optimal management of elderly patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22722053,increase,increasing,patients with glioblastoma (gb) is slowly increasing with an aging
Abstract,"""Theranostic nanoparticles enhance the response of glioblastomas to radiation.""",https://pubmed.ncbi.nlm.nih.gov/31723547,initiate,initiating,"cells, glioblastoma initiating cells (gics), which could be"
Abstract,"""Hydrocephalus after resection and adjuvant radiochemotherapy in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/24731571,associate,associated,factors in glioblastoma patients that are closely associated with communicating hydrocephalus.
Abstract,"""Hydrocephalus after resection and adjuvant radiochemotherapy in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/24731571,undergo,underwent,with a glioblastoma between 2007 and 2011 and underwent complete surgical resection
Abstract,"""Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27716625,remain,remain,on intracranial glioblastomas remain untested.
Abstract,"""Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27716625,show,showed,"-treated glioblastomas showed less cyclin d1 staining, enhanced autophagy with"
Abstract,"""Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27716625,inactivate,inactivating,orthotopic rat glioblastoma growth by inactivating stat3 signaling and enhancing autophagy and
Title,"""Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.""",https://pubmed.ncbi.nlm.nih.gov/22529983,optimize,optimized,glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence
Abstract,"""Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.""",https://pubmed.ncbi.nlm.nih.gov/22529983,base,based,to optimize glioblastoma therapy based on the use of genetically modified hamscs
Abstract,"""Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.""",https://pubmed.ncbi.nlm.nih.gov/22529983,express,expressing,glioblastoma u87 cells expressing photinus pyralis luciferase (pluc)
Abstract,"""Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.""",https://pubmed.ncbi.nlm.nih.gov/22529983,follow,following,therapy to glioblastoma surgical borders following tumor resection.
Abstract,"""The clinical characteristics and outcomes of incidentally discovered glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34985720,identify,identified,number of glioblastomas (gbms) are identified by incidental radiological images
Title,"""Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.""",https://pubmed.ncbi.nlm.nih.gov/37129737,use,using,patients with glioblastoma using a multiparametric mri-based prediction model.
Abstract,"""Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.""",https://pubmed.ncbi.nlm.nih.gov/37129737,treat,treated,response in glioblastoma patients treated with dcvax-l. methods: seventeen
Abstract,"""Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.""",https://pubmed.ncbi.nlm.nih.gov/37129737,treat,treated,: seventeen glioblastoma patients treated with standard-of-care therapy
Abstract,"""Therapeutic targeting of malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/25175690,evaluate,evaluating,"used to glioblastoma treatments, evaluating their efficacy in controlling and eradicatig"
Title,"""Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.""",https://pubmed.ncbi.nlm.nih.gov/28334886,associate,associated,glioblastoma-associated microglia and macrophages: targets for therapies
Abstract,"""Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.""",https://pubmed.ncbi.nlm.nih.gov/28334886,carry,carries,diagnosis of glioblastoma carries a dismal prognosis.
Abstract,"""Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.""",https://pubmed.ncbi.nlm.nih.gov/28334886,associate,associated,"thus, glioblastoma-associated microglia and macrophages are logical therapeutic targets"
Abstract,"""Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.""",https://pubmed.ncbi.nlm.nih.gov/28334886,reflect,reflected,roles in glioblastoma progression are reflected in the burgeoning research into therapeutics
Abstract,"""Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.""",https://pubmed.ncbi.nlm.nih.gov/28334886,associate,associated,"biology of glioblastoma-associated microglia and macrophages, and model systems"
Abstract,"""Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.""",https://pubmed.ncbi.nlm.nih.gov/28334886,associate,associated,that affect glioblastoma-associated microglia and macrophages hold considerable promise to
Title,"""Management of glioblastoma after recurrence: A changing paradigm.""",https://pubmed.ncbi.nlm.nih.gov/27476474,change,changing,management of glioblastoma after recurrence: a changing paradigm.
Abstract,"""Management of glioblastoma after recurrence: A changing paradigm.""",https://pubmed.ncbi.nlm.nih.gov/27476474,remain,remains,glioblastoma remains the most common primary brain tumor after the
Abstract,"""A Reactive Oxygen Species-Responsive Poly(amino acids) Nanoparticle Loading Doxorubicin for Glioblastoma Multiforme Treatment.""",https://pubmed.ncbi.nlm.nih.gov/33187588,receive,received,"them, glioblastoma multiforme received special attention and numerous efforts regarding to"
Abstract,"""Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.""",https://pubmed.ncbi.nlm.nih.gov/35486306,investigate,investigated,newly diagnosed glioblastoma were investigated.
Abstract,"""Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.""",https://pubmed.ncbi.nlm.nih.gov/35486306,use,using,newly diagnosed glioblastoma using custom made or commercially available assays.
Abstract,"""Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy.""",https://pubmed.ncbi.nlm.nih.gov/36306728,present,presented,models of glioblastoma has been presented.
Abstract,"""Trends in Immunotherapy Clinical Trials to Treat Glioblastoma: A Look at Progress and Challenges.""",https://pubmed.ncbi.nlm.nih.gov/37574192,discover,discover,treatments for glioblastoma (gbm) and discover relevant trends in this
Abstract,"""Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36532035,characterize,characterized,"tumor, glioblastoma (gbm) is characterized by intratumor heterogeneity,"
Abstract,"""Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis.""",https://pubmed.ncbi.nlm.nih.gov/36748348,make,makes,introduction: glioblastoma multiforme (gbm) makes 60-70%
Abstract,"""Tumor treating fields with radiation for glioblastoma: a narrative review.""",https://pubmed.ncbi.nlm.nih.gov/36336899,present,present,"patients with glioblastoma (gbm), we present the following narrative"
Abstract,"""Tumor treating fields with radiation for glioblastoma: a narrative review.""",https://pubmed.ncbi.nlm.nih.gov/36336899,synthesize,synthesized,management of glioblastoma with regard to concurrent chemoradiation and ttfields and synthesized
Abstract,"""Spinal drop metastases in recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/9856242,increase,increasing,dissemination of glioblastomas is very rare but is increasing as patients live
Abstract,"""Spinal drop metastases in recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/9856242,operate,operated,histologically proven glioblastoma multiforme were operated on in the neurosurgical department of
Abstract,"""Spinal drop metastases in recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/9856242,include,including,spread of glioblastoma multiforme including spinal drop metastases.
Abstract,"""Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis.""",https://pubmed.ncbi.nlm.nih.gov/17161482,treat,treated,bearing u87 glioblastoma xenografts were treated with concomitant rapamycin and radiotherapy over
Abstract,"""The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22959214,have,have,"treatment of glioblastoma recurrence can have a palliative aim, after considering"
Abstract,"""Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/33441554,report,reported,in recurrent glioblastoma have reported long-term survival benefits in 10
Abstract,"""Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/33441554,acquire,acquired,grade iv glioblastoma patients acquired prior to immunotherapy intervention.
Abstract,"""Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/33441554,imply,implying,"newly diagnosed glioblastoma tumors, implying that a relationship between tumor mutation"
Title,"""Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival.""",https://pubmed.ncbi.nlm.nih.gov/30652553,predict,predict,clusters of glioblastoma growth and response kinetics predict survival.
Abstract,"""Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival.""",https://pubmed.ncbi.nlm.nih.gov/30652553,be,is,"seen in glioblastoma multiforme (gbm), there is little definitive"
Abstract,"""Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.""",https://pubmed.ncbi.nlm.nih.gov/15465203,cure,cures,treatment of glioblastoma multiforme (gbm) cures less than 5%
Abstract,"""Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29026302,remain,remains,"treatments, glioblastoma outcome remains poor with frequent local recurrences, indicating"
Title,"""Anti-tumour immune response in GL261 glioblastoma generated by Temozolomide Immune-Enhancing Metronomic Schedule monitored with MRSI-based nosological images.""",https://pubmed.ncbi.nlm.nih.gov/31926117,generate,generated,in gl261 glioblastoma generated by temozolomide immune-enhancing metronomic schedule monitored
Title,"""Impact of state lockdown on glioblastoma treatment with tumor treating fields.""",https://pubmed.ncbi.nlm.nih.gov/36153883,treat,treating,lockdown on glioblastoma treatment with tumor treating fields.
Abstract,"""Computed modeling of alternating electric fields therapy for recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26311253,locate,located,the primary glioblastoma and it was located at a site of relatively
Abstract,"""Immunotherapy advances for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25190673,require,require,"benefit for glioblastoma patients, although multiple variables will likely require systematic"
Abstract,"""Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators.""",https://pubmed.ncbi.nlm.nih.gov/37165457,have,have,", including glioblastomas (gbm), have one of the worst"
Title,"""Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current.""",https://pubmed.ncbi.nlm.nih.gov/25361004,mediate,mediated,"in human glioblastoma stem cells, via inhibition of clic1-mediated"
Abstract,"""Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29688039,carry,carrying,experiments with glioblastoma-carrying rats.
Abstract,"""Efficacy of clinical prognostic factors on survival in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20401838,identify,identify,series of glioblastomas to identify prognostic factors.
Abstract,"""Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25434382,develop,develop,and secondary glioblastomas (gbms) that develop from low-grade
Abstract,"""Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25434382,represent,represent,metabolic enzyme glioblastomas (idh1) represent a distinguishing feature of low
Abstract,"""Gap junctions in human glioblastomas: implications for suicide gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/21779029,define,defined,status in glioblastoma is not well defined.
Abstract,"""Gap junctions in human glioblastomas: implications for suicide gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/21779029,detect,detected,74 human glioblastoma samples; its expression was detected in 77%
Abstract,"""Gap junctions in human glioblastomas: implications for suicide gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/21779029,regard,regards,here that glioblastoma is a heterogenous disease as regards cx43 expression with
Abstract,"""Gap junctions in human glioblastomas: implications for suicide gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/21779029,establish,established,eight primary glioblastoma cultures that we have established.
Abstract,"""Visualization of angiographical arteriovenous shunting in perisylvian glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23435867,tend,tend,conclusions: glioblastomas in the perisylvian region tend to be associated with
Abstract,"""Immunotherapy for glioblastoma: the promise of combination strategies.""",https://pubmed.ncbi.nlm.nih.gov/35078492,remain,remained,glioblastoma (gbm) treatment has remained almost unchanged for
Abstract,"""[Reirradiation of recurrent glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/21312096,treat,treated,patients with glioblastoma are treated by radiotherapy in combination with temozolamid.
Abstract,"""Dendritic cell vaccine trials in gliomas: Untangling the lines.""",https://pubmed.ncbi.nlm.nih.gov/37289203,prove,proven,nature of glioblastoma have proven to be major limitations to translational application
Abstract,"""Dendritic cell vaccine trials in gliomas: Untangling the lines.""",https://pubmed.ncbi.nlm.nih.gov/37289203,interpret,interpret,trials in glioblastoma are difficult to interpret due to a lack of
Abstract,"""Dendritic cell vaccine trials in gliomas: Untangling the lines.""",https://pubmed.ncbi.nlm.nih.gov/37289203,discuss,discuss,"vaccines targeting glioblastoma, discuss challenges in clinical trial design, and"
Abstract,"""GammaTile() (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials.""",https://pubmed.ncbi.nlm.nih.gov/38281303,grow,grew,-type glioblastoma that grew > 100% in volume during the
Abstract,"""GammaTile() (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials.""",https://pubmed.ncbi.nlm.nih.gov/38281303,lie,lay,rapidly proliferating glioblastomas and lay the foundation for future clinical trial design
Title,"""Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma.""",https://pubmed.ncbi.nlm.nih.gov/28303729,treat,treated,case of glioblastoma patient treated with tumor treating fields therapy at recurrence
Abstract,"""Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma.""",https://pubmed.ncbi.nlm.nih.gov/28303729,employ,employs,treatment for glioblastoma (gbm) that employs alternating electric fields.
Abstract,"""Results of interstitial brachytherapy for malignant brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/12239621,have,had,17 were glioblastomas) and 46 had brachytherapy at the time of
Title,"""Sodium phenylacetate (NaPa) improves the TAM effect on glioblastoma experimental tumors by inducing cell growth arrest and apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/17465226,induce,inducing,effect on glioblastoma experimental tumors by inducing cell growth arrest and apoptosis
Abstract,"""Sodium phenylacetate (NaPa) improves the TAM effect on glioblastoma experimental tumors by inducing cell growth arrest and apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/17465226,represent,represent,: multiform glioblastomas represent the most aggressive brain tumors.
Title,"""Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations.""",https://pubmed.ncbi.nlm.nih.gov/2557310,base,based,in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic
Abstract,"""Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations.""",https://pubmed.ncbi.nlm.nih.gov/2557310,receive,received,adults with glioblastoma multiforme who received minimal or no radiotherapy we determined
Title,"""Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/25791534,use,using,with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
Title,"""Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22076316,have,have,adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma.
Abstract,"""Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22076316,pseudopalisade,pseudopalisading,cases was glioblastoma with pseudopalisading necrosis.
Abstract,"""Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22076316,have,had,"adult cerebellar glioblastoma cases had similar clinical and pathological characteristics, and"
Abstract,"""Childhood glioblastoma multiforme of the spinal cord.""",https://pubmed.ncbi.nlm.nih.gov/16884424,prevent,preventing,"spinal cord glioblastoma multiforme in preventing tumour recurrence, with acceptable morbidity"
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,have,have,diagnosed as glioblastoma lack contrast enhancement and have a 'low-
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,identify,identified,"-wildtype glioblastomas, we identified 98 patients (7.4%)"
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,have,had,"to ce glioblastoma, patients with non-ce glioblastoma had a"
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,have,had,-ce glioblastoma had a more favorable clinical profile and superior outcome
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,use,using,-ce glioblastoma to patients with ce glioblastoma using a large set
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,use,using,with ce glioblastoma using a large set of clinical variables.
Abstract,"""Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.""",https://pubmed.ncbi.nlm.nih.gov/22668241,follow,following,"reports of glioblastoma remissions following vpa treatment, several clinical studies currently"
Abstract,"""Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.""",https://pubmed.ncbi.nlm.nih.gov/22668241,appear,appears,radiotherapy in glioblastoma appears a rational option that deserves well-designed
Abstract,"""Glioblastoma in the elderly: the impact of advanced age on treatment and survival.""",https://pubmed.ncbi.nlm.nih.gov/24390930,compare,compared,patients with glioblastoma as compared with younger ones.
Abstract,"""Glioblastoma in the elderly: the impact of advanced age on treatment and survival.""",https://pubmed.ncbi.nlm.nih.gov/24390930,follow,followed,of brain glioblastoma followed by irradiation and chemotherapy with temozolomide between 2004
Abstract,"""Glioblastoma in the elderly: the impact of advanced age on treatment and survival.""",https://pubmed.ncbi.nlm.nih.gov/24390930,age,aged,"with 50 glioblastoma patients aged < 65 years, treated in the"
Abstract,"""Glioblastoma in the elderly: the impact of advanced age on treatment and survival.""",https://pubmed.ncbi.nlm.nih.gov/24390930,benefit,benefit,"patients with glioblastoma may benefit from combined treatments, including surgery,"
Title,"""[Should elderly patients with glioblastoma be proposed to radiotherapy?].""",https://pubmed.ncbi.nlm.nih.gov/18650111,propose,proposed,patients with glioblastoma be proposed to radiotherapy?].
Abstract,"""[Should elderly patients with glioblastoma be proposed to radiotherapy?].""",https://pubmed.ncbi.nlm.nih.gov/18650111,associate,associated,"in glioblastoma multiform-patients, advanced age has been associated"
Abstract,"""Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity.""",https://pubmed.ncbi.nlm.nih.gov/36599004,induce,inducing,eliminated established glioblastoma tumors in mice by inducing caspase-mediated cancer
Title,"""[Glioblastoma multiforme developing separately from the initial lesion 9 years after successful treatment for gliomatosis cerebri: a case report].""",https://pubmed.ncbi.nlm.nih.gov/18700534,develop,developing,[glioblastoma multiforme developing separately from the initial lesion 9 years
Abstract,"""[Glioblastoma multiforme developing separately from the initial lesion 9 years after successful treatment for gliomatosis cerebri: a case report].""",https://pubmed.ncbi.nlm.nih.gov/18700534,occur,occurred,histologically confirmed glioblastoma multiforme in the cerebellar vermis which occurred 9 years
Abstract,"""[Glioblastoma multiforme developing separately from the initial lesion 9 years after successful treatment for gliomatosis cerebri: a case report].""",https://pubmed.ncbi.nlm.nih.gov/18700534,develop,develop,suggests that glioblastoma multiforme could develop in the long term after initial
Abstract,"""The effect of temozolomide in combination with doxorubicin in glioblastoma cells in vitro.""",https://pubmed.ncbi.nlm.nih.gov/33021886,consist,consist,treatments for glioblastoma patients consist of surgery followed by radiation in combination
Abstract,"""The effect of temozolomide in combination with doxorubicin in glioblastoma cells in vitro.""",https://pubmed.ncbi.nlm.nih.gov/33021886,remain,remains,"prognosis for glioblastoma patients remains grim, with a five-year"
Abstract,"""EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.""",https://pubmed.ncbi.nlm.nih.gov/24671641,represent,represents,"% of glioblastomas, it currently represents one of the most promising"
Title,"""Treatment of experimental glioblastoma with a human major histocompatibility complex nonrestricted cytotoxic T cell line.""",https://pubmed.ncbi.nlm.nih.gov/7805048,nonrestricte,nonrestricted,of experimental glioblastoma with a human major histocompatibility complex nonrestricted cytotoxic t
Abstract,"""Treatment of experimental glioblastoma with a human major histocompatibility complex nonrestricted cytotoxic T cell line.""",https://pubmed.ncbi.nlm.nih.gov/7805048,use,using,therapy of glioblastoma using as antitumor effector a potent major histocompatibility complex
Abstract,"""Treatment of experimental glioblastoma with a human major histocompatibility complex nonrestricted cytotoxic T cell line.""",https://pubmed.ncbi.nlm.nih.gov/7805048,engraft,engrafted,the human glioblastoma cell line u-87 mg could be successfully engrafted in
Abstract,"""Treatment of experimental glioblastoma with a human major histocompatibility complex nonrestricted cytotoxic T cell line.""",https://pubmed.ncbi.nlm.nih.gov/7805048,localize,localized,therapy against glioblastomas and other well-localized tumors is discussed.
Abstract,"""The significance of dose heterogeneity on the anti-tumor response of minibeam radiation therapy.""",https://pubmed.ncbi.nlm.nih.gov/39393469,undergo,underwent,model of glioblastoma underwent several pmbrt configurations.
Title,"""Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation.""",https://pubmed.ncbi.nlm.nih.gov/34940063,follow,following,metabolism in glioblastoma following chemoradiation.
Abstract,"""Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation.""",https://pubmed.ncbi.nlm.nih.gov/34940063,visualize,visualized,infiltration with glioblastoma (gb) cannot be entirely visualized by
Abstract,"""Effects of treatment on long-term survivors with malignant astrocytomas.""",https://pubmed.ncbi.nlm.nih.gov/2178330,evaluate,evaluate,patients with glioblastoma and anaplastic astrocytoma to evaluate the long-term
Abstract,"""Effects of treatment on long-term survivors with malignant astrocytomas.""",https://pubmed.ncbi.nlm.nih.gov/2178330,live,lived,patients with glioblastoma or anaplastic astrocytoma who lived at least 100%
Title,"""Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment.""",https://pubmed.ncbi.nlm.nih.gov/31663592,hyperthermia,hyperthermia,disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment.
Abstract,"""Optimizing glioblastoma resection: intraoperative mapping and beyond.""",https://pubmed.ncbi.nlm.nih.gov/25363008,start,starts,"management of glioblastomas starts with surgical resection if possible, along with"
Title,"""Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management.""",https://pubmed.ncbi.nlm.nih.gov/35049706,move,moving,patients with glioblastoma: moving towards the inclusion of a comprehensive geriatric
Abstract,"""Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management.""",https://pubmed.ncbi.nlm.nih.gov/35049706,include,includes,management of glioblastoma in older patients includes maximal safe resection followed by
Title,"""Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36104135,randomise,randomised,-arm glioblastoma australasia (magma): protocol for a multiarm randomised
Abstract,"""Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36104135,test,test,-arm glioblastoma australasia (magma) trial is to test hypotheses
Title,"""Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.""",https://pubmed.ncbi.nlm.nih.gov/26116770,require,requires,treatment of glioblastoma requires crossing the blood-brain barrier and targeting
Abstract,"""National cancer database analysis of outcomes in pediatric glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29532996,define,defined,glioblastoma in children is an aggressive disease with no defined
Abstract,"""Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.""",https://pubmed.ncbi.nlm.nih.gov/35151819,appear,appears,effect against glioblastoma appears limited when the conventional oral administration route is
Abstract,"""Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.""",https://pubmed.ncbi.nlm.nih.gov/28374095,have,has,of recurrent glioblastoma (gbm) has yet to be determined.
Abstract,"""Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation.""",https://pubmed.ncbi.nlm.nih.gov/36166963,experience,experience,"tumor, glioblastoma multiforme (gbm), experience an average survival"
Abstract,"""Automatic VMAT technique to treat glioblastoma: A two years' experience.""",https://pubmed.ncbi.nlm.nih.gov/34627029,give,giving,treatment of glioblastoma multiforme (gbm) by giving a recipe that
Abstract,"""Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/35442747,target,targeting,evidenced promising glioblastoma tissue targeting that led to high plk1 gene editing
Abstract,"""Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27777151,treat,treated,spinal cord glioblastoma treated in our department were included in this study
Abstract,"""Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27777151,identify,identified,"spinal cord glioblastoma were identified between 2006 and 2015, all of"
Abstract,"""Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27777151,remain,remains,spinal cord glioblastoma still remains poor.
Abstract,"""Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29427211,increase,increased,"reduced human glioblastoma cell viability, increased cellular apoptosis, and reduced"
Abstract,"""Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29427211,treat,treated,", intracerebral glioblastomas treated with 5-azacitidine showed a clearly visible"
Title,"""Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.""",https://pubmed.ncbi.nlm.nih.gov/29581794,predict,predicting,noninvasive glioblastoma testing: multimodal approach to monitoring and predicting treatment
Abstract,"""Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.""",https://pubmed.ncbi.nlm.nih.gov/29581794,cause,causing,"treatment of glioblastoma, causing differences in treatment response and outcome."
Abstract,"""Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.""",https://pubmed.ncbi.nlm.nih.gov/29581794,use,uses,testing of glioblastoma uses multiple techniques that can capture the heterogeneity of
Abstract,"""Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.""",https://pubmed.ncbi.nlm.nih.gov/29581794,have,has,benefit for glioblastoma patients still has to be demonstrated.
Title,"""Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3-Targeted Liposomes.""",https://pubmed.ncbi.nlm.nih.gov/28619756,use,using,permeabilization in glioblastomas using integrin alpha-v beta-3-targeted liposomes
Abstract,"""Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?""",https://pubmed.ncbi.nlm.nih.gov/30346600,attract,attracted,of recurrent glioblastoma (gbm) has attracted attention due to 8
Title,"""Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.""",https://pubmed.ncbi.nlm.nih.gov/20410057,treat,treated,supratentorial glioblastoma treated with radiotherapy: use of the radiation therapy
Abstract,"""Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.""",https://pubmed.ncbi.nlm.nih.gov/20410057,treat,treated,with supratentorial glioblastoma treated with radiotherapy and to determine prognostic factors for
Abstract,"""Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.""",https://pubmed.ncbi.nlm.nih.gov/20410057,treat,treated,of 108 glioblastoma patients treated with radiotherapy between january 1987 and december
Abstract,"""Sequencing and curation strategies for identifying candidate glioblastoma treatments.""",https://pubmed.ncbi.nlm.nih.gov/31023376,generate,generate,to analyze glioblastoma tumors and generate real-time potential treatment options
Abstract,"""Sequencing and curation strategies for identifying candidate glioblastoma treatments.""",https://pubmed.ncbi.nlm.nih.gov/31023376,perform,performed,patients with glioblastoma and performed tumor whole genome sequencing (wgs)
Abstract,"""Novel diagnostic and therapeutic approaches to malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/21607882,represent,represents,"patients with glioblastoma represents a particular challenge, with surgery followed by"
Abstract,"""Novel diagnostic and therapeutic approaches to malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/21607882,complete,completed,newly diagnosed glioblastoma have completed enrolment.
Title,"""Deep Penetrating and Sensitive Targeted Magnetic Particle Imaging and Photothermal Therapy of Early-Stage Glioblastoma Based on a Biomimetic Nanoplatform.""",https://pubmed.ncbi.nlm.nih.gov/37150856,base,based,-stage glioblastoma based on a biomimetic nanoplatform.
Abstract,"""Nanotechnology applications for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22748656,remain,remains,glioblastoma remains one of the most difficult cancers to treat
Title,"""Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study.""",https://pubmed.ncbi.nlm.nih.gov/37697237,stretch,stretched,"pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched"
Abstract,"""Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study.""",https://pubmed.ncbi.nlm.nih.gov/37697237,exhibit,exhibiting,pathologically confirmed glioblastoma exhibiting enhancing lesions after completion of chemoradiation therapy were
Title,"""Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.""",https://pubmed.ncbi.nlm.nih.gov/25605197,depend,depends,mutation in glioblastomas depends on idh1 mutation.
Abstract,"""Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.""",https://pubmed.ncbi.nlm.nih.gov/25605197,treat,treated,histologically confirmed glioblastomas treated with radiation therapy and chemotherapy were reviewed retrospectively
Abstract,"""Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.""",https://pubmed.ncbi.nlm.nih.gov/25605197,improve,improved,indicate that glioblastomas with mgmt methylation or tp53 mutations have improved survival
Abstract,"""Metronomic Photodynamic Therapy with Conjugated Polymer Nanoparticles in Glioblastoma Tumor Microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/37296661,overcome,overcome,proposed for glioblastoma (gbm) management to overcome conventional treatment issues
Title,"""Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/31232425,associate,associated,capacity in glioblastoma: a potentially actionable toxicity associated with reduced efficacy
Title,"""Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes.""",https://pubmed.ncbi.nlm.nih.gov/26459327,base,based,in recurrent glioblastoma in switzerland: a multicentre national approach based on
Abstract,"""Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes.""",https://pubmed.ncbi.nlm.nih.gov/26459327,have,having,for recurrent glioblastoma of eight neuro-oncology centres in switzerland having
Abstract,"""Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes.""",https://pubmed.ncbi.nlm.nih.gov/26459327,recommend,recommended,promoter methylated glioblastoma temozolomide was recommended by most.
Abstract,"""Identification of Potent VEGF Inhibitors for the Clinical Treatment of Glioblastoma, A Virtual Screening Approach.""",https://pubmed.ncbi.nlm.nih.gov/31554364,analyse,analysed,vegf in glioblastoma and positively can be further analysed through in vitro
Abstract,"""Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.""",https://pubmed.ncbi.nlm.nih.gov/33053763,reside,residing,glioblastoma (gbm) is aggressive malignant tumor residing within
Title,"""Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions.""",https://pubmed.ncbi.nlm.nih.gov/29759570,provide,provide,in recurrent glioblastoma: a comprehensive literature review to provide practical answers
Title,"""A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the Multi ELectrode Current Source (MECS) system.""",https://pubmed.ncbi.nlm.nih.gov/15277019,use,using,radiotherapy in glioblastoma multiforme using the multi electrode current source (mecs
Abstract,"""A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the Multi ELectrode Current Source (MECS) system.""",https://pubmed.ncbi.nlm.nih.gov/15277019,show,showed,"hyperthermia in glioblastoma multiforme showed a survival benefit for hyperthermia, though"
Abstract,"""A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the Multi ELectrode Current Source (MECS) system.""",https://pubmed.ncbi.nlm.nih.gov/15277019,treat,treated,with a glioblastoma multiforme were treated with interstitial hyperthermia using the multi
Title,"""Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/4348472,control,controlled,glioblastoma multiforme: a controlled trial to assess the value
Abstract,"""Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/4348472,treat,treated,patients with glioblastoma multiforme treated by radical surgery and post-operative
Title,"""Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/4348472,control,controlled,glioblastoma multiforme: a controlled trial to assess the value
Abstract,"""Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/4348472,treat,treated,patients with glioblastoma multiforme treated by radical surgery and post-operative
Abstract,"""[Fluorescence guided resection of malignant brain tumors - breakthrough in the surgery of brain tumors].""",https://pubmed.ncbi.nlm.nih.gov/19513974,represent,represents,the glioblastoma itself represents the most unfavorable tumor.
Abstract,"""[Fluorescence guided resection of malignant brain tumors - breakthrough in the surgery of brain tumors].""",https://pubmed.ncbi.nlm.nih.gov/19513974,challenge,challenging,removal of glioblastomas is challenging due to their infiltrative growth pattern.
Title,"""Phage display discovery of novel molecular targets in glioblastoma-initiating cells.""",https://pubmed.ncbi.nlm.nih.gov/24832468,initiate,initiating,targets in glioblastoma-initiating cells.
Abstract,"""Phage display discovery of novel molecular targets in glioblastoma-initiating cells.""",https://pubmed.ncbi.nlm.nih.gov/24832468,display,display,glioblastomas display cellular hierarchies with self-renewing glioma-
Abstract,"""Phage display discovery of novel molecular targets in glioblastoma-initiating cells.""",https://pubmed.ncbi.nlm.nih.gov/24832468,derive,derived,to a glioblastoma xenograft in vivo then derived gics.
Abstract,"""Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors.""",https://pubmed.ncbi.nlm.nih.gov/33281826,achieve,achieve,", including glioblastoma (gbm), researchers are yet to achieve"
Abstract,"""Oncolytic viral therapy for gliomas: Advances in the mechanisms and approaches to delivery.""",https://pubmed.ncbi.nlm.nih.gov/38442508,stand,stands,"aggressive is glioblastoma multiforme (gbm), which stands as the"
Abstract,"""Glioblastoma multiforme from diagnosis to death: a prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs.""",https://pubmed.ncbi.nlm.nih.gov/25135840,have,have,purpose: glioblastoma (gbm) patients have many palliative care (
Abstract,"""NIR-II absorptive dithienopyrrole-thiadiazolobenzotriazole conjugated polymer for photoacoustic imaging-guided glioblastoma multiforme photothermal therapy.""",https://pubmed.ncbi.nlm.nih.gov/36031034,improve,improve,methods for glioblastoma multiforme (gbm) is significant to improve patients
Abstract,"""The molecular basis for novel therapies.""",https://pubmed.ncbi.nlm.nih.gov/22290255,arrive,arrived,"therapy for glioblastoma has arrived, but results have been modest thus"
Abstract,"""The molecular basis for novel therapies.""",https://pubmed.ncbi.nlm.nih.gov/22290255,target,targeted,to treating glioblastoma with targeted therapy and delves into the complex signaling
Abstract,"""A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology.""",https://pubmed.ncbi.nlm.nih.gov/35580289,develop,develops,what sets glioblastoma apart from all other cancers is that it develops
Abstract,"""Current Combinatorial Therapeutic Aspects: The Future Prospect for Glioblastoma Treatment.""",https://pubmed.ncbi.nlm.nih.gov/39695017,discuss,discussed,for alternative glioblastoma therapy are also discussed.
Abstract,"""An overview of targets and therapies for glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/35900527,affect,affects,glioblastoma multiforme (gbm) affects individuals above 65 years
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,recognize,recognized,) in glioblastomas is recognized as an important treatment target.
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,use,using,"-mediated glioblastoma progression by using cell proliferation (3-(4,5-dimethylthiazol-2"
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,bear,bearing,", a glioblastoma-bearing animal model was used to validate the"
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,induce,induces,anti-glioblastoma drug which induces apoptosis and has the capacity to
Abstract,"""Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis.""",https://pubmed.ncbi.nlm.nih.gov/35200574,emerge,emerges,"patients suffering glioblastoma multiforme (gbm), but its impact emerges"
Abstract,"""Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies.""",https://pubmed.ncbi.nlm.nih.gov/33668856,identify,identified,"tumor, glioblastoma (gbm) in patients and identified novel immune"
Title,"""Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/26933808,reveal,reveals,cohort of glioblastomas reveals potential therapeutic strategies.
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,display,display,glioblastomas display variable phenotypes that include increased drug-resistance
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,chemotherapy,chemotherapy,to sensitize glioblastoma cells to chemotherapy.
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,inhibit,inhibit,"motility in glioblastomas, irrespective of their ability to inhibit tg2."
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,associate,associated,treatment of glioblastoma cells with erw1227b was associated with both down-
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,treat,treated,photography of glioblastoma cells treated with erw1227b showed cell death and rapid
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,demonstrate,demonstrated,in vivo glioblastoma models demonstrated the ability of erw1227b to sensitize tumor
Abstract,"""Combining Pr(3+)-Doped Nanoradiosensitizers and Endogenous Protoporphyrin IX for X-ray-Mediated Photodynamic Therapy of Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/37267436,enable,enabling,"resection of glioblastoma, enabling dual detection and treatment of malignant cells"
Abstract,"""A review of recent advances in magnetic nanoparticle-based theranostics of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35000429,make,making,"are some glioblastoma multiforme (gbm) characteristics, making it the"
Abstract,"""Actively personalized vaccination trial for newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30568303,benefit,benefit,patients with glioblastoma currently do not sufficiently benefit from recent breakthroughs in
Abstract,"""Actively personalized vaccination trial for newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30568303,contain,contain,cells4 in glioblastoma and these tumours contain only 30-50 non
Abstract,"""Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/20646863,treat,treated,patients with glioblastoma were treated by surgery and subsequent rcx (whole
Abstract,"""Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20.""",https://pubmed.ncbi.nlm.nih.gov/25602259,validate,validated,"prognosticator in glioblastomas, this effect being validated in an independent set"
Title,"""Glioblastoma therapy: going beyond Hercules Columns.""",https://pubmed.ncbi.nlm.nih.gov/20367204,go,going,glioblastoma therapy: going beyond hercules columns.
Abstract,"""Primary glioblastoma multiforme in younger patients: a single-institution experience.""",https://pubmed.ncbi.nlm.nih.gov/17168433,evaluate,evaluating,"with primary glioblastoma multiforme of young age by evaluating the characteristics,"
Abstract,"""Primary glioblastoma multiforme in younger patients: a single-institution experience.""",https://pubmed.ncbi.nlm.nih.gov/17168433,treat,treated,with primary glioblastoma multiforme (gbm) treated at our department between
Abstract,"""Machine Learning-Based Prediction of Early Recurrence in Glioblastoma Patients: A Glance Towards Precision Medicine.""",https://pubmed.ncbi.nlm.nih.gov/34459917,give,given,"patients with glioblastoma multiforme (gbm), given its dismal prognosis"
Title,"""Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.""",https://pubmed.ncbi.nlm.nih.gov/24516010,revisit,revisited,resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival
Abstract,"""Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.""",https://pubmed.ncbi.nlm.nih.gov/24516010,diagnose,diagnosed,"approximately 12,000 glioblastomas are diagnosed annually in the united states."
Abstract,"""Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.""",https://pubmed.ncbi.nlm.nih.gov/24516010,model,model,patients with glioblastoma (from 1993 to 2010) to model the
Title,"""Glioblastoma brain tumours: estimating the time from brain tumour initiation and resolution of a patient survival anomaly after similar treatment protocols.""",https://pubmed.ncbi.nlm.nih.gov/22882019,estimate,estimating,glioblastoma brain tumours: estimating the time from brain tumour
Abstract,"""Glioblastoma brain tumours: estimating the time from brain tumour initiation and resolution of a patient survival anomaly after similar treatment protocols.""",https://pubmed.ncbi.nlm.nih.gov/22882019,incorporate,incorporates,"model for glioblastomas (brain tumours), which incorporates the two"
Abstract,"""What next for newly diagnosed glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/26558493,identify,identified,alterations in glioblastoma has identified prognostic subgroups and therapeutic opportunities for clinical
Abstract,"""Effectiveness of radiotherapy for elderly patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20675068,remain,remains,"patients with glioblastoma remains controversial, as the relative benefit in this"
Abstract,"""Effectiveness of radiotherapy for elderly patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20675068,analyze,analyzed,"treatment of glioblastoma in the elderly, we analyzed factors influencing patient"
Abstract,"""Effectiveness of radiotherapy for elderly patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20675068,identify,identified,diagnosed with glioblastoma between 1993 and 2005 were identified from the surveillance
Abstract,"""Effectiveness of radiotherapy for elderly patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20675068,undergo,underwent,patients with glioblastoma who underwent radiotherapy had improved cancer-specific survival
Abstract,"""Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow.""",https://pubmed.ncbi.nlm.nih.gov/32860571,include,including,"of 5 glioblastomas and 5 grade ii or iii gliomas, including"
Abstract,"""Prognostic value of ALDH1A3 promoter methylation in gliob;astoma: a single center experience in Western China.""",https://pubmed.ncbi.nlm.nih.gov/25684492,remain,remains,of primary glioblastomas (gbms) in western china remains unclear.
Abstract,"""A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.""",https://pubmed.ncbi.nlm.nih.gov/23333005,have,have,: elderly glioblastoma multiforme (gbm) patients have a worse prognosis
Abstract,"""Cytotoxicity of ultraviolet-C radiation on a heterogeneous population of human glioblastoma multiforme cells: Meta-analysis.""",https://pubmed.ncbi.nlm.nih.gov/30308311,limit,limited,strategies for glioblastoma multiforme are limited due to early recurrence and heterogeneity
Abstract,"""Growth dynamics of untreated glioblastomas in vivo.""",https://pubmed.ncbi.nlm.nih.gov/25758748,reach,reach,assumption that glioblastomas reach a plateau phase and thus exhibit gompertzian growth
Abstract,"""Growth dynamics of untreated glioblastomas in vivo.""",https://pubmed.ncbi.nlm.nih.gov/25758748,show,shown,"rate of glioblastoma shown in this study, it is evident that"
Abstract,"""Targeted Therapies for the Treatment of Glioblastoma in Adults.""",https://pubmed.ncbi.nlm.nih.gov/31102038,remain,remain,"in glioblastoma, where therapeutic options remain scarce and prognosis poor"
Abstract,"""Targeted Therapies for the Treatment of Glioblastoma in Adults.""",https://pubmed.ncbi.nlm.nih.gov/31102038,fail,failed,patients with glioblastoma have largely failed.
Abstract,"""Targeted Therapies for the Treatment of Glioblastoma in Adults.""",https://pubmed.ncbi.nlm.nih.gov/31102038,prioritize,prioritized,patients with glioblastoma should be prioritized for clinical trial participation.
Abstract,"""[Radiotherapy of glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/9295873,appear,appear,glioblastoma cells appear to be inherently radioresistant and to present
Abstract,"""[Radiotherapy of glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/9295873,lead,leads,"patients with glioblastoma leads to an increase in the median survival,"
Abstract,"""Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.""",https://pubmed.ncbi.nlm.nih.gov/11121633,treat,treated,-ineligible glioblastoma multiforme (gbm) patients treated with tumor volume
Title,"""Identification of hypoxic macrophages in glioblastoma: Unveiling therapeutic insights from tumour microenvironment analysis.""",https://pubmed.ncbi.nlm.nih.gov/39297872,unveil,unveiling,macrophages in glioblastoma: unveiling therapeutic insights from tumour microenvironment analysis.
Abstract,"""Identification of hypoxic macrophages in glioblastoma: Unveiling therapeutic insights from tumour microenvironment analysis.""",https://pubmed.ncbi.nlm.nih.gov/39297872,propose,propose,"locations in glioblastomas, and propose future directions for studying the temporospatial"
Abstract,"""Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients older than 80 years.""",https://pubmed.ncbi.nlm.nih.gov/16724687,exclude,excluded,diagnosis of glioblastoma multiforme are thus generally excluded from clinical trials of
Abstract,"""Role of extent of resection on quality of life in patients with newly diagnosed GBM.""",https://pubmed.ncbi.nlm.nih.gov/29371739,know,known,glioblastomas known for their adverse outcomes are most reportedly managed
Abstract,"""Neutron Capture Enhances Dose and Reduces Cancer Cell Viability in and out of Beam During Helium and Carbon Ion Therapy.""",https://pubmed.ncbi.nlm.nih.gov/38479560,irradiate,irradiated,: human glioblastoma cells (t98g) were irradiated by carbon
Title,"""Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy.""",https://pubmed.ncbi.nlm.nih.gov/39091260,use,using,in recurrent glioblastoma using nanotherapy.
Abstract,"""Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy.""",https://pubmed.ncbi.nlm.nih.gov/39091260,impact,impacts,nature of glioblastoma negatively impacts conventional treatment strategies leading to a growing
Title,"""Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports.""",https://pubmed.ncbi.nlm.nih.gov/22198964,treat,treated,reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide:
Abstract,"""Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports.""",https://pubmed.ncbi.nlm.nih.gov/22198964,undergo,underwent,two glioblastoma multiforme patients underwent (18)f-fmiso (fluoromisonidazole
Abstract,"""Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports.""",https://pubmed.ncbi.nlm.nih.gov/22198964,treat,treated,status in glioblastoma multiforme treated through radiation therapy with temozolomide.
Abstract,"""Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17993634,need,needed,patients with glioblastoma are needed because such studies differ importantly from trials
Abstract,"""Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17993634,treat,treated,newly diagnosed glioblastoma who were treated consecutively at a single institution over
Abstract,"""Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17993634,withhold,withheld,"patients with glioblastoma, and these treatments should not be withheld because"
Abstract,"""Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.""",https://pubmed.ncbi.nlm.nih.gov/32328653,discuss,discussed,idhwt) glioblastomas will be discussed.
Title,"""Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/39160236,derive,derived,"human glioblastoma-derived cell membrane nanovesicles: a novel,"
Abstract,"""MicroRNA-Based Drugs for Brain Tumors.""",https://pubmed.ncbi.nlm.nih.gov/29506672,provide,provides,"focus on glioblastoma (gbm), this review provides an up"
Abstract,"""Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/32210117,induce,induced,in human glioblastomas was induced.
Abstract,"""Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/32210117,select,selected,-r9 glioblastoma cells were selected and prepared from human drug-
Abstract,"""Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/32210117,augment,augmented,-tolerant glioblastoma cells were augmented following honokiol administration.
Abstract,"""Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/32210117,induce,induced,-resistant glioblastoma cells with honokiol induced cell apoptosis but did not
Abstract,"""Exophytic giant cell glioblastoma of the medulla oblongata.""",https://pubmed.ncbi.nlm.nih.gov/19061354,associate,associated,giant cell glioblastoma may be associated with a better prognosis than the
Abstract,"""Exophytic giant cell glioblastoma of the medulla oblongata.""",https://pubmed.ncbi.nlm.nih.gov/19061354,occur,occur,giant cell glioblastoma may occur at various sites in the brain and
Title,"""Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/32748120,treat,treated,-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide
Abstract,"""Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/32748120,treat,treated,-wildtype glioblastoma patients treated between 2013 and 2017 with open resection
Abstract,"""New frontiers for astrocytic tumours.""",https://pubmed.ncbi.nlm.nih.gov/22753735,remain,remain,"genetics of glioblastoma multiforme, but clinically effective treatments remain elusive."
Abstract,"""Multiphoton imaging reveals that nanosecond pulsed electric fields collapse tumor and normal vascular perfusion in human glioblastoma xenografts.""",https://pubmed.ncbi.nlm.nih.gov/27698479,exist,existing,cancers including glioblastoma are still resistant to existing therapies leaving patients with
Abstract,"""Multiphoton imaging reveals that nanosecond pulsed electric fields collapse tumor and normal vascular perfusion in human glioblastoma xenografts.""",https://pubmed.ncbi.nlm.nih.gov/27698479,apply,apply,model of glioblastoma and apply intravital multiphoton microscopy to assess their response
Abstract,"""Megavoltage therapy of glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/211810,compare,compared,treatment of glioblastoma multiforme as compared to orthovolt therapy.
Title,"""Using the molecular classification of glioblastoma to inform personalized treatment.""",https://pubmed.ncbi.nlm.nih.gov/24114756,inform,inform,classification of glioblastoma to inform personalized treatment.
Abstract,"""'Security dilemma': active immunotherapy before versus after radiation therapy alone or chemo-radiotherapy for newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35851769,increase,increase,management of glioblastoma should be aggressive and personalised to increase the quality
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,treat,treated,grade iv glioblastoma treated between 1993 and 1997.
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,find,found,secondary glioblastomas were found in only 4% of the standard
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,show,show,primary glioblastomas typically show egfr over expression and mutation (variant
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,involve,involves,to secondary glioblastoma involves early p53 mutation.
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,evolve,evolve,subtypes of glioblastomas are distinct disease entities which evolve through different genetic
Title,"""Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/27693246,treat,treated,factor in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
Abstract,"""Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/27693246,include,includes,"newly diagnosed glioblastoma (gbm) includes surgery, radiotherapy, and"
Abstract,"""Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32206976,include,includes,care for glioblastoma includes concurrent chemoradiation and maintenance temozolomide with tumor treatment
Abstract,"""Glioblastoma and brain connectivity: the need for a paradigm shift.""",https://pubmed.ncbi.nlm.nih.gov/38876751,remain,remains,patients with glioblastoma prognosis remains bleak.
Abstract,"""Glioblastoma and brain connectivity: the need for a paradigm shift.""",https://pubmed.ncbi.nlm.nih.gov/38876751,encompass,encompassing,"interplays between glioblastoma and the cellular architecture of the brain, encompassing"
Abstract,"""Glioblastoma and brain connectivity: the need for a paradigm shift.""",https://pubmed.ncbi.nlm.nih.gov/38876751,reveal,revealing,"of a glioblastoma, and a patient's overall survival, revealing"
Abstract,"""Glioblastoma and brain connectivity: the need for a paradigm shift.""",https://pubmed.ncbi.nlm.nih.gov/38876751,unveil,unveil,"treatment of glioblastomas, which could unveil new prognostic factors and surgical"
Abstract,"""Multiparametric MRI-guided Hypofractionated Intensity-modulated Radiation Therapy With Simultaneous Integrated Boost for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34969741,use,using,sib for glioblastoma using three mri sequences: double inversion recovery (
Title,"""Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.""",https://pubmed.ncbi.nlm.nih.gov/37830597,modify,modified,vivo primary glioblastoma tumors to oncolytic effect of modified zika virus.
Abstract,"""Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.""",https://pubmed.ncbi.nlm.nih.gov/28298023,remain,remains,"treatment for glioblastoma (gbm) remains largely unsuccessful, even with"
Abstract,"""Malignant transformation of a conservatively managed incidental childhood cerebral mass lesion: controversy regarding management paradigm.""",https://pubmed.ncbi.nlm.nih.gov/28808787,grade,grade,"surprisingly, glioblastoma multiforme (who grade iv, braf v-600e mutation"
Abstract,"""Physical approaches to treat glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32925205,have,have,review: glioblastoma (gbm) patients have a poor prognosis despite
Abstract,"""Treatment of elderly patients with glioblastoma: from clinical evidence to molecular highlights.""",https://pubmed.ncbi.nlm.nih.gov/22289687,characterize,characterized,patients with glioblastoma are characterized by a high rate of associated morbidities
Abstract,"""Immunohistochemical markers for prognosis of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12187957,test,tested,markers for glioblastomas has been broadly tested but the results obtained are
Abstract,"""Immunohistochemical markers for prognosis of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12187957,study,studied,", 302 glioblastoma specimens were studied to evaluate a possible association between"
Abstract,"""Immunohistochemical markers for prognosis of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12187957,appear,appear,"significant for glioblastoma outcome, they appear to be closely related to"
Abstract,"""Immunohistochemical markers for prognosis of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12187957,propose,proposed,", the glioblastoma subdivision on three cytological subsets proposed by us is"
Abstract,"""Chemotherapy increases amenability of surgical resection in congenital glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22816875,hamper,hampered,of congenital glioblastoma whose initial surgery was hampered by tumor hypervascularity and
Title,"""Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).""",https://pubmed.ncbi.nlm.nih.gov/16826359,treat,treated,human glioblastoma and carcinoma xenograft tumors treated by combined radiation and
Abstract,"""Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).""",https://pubmed.ncbi.nlm.nih.gov/16826359,reduce,reduced,and the glioblastoma models at reduced microvessel densities.
Abstract,"""Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study.""",https://pubmed.ncbi.nlm.nih.gov/8727138,receive,receive,patients with glioblastomas who receive at least twice weekly poly-iclc
Abstract,"""Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study.""",https://pubmed.ncbi.nlm.nih.gov/8727138,suggest,suggests,astrocytomas and glioblastomas suggests that more extensive laboratory and controlled clinical studies
Title,"""Histopathological investigation of glioblastomas resected under bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/27244880,resect,resected,investigation of glioblastomas resected under bevacizumab treatment.
Abstract,"""Histopathological investigation of glioblastomas resected under bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/27244880,resect,resected,collected six glioblastomas resected under bevacizumab treatment.
Abstract,"""Histopathological investigation of glioblastomas resected under bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/27244880,assess,assess,"eleven control glioblastomas to assess the differences in histological features, microvessel"
Abstract,"""Short-course hypofractionated proton beam therapy, incorporating (18)F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial.""",https://pubmed.ncbi.nlm.nih.gov/39571596,have,have,) with glioblastoma have a worse prognosis than younger patients and a
Title,"""Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.""",https://pubmed.ncbi.nlm.nih.gov/11088567,follow,following,in human glioblastomas following administration of na2b12h11sh.
Abstract,"""Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.""",https://pubmed.ncbi.nlm.nih.gov/11088567,administer,administered,analyzed human glioblastoma tissue from two patients administered and one not administered
Title,"""Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152.""",https://pubmed.ncbi.nlm.nih.gov/27490930,target,targeting,expression in glioblastomas and their in vitro and in vivo targeting by
Abstract,"""Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience.""",https://pubmed.ncbi.nlm.nih.gov/28454549,diagnose,diagnosed,background: glioblastoma is usually diagnosed around the age of 60-
Abstract,"""Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience.""",https://pubmed.ncbi.nlm.nih.gov/28454549,treat,treated,of elderly glioblastoma patients treated at our facility.
Abstract,"""Signaling Pathways in the Relapse of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36961958,accord,according,diagnosis of glioblastoma according to louis criteria and focused on signaling pathways
Title,"""Untangling the web of glioblastoma treatment resistance using a multi-omic and multidisciplinary approach.""",https://pubmed.ncbi.nlm.nih.gov/37330006,use,using,web of glioblastoma treatment resistance using a multi-omic and multidisciplinary
Abstract,"""Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22926763,evaluate,evaluated,biomarkers in glioblastomas was evaluated.
Abstract,"""Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22926763,overexpresse,overexpressed,") of glioblastomas, while cd151 was rarely overexpressed in most of"
Abstract,"""Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34578259,lack,lacking,glioblastoma is a lethal primary brain tumor lacking effective therapy
Abstract,"""Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34578259,spread,spread,retargeted to glioblastoma cells and able to spread across the tumor cells
Abstract,"""Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34578259,increase,increased,expressing human glioblastoma significantly increased the median survival time of mice.
Abstract,"""Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34578259,monitor,monitored,of human glioblastoma xenotransplants was monitored by a secreted luciferase reporter and
Abstract,"""Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34578259,appear,appeared,"-established glioblastomas, r-613 appeared to be less effective."
Abstract,"""DNA repair mechanisms and their clinical impact in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27543314,remain,remains,"temozolomide, glioblastoma remains one of the most lethal cancers, due"
Abstract,"""DNA repair mechanisms and their clinical impact in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27543314,discuss,discuss,"makeup of glioblastoma cells, and discuss their potential therapeutic impact and"
Abstract,"""Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19330482,treat,treated,diagnoses of glioblastoma (gbm) that were treated with srs over
Abstract,"""Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/23142818,shed,shed,"glioblastomas shed large quantities of small, membrane-bound"
Abstract,"""[Malignant brain tumors after radiation - glioblastomas after operation and radiation of meningiomas - 2 case reports].""",https://pubmed.ncbi.nlm.nih.gov/11786936,describe,described,development of glioblastomas is described as a rare complication in the literature
Abstract,"""Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial.""",https://pubmed.ncbi.nlm.nih.gov/34850166,report,reported,in recurrent glioblastoma (rgbm) was reported to show tumor infiltration
